DNA O
elements O
recognizing O
NF B
- I
Y I
and O
Sp1 B
regulate O
the O
human B
multidrug I
- I
resistance I
gene I
promoter I
. O

Id B
- I
1H I
and O
Id B
- I
2H I
seem O
to O
be O
human O
homologues O
of O
mouse B
Id I
- I
1 I
and O
Id B
- I
2 I
, O
respectively O
, O
and O
have O
potential O
to O
encode O
154 O
and O
135 O
amino O
acid O
proteins O
. O

Id B
- I
1H I
and O
Id B
- I
2H I
seem O
to O
be O
human O
homologues O
of O
mouse B
Id I
- I
1 I
and O
Id B
- I
2 I
, O
respectively O
, O
and O
have O
potential O
to O
encode O
154 O
and O
135 O
amino O
acid O
proteins O
. O

Id B
- I
1H I
and O
Id B
- I
2H I
seem O
to O
be O
human O
homologues O
of O
mouse B
Id I
- I
1 I
and O
Id B
- I
2 I
, O
respectively O
, O
and O
have O
potential O
to O
encode O
154 O
and O
135 O
amino O
acid O
proteins O
. O

Characterization O
of O
insertion O
mutations O
in O
the O
Saccharomyces B
cerevisiae I
MSH1 I
and O
MSH2 B
genes I
: O
evidence O
for O
separate O
mitochondrial O
and O
nuclear O
functions O
. O

A O
GT O
- O
rich O
sequence O
binding O
the O
transcription B
factor I
Sp1 I
is O
crucial O
for O
high O
expression O
of O
the O
human B
type I
VII I
collagen I
gene I
( O
COL7A1 B
) O
in O
fibroblasts O
and O
keratinocytes O
. O

The O
XPR2 B
gene I
from O
Yarrowia O
lipolytica O
encodes O
an O
inducible O
alkaline B
extracellular I
protease I
. O

Like O
other O
IAPs B
, O
ch B
- I
IAP1 I
contains O
the O
N B
- I
terminal I
baculovirus I
IAP I
repeats I
and O
C O
- O
terminal O
RING O
finger O
motifs O
. O

Interestingly O
, O
basal O
MAPK B
, O
but O
not O
Raf B
- I
1 I
, O
activity O
was O
constitutively O
enhanced O
in O
Jak1 B
- O
deficient O
HeLa O
cells O
. O

Thus O
, O
primate O
vs O
. O
rodent O
promoter O
selectivity O
mediated O
by O
the O
TBP B
- O
TAFI B
complex O
is O
likely O
to O
be O
the O
result O
of O
cumulative O
subtle O
differences O
between O
individual O
subunits O
that O
lead O
to O
species O
- O
specific O
properties O
of O
RNA B
polymerase I
I I
transcription O
. O

Synergy O
between O
interferon B
- I
gamma I
and O
tumor B
necrosis I
factor I
- I
alpha I
in O
transcriptional O
activation O
is O
mediated O
by O
cooperation O
between O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
and O
nuclear B
factor I
kappaB I
. O

Synergy O
between O
interferon B
- I
gamma I
and O
tumor B
necrosis I
factor I
- I
alpha I
in O
transcriptional O
activation O
is O
mediated O
by O
cooperation O
between O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
and O
nuclear B
factor I
kappaB I
. O

A O
cDNA O
for O
human B
microfibril I
- I
associated I
glycoprotein I
- I
2 I
( O
MAGP B
- I
2 I
) O
was O
used O
to O
screen O
a O
human O
leukocyte O
genomic O
DNA O
library O
in O
EMBL O
- O
3 O
vector O
. O

A O
Meis1 B
cDNA I
clone O
that O
encoded O
a O
novel O
member O
of O
the O
homeobox B
gene I
family I
was O
identified O
. O

The O
levels O
of O
soluble O
L B
- I
selectin I
and O
ICAM B
- I
1 I
in O
the O
serum O
were O
determined O
by O
the O
ELISA O
method O
. O

The O
levels O
of O
soluble O
L B
- I
selectin I
and O
ICAM B
- I
1 I
in O
the O
serum O
were O
determined O
by O
the O
ELISA O
method O
. O

Comparison O
to O
the O
murine O
homologues O
of O
these O
molecules O
reveals O
a O
high O
degree O
of O
conservation O
between O
the O
products O
of O
one O
of O
these O
genes O
, O
Fc B
gamma I
RIIb I
, O
and O
the O
murine B
beta I
gene I
in O
primary O
sequence O
, O
splicing O
pattern O
, O
and O
tissue O
distribution O
. O

Comparison O
to O
the O
murine O
homologues O
of O
these O
molecules O
reveals O
a O
high O
degree O
of O
conservation O
between O
the O
products O
of O
one O
of O
these O
genes O
, O
Fc B
gamma I
RIIb I
, O
and O
the O
murine B
beta I
gene I
in O
primary O
sequence O
, O
splicing O
pattern O
, O
and O
tissue O
distribution O
. O

The O
results O
of O
the O
transient O
- O
transfection O
assay O
showed O
that O
the O
Sp1 B
binding I
element I
located O
in O
the O
core O
region O
( O
positions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpha2 B
- I
integrin I
promoter I
plays O
an O
essential O
role O
in O
the O
alpha2 B
- I
integrin I
promoter I
activity O
and O
its O
downregulation O
by O
Erb B
- O
B2 B
. O

To O
test O
this O
hypothesis O
, O
we O
developed O
a O
system O
of O
transient O
transfection O
of O
rat O
adipocytes O
with O
constructs O
containing O
glyceraldehyde B
- I
3 I
- I
phosphate I
dehydrogenase I
( O
GAPDH B
) O
and O
fatty B
acid I
synthetase I
( O
FAS B
) O
promoters O
fused O
to O
gene B
reporter I
CAT I
. O

To O
test O
this O
hypothesis O
, O
we O
developed O
a O
system O
of O
transient O
transfection O
of O
rat O
adipocytes O
with O
constructs O
containing O
glyceraldehyde B
- I
3 I
- I
phosphate I
dehydrogenase I
( O
GAPDH B
) O
and O
fatty B
acid I
synthetase I
( O
FAS B
) O
promoters O
fused O
to O
gene B
reporter I
CAT I
. O

They O
are O
growth O
- O
inhibited O
by O
TGF B
- I
beta1 I
. O

To O
investigate O
the O
in O
vivo O
role O
of O
this O
chimeric B
bZIP I
protein I
in O
oncogenic O
transformation O
, O
its O
expression O
was O
directed O
to O
the O
lymphoid O
compartments O
of O
transgenic O
mice O
. O

LT B
- I
beta I
transcription O
is O
maximal O
in O
the O
thymic O
medulla O
and O
in O
splenic O
white O
pulp O
. O

We O
report O
that O
Nim1 B
possesses O
intrinsic O
serine B
- I
kinase I
, O
threonine B
- I
kinase I
and O
tyrosine B
- I
kinase I
activities O
. O

We O
report O
that O
Nim1 B
possesses O
intrinsic O
serine B
- I
kinase I
, O
threonine B
- I
kinase I
and O
tyrosine B
- I
kinase I
activities O
. O

We O
report O
that O
Nim1 B
possesses O
intrinsic O
serine B
- I
kinase I
, O
threonine B
- I
kinase I
and O
tyrosine B
- I
kinase I
activities O
. O

BACKGROUND O
- O
- O
Platelet B
activating I
factor I
( O
PAF B
) O
has O
been O
implicated O
in O
the O
pathogenesis O
of O
airway O
hyperresponsiveness O
in O
asthma O
. O

The O
effect O
on O
FIV B
LTR I
promoter I
activity O
of O
progressively O
deleting O
these O
nuclear O
factor O
binding O
sites O
was O
examined O
by O
linking O
LTR O
deletion O
mutants O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
gene O
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

We O
have O
previously O
shown O
that O
UNC B
- I
4 I
expression O
in O
the O
VA O
motor O
neurons O
specifies O
the O
wild O
- O
type O
pattern O
of O
presynaptic O
input O
. O

It O
has O
become O
clear O
that O
there O
is O
not O
one O
mediator O
responsible O
for O
ALI O
, O
but O
rather O
a O
complex O
interplay O
exists O
between O
diverse O
proinflammatory O
( O
e O
. O
g O
. O
, O
lipopolysaccharide O
, O
complement O
products O
, O
cytocains O
, O
chemocains O
, O
reactive O
oxygen O
species O
and O
arachidonic O
acid O
products O
) O
and O
anti O
- O
inflammatory O
( O
IL B
- I
10 I
, O
IL B
- I
1 I
- I
RA I
, O
PGI2 O
) O
mediators O
. O

The O
unc B
- I
101 I
, O
sli B
- I
1 I
, O
and O
rok B
- I
1 I
genes I
encode O
a O
distinct O
set O
of O
negative O
regulators O
of O
vulval O
differentiation O
. O

The O
unc B
- I
101 I
, O
sli B
- I
1 I
, O
and O
rok B
- I
1 I
genes I
encode O
a O
distinct O
set O
of O
negative O
regulators O
of O
vulval O
differentiation O
. O

SYC1 B
( O
suppressor B
of I
yeast I
cbf5 I
- I
1 I
) O
was O
identified O
as O
a O
multicopy O
suppressor O
of O
cbf5 B
- I
1 I
and O
subsequently O
was O
found O
to O
be O
identical O
to O
RRN3 B
, O
an O
RNA B
polymerase I
I I
transcription I
factor I
. O

RESULTS O
: O
BMK B
- I
1 I
and O
other O
19 O
contents O
significantly O
decreased O
depolarization O
parameters O
Vmax O
, O
APA O
, O
OS O
, O
and O
MDP O
, O
which O
was O
similar O
to O
that O
of O
TTX B
and O
different O
from O
that O
of O
Nim O
and O
BaCl2 O
. O

This O
enzyme O
is O
distinct O
from O
other O
known O
E3s B
, O
including O
E3 B
alpha I
/ O
UBR1 B
, O
E3 B
beta I
, O
and O
E6 B
- I
AP I
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

At O
least O
one O
such O
complex O
is O
eliminated O
by O
preincubating O
the O
nuclear O
extract O
with O
an O
antibody O
with O
broad O
cross O
- O
reactivity O
with O
Ets B
- I
1 I
and O
Ets B
- I
2 I
proteins I
, O
thus O
confirming O
that O
an O
ETS B
transcription I
factor I
( I
s I
) I
recognizes O
the O
- O
12 O
motif O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

These O
data O
may O
indicate O
redundancy O
between O
members O
of O
the O
NGFI B
- I
B I
/ O
Nurr1 B
/ O
Nor1 B
subfamily O
and O
could O
explain O
why O
no O
phenotypic O
disturbances O
have O
yet O
been O
found O
in O
mice O
in O
which O
the O
NGFI B
- I
B I
gene I
has O
been O
inactivated O
. O

These O
results O
indicate O
that O
H B
- I
2RIIBP I
( O
i O
) O
is O
a O
member O
of O
the O
superfamily O
of O
nuclear B
hormone I
receptors I
and O
( O
ii O
) O
may O
regulate O
not O
only O
MHC B
class I
I I
genes I
but O
also O
genes O
containing O
the O
ERE O
and O
related O
sequences O
. O

These O
results O
indicate O
that O
H B
- I
2RIIBP I
( O
i O
) O
is O
a O
member O
of O
the O
superfamily O
of O
nuclear B
hormone I
receptors I
and O
( O
ii O
) O
may O
regulate O
not O
only O
MHC B
class I
I I
genes I
but O
also O
genes O
containing O
the O
ERE O
and O
related O
sequences O
. O

The O
Aspergillus B
uvsH I
gene I
encodes O
a O
product O
homologous O
to O
yeast B
RAD18 I
and O
Neurospora B
UVS I
- I
2 I
. O

Transcription O
analysis O
of O
the O
EcoRI B
D I
region I
of O
the O
baculovirus O
Autographa O
californica O
nuclear O
polyhedrosis O
virus O
identifies O
an O
early O
4 O
- O
kilobase O
RNA O
encoding O
the O
essential O
p143 B
gene I
. O

Soggy B
, O
a O
spermatocyte O
- O
specific O
gene O
, O
lies O
3 O
. O
8 O
kb O
upstream O
of O
and O
antipodal O
to O
TEAD B
- I
2 I
, O
a O
transcription O
factor O
expressed O
at O
the O
beginning O
of O
mouse O
development O
. O

The O
Ras B
GTPase I
- I
activating I
- I
protein I
- I
related I
human I
protein I
IQGAP2 B
harbors O
a O
potential O
actin B
binding I
domain I
and O
interacts O
with O
calmodulin B
and O
Rho B
family I
GTPases I
. O

The O
Ras B
GTPase I
- I
activating I
- I
protein I
- I
related I
human I
protein I
IQGAP2 B
harbors O
a O
potential O
actin B
binding I
domain I
and O
interacts O
with O
calmodulin B
and O
Rho B
family I
GTPases I
. O

The O
adoption O
of O
a O
twisted O
structure O
of O
importin B
- I
beta I
is O
essential O
for O
the O
protein O
- O
protein O
interaction O
required O
for O
nuclear O
transport O
. O

Moreover O
, O
a O
hybrid O
protein O
composed O
of O
a O
PvALF B
activation I
domain I
and O
the O
DNA O
binding O
and O
dimerization O
domain O
of O
ROM2 B
activated O
gene O
expression O
, O
indicating O
that O
ROM2 B
recognizes O
the O
DLEC2 B
enhancer I
in O
vivo O
; O
consequently O
, O
ROM2 B
functions O
as O
a O
DNA O
binding O
site O
- O
dependent O
repressor O
. O

In O
transient O
transfections O
using O
luciferase B
reporter I
genes I
driven O
by O
1 O
kb O
of O
the O
5 O
' O
flanking O
DNA O
of O
the O
three O
CALM B
genes I
, O
the O
promoter O
activity O
correlated O
with O
the O
endogenous B
CALM I
transcriptional O
activity O
, O
but O
only O
when O
the O
5 O
' O
untranslated O
regions O
were O
included O
in O
the O
constructs O
. O

Both O
viruses O
express O
the O
mil B
/ O
raf B
oncogene O
product O
as O
a O
gag B
- I
fusion I
polyprotein O
, O
while O
the O
myc B
oncogene O
of O
MH2 O
is O
expressed O
via O
a O
subgenomic O
mRNA O
. O

Recombinant O
protein O
encoded O
by O
ESX B
( O
for O
epithelial B
- I
restricted I
with I
serine I
box I
) O
exhibits O
Ets B
- I
like I
DNA O
binding O
specificity O
in O
electrophoretic O
mobility O
shift O
assays O
and O
, O
in O
transient O
transfection O
assays O
, O
transactivates O
Ets B
- I
responsive I
promoter I
elements I
including O
that O
found O
in O
the O
HER2 B
/ O
neu B
oncogene O
. O

Non O
- O
finger O
- O
coding O
modules O
conserved O
among O
members O
of O
subfamilies O
of O
zinc B
finger I
genes I
have O
been O
described O
in O
the O
murine O
genome O
( O
finger O
- O
associated O
boxes O
, O
or O
FAX O
domain O
) O
and O
the O
human O
genome O
( O
Kruppel B
- I
associated I
boxes I
, O
or O
KRAB B
domain I
) O
. O

Therefore O
, O
a O
structural O
interaction O
between O
PsaL B
and O
PsaI B
may O
stabilize O
the O
association O
of O
PsaL B
with O
the O
photosystem B
I I
core I
. O

Negative O
modulation O
of O
alpha1 B
( I
I I
) I
procollagen I
gene I
expression O
in O
human O
skin O
fibroblasts O
: O
transcriptional O
inhibition O
by O
interferon B
- I
gamma I
. O

On O
the O
basis O
of O
this O
homology O
, O
we O
examined O
the O
potential O
role O
of O
c B
- I
Rel I
in O
controlling O
IL B
- I
2R I
alpha I
transcription O
. O

Together O
with O
previous O
work O
our O
results O
suggest O
that O
C B
/ I
EBP I
may O
be O
a O
general O
cooperation O
partner O
for O
v B
- I
Myb I
in O
myelomonocytic O
cells O
. O

Together O
with O
previous O
work O
our O
results O
suggest O
that O
C B
/ I
EBP I
may O
be O
a O
general O
cooperation O
partner O
for O
v B
- I
Myb I
in O
myelomonocytic O
cells O
. O

Fig1p B
and O
Fig2p B
are O
likely O
to O
act O
at O
the O
cell O
surface O
as O
Fig1 B
: O
: O
beta B
- I
gal I
and O
Fig2 B
: O
: O
beta B
- I
gal I
fusion I
proteins I
localize O
to O
the O
periphery O
of O
mating O
cells O
. O

Clinical O
development O
of O
interleukin B
- I
10 I
. O

To O
identify O
the O
GRK6 B
homologue I
on O
chromsome O
13 O
, O
several O
sets O
of O
closely O
- O
spaced O
primers O
were O
designed O
based O
on O
the O
GRK6 B
cDNA I
sequence I
and O
then O
used O
to O
amplify O
human O
genomic O
DNA O
by O
PCR O
. O

DSS4 B
- I
1 I
is O
a O
dominant O
suppressor O
of O
sec4 B
- I
8 I
that O
encodes O
a O
nucleotide O
exchange O
protein O
that O
aids O
Sec4p B
function O
. O

DSS4 B
- I
1 I
is O
a O
dominant O
suppressor O
of O
sec4 B
- I
8 I
that O
encodes O
a O
nucleotide O
exchange O
protein O
that O
aids O
Sec4p B
function O
. O

The O
vaccine O
was O
highly O
immunogenic O
, O
since O
111 O
of O
113 O
patients O
( O
98 O
% O
) O
produced O
anti B
- I
HBs I
( O
10 O
mIU O
/ O
ml O
or O
more O
) O
. O

NER O
was O
also O
measured O
by O
a O
plasmid O
host O
cell O
re O
- O
activation O
assay O
using O
a O
vector O
containing O
a O
luciferase B
reporter I
gene I
. O

In O
the O
fungus O
Neurospora O
crassa O
, O
nit B
- I
2 I
, O
the O
major O
nitrogen O
regulatory O
gene O
, O
activates O
the O
expression O
of O
unlinked O
structural O
genes O
that O
specify O
nitrogen O
- O
catabolic O
enzymes O
during O
conditions O
of O
nitrogen O
limitation O
. O

Using O
green B
fluorescent I
protein I
fusions O
we O
demonstrate O
that O
the O
SYT B
, O
SSX B
and O
the O
SYT B
- O
SSX B
proteins O
are O
nuclear O
proteins O
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

We O
found O
4 O
highly O
conserved O
regions O
to O
vertebrate B
Hsp90 I
exclusively O
and O
27 O
amino O
acids O
conserved O
among O
but O
differing O
between O
Hsp90 B
alpha I
and O
Hsp90 B
beta I
sequences I
. O

The O
library O
will O
thus O
be O
useful O
for O
the O
selection O
of O
cosmid O
clones O
which O
carry O
CDC B
genes I
from I
yeast I
by O
complementing O
first O
, O
with O
the O
vectorial O
yeast B
gene I
URA1 I
, O
the O
pyrimidine O
auxotrophy O
of O
most O
cdc B
- O
strains O
and O
then O
, O
with O
the O
respective O
CDC B
wild I
- I
type I
genes I
, O
of O
the O
temperature O
- O
sensitive O
mutant O
alleles O
. O

The O
electron O
spin O
resonance O
study O
also O
demonstrated O
that O
the O
formation O
of O
superoxide O
- O
DMPO O
spin O
adduct O
was O
strongly O
inhibited O
by O
a O
selective O
cyclooxygenase B
- I
2 I
inhibitor O
, O
etodolac O
, O
in O
a O
concentration O
- O
dependent O
manner O
. O

Here O
we O
describe O
the O
characterization O
of O
cDNAs O
encoding O
two O
unusual O
E2Fs B
, O
E2F B
- I
4 I
and O
E2F B
- I
5 I
, O
each O
identified O
by O
the O
ability O
of O
their O
gene O
product O
to O
interact O
with O
p130 B
in O
a O
yeast O
two O
- O
hybrid O
system O
. O

Here O
we O
describe O
the O
characterization O
of O
cDNAs O
encoding O
two O
unusual O
E2Fs B
, O
E2F B
- I
4 I
and O
E2F B
- I
5 I
, O
each O
identified O
by O
the O
ability O
of O
their O
gene O
product O
to O
interact O
with O
p130 B
in O
a O
yeast O
two O
- O
hybrid O
system O
. O

Tumor B
necrosis I
factor I
levels O
were O
measured O
by O
enzyme O
- O
linked O
immunoabsorbent O
assay O
in O
plasma O
samples O
obtained O
from O
the O
hyperthermic O
isolated O
limb O
perfusion O
circuit O
and O
systemic O
circulation O
. O

The O
recombinant O
containing O
the O
full O
- O
length O
polyhedrin B
leader O
sequence O
gave O
levels O
of O
N B
mRNA I
comparable O
to O
those O
of O
AcNPV B
polyhedrin I
mRNA I
. O

Thus O
, O
CARP B
is O
a O
YB B
- I
1 I
associated I
factor I
and O
represents O
the O
first O
identified O
cardiac O
- O
restricted O
downstream O
regulatory O
gene O
in O
the O
homeobox O
gene O
Nkx2 B
- I
5 I
pathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF B
- I
1 I
- O
dependent O
pathways O
for O
ventricular O
muscle O
gene O
expression O
. O

Thus O
, O
CARP B
is O
a O
YB B
- I
1 I
associated I
factor I
and O
represents O
the O
first O
identified O
cardiac O
- O
restricted O
downstream O
regulatory O
gene O
in O
the O
homeobox O
gene O
Nkx2 B
- I
5 I
pathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF B
- I
1 I
- O
dependent O
pathways O
for O
ventricular O
muscle O
gene O
expression O
. O

Transforming B
growth I
factor I
- I
beta I
( O
TGF B
- I
beta I
) O
inhibits O
cell O
cycle O
progression O
, O
in O
part O
through O
up O
- O
regulation O
of O
gene O
expression O
of O
the O
p21 B
( O
WAF1 B
/ O
Cip1 B
) O
( O
p21 B
) O
cell O
cycle O
inhibitor O
. O

7 O
- O
Nitroindazole O
( O
7NI O
) O
, O
a O
relatively O
selective O
neuronal O
nitric B
oxide I
synthase I
( O
nNOS B
) O
inhibitor O
. O
was O
intraperitoneally O
administered O
to O
the O
guinea O
pigs O
30 O
minutes O
before O
the O
onset O
of O
local O
anoxia O
. O

In O
vitro O
death O
assays O
with O
transient O
overexpression O
of O
deletion O
constructs O
of O
both O
isoforms O
using O
beta B
- I
galactosidase I
as O
a O
reporter O
gene O
in O
MCF7 O
cells O
suggest O
the O
following O
: O
1 O
) O
the O
nucleotide O
binding O
domain O
may O
act O
as O
a O
negative O
regulator O
of O
the O
killing O
activity O
of O
DEFCAP B
; O
2 O
) O
the O
LRR B
/ O
CARD B
represents O
a O
putative O
constitutively O
active O
inducer O
of O
apoptosis O
; O
3 O
) O
the O
killing O
activity O
of O
LRR B
/ O
CARD B
is O
inhibitable O
by O
benzyloxycarbonyl O
- O
Val O
- O
Ala O
- O

The O
use O
of O
sigma B
54 I
promoters I
, O
known O
to O
require O
cognate O
binding O
proteins O
, O
could O
allow O
the O
fine O
- O
tuning O
that O
provides O
the O
temporal O
ordering O
of O
flagellar O
gene O
transcription O
. O

The O
association O
of O
I B
- I
92 I
with O
p92 B
, O
p84 B
, O
p75 B
, O
p73 B
, O
p69 B
, O
and O
p57 B
was O
completely O
reversible O
after O
treatment O
with O
the O
detergent O
deoxycholate O
( O
DOC O
) O
. O

Human B
parvovirus I
B19 I
gene I
expression O
from O
the O
viral B
p6 I
promoter I
( O
B19p6 B
) O
is O
restricted O
to O
primary O
human O
hematopoietic O
cells O
undergoing O
erythroid O
differentiation O
. O

Strains O
lacking O
a O
functional B
RPL16A I
gene I
grow O
as O
rapidly O
as O
wild O
type O
, O
whereas O
those O
containing O
a O
null O
allele O
of O
RPL16B B
grow O
more O
slowly O
than O
wild O
type O
. O

In O
summary O
, O
FGFR3 B
signaling O
pathway O
utilizes O
two O
GRB2 B
- I
containing I
complexes I
; O
Shc B
. O
GRB2 B
. O
Sos B
and O
80K B
- I
H I
. O
pp66 B
. O
GRB2 B
. O
Sos B
; O
these O
two O
complexes O
may O
alternatively O
link O
FGFG3 B
to O
mitogen B
- I
activated I
protein I
kinase I
. O

In O
an O
effort O
to O
identify O
factors O
involved O
in O
the O
expression O
of O
this O
important O
erythroid O
- O
specific O
regulatory O
protein O
, O
we O
have O
isolated O
the O
mouse B
EKLF I
gene I
and O
systematically O
analyzed O
the O
promoter O
region O
. O

Four O
families O
of O
homing B
endonucleases I
have O
been O
identified O
, O
including O
the O
LAGLIDADG B
, O
the O
His B
- I
Cys I
box I
, O
the O
GIY B
- I
YIG I
and O
the O
H B
- I
N I
- I
H I
endonucleases I
. O

The O
yeast B
mitochondrial I
Hsp70 I
, O
Ssc1p B
, O
functions O
as O
a O
molecular O
chaperone O
with O
its O
partner O
proteins O
, O
Mdj1p B
( O
DnaJ B
homologue I
) O
and O
Yge1p B
( O
GrpE B
homologue I
) O
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP B
genes I
, O
no O
significative O
synergistic O
effect O
on O
CAT B
activity O
between O
the O
AP B
- I
1 I
and O
PEA B
- I
3 I
elements I
found O
in O
the O
collagenase B
- I
3 I
gene I
promoter I
was O
found O
. O

The O
human B
parvalbumin I
mRNA I
contains O
the O
putative O
polyadenylation O
signal O
AATAAA O
13 O
nucleotides O
upstream O
from O
the O
polyadenylation O
site O
. O

The O
delta O
Mo O
+ O
SV O
tumor O
DNAs O
from O
B O
- O
lineage O
tumors O
were O
typically O
rearranged O
at O
the O
immunoglobulin B
gene I
loci I
and O
contained O
germ O
line O
configurations O
of O
the O
T B
- I
cell I
receptor I
beta I
gene I
. O

Whereas O
the O
sequence O
of O
alpha B
- I
actinin I
( O
Noegel O
, O
A O
. O
, O
W O
. O

The O
shift O
from O
complex O
I O
to O
complex O
II O
seen O
only O
in O
SCM B
- I
1 I
- O
producer O
T O
cell O
lines O
upon O
activation O
was O
completely O
suppressed O
by O
cyclosporin O
A O
. O

Disruption O
of O
PML B
subnuclear I
domains I
by O
the O
acidic B
IE1 I
protein I
of O
human O
cytomegalovirus O
is O
mediated O
through O
interaction O
with O
PML B
and O
may O
modulate O
a O
RING O
finger O
- O
dependent O
cryptic O
transactivator O
function O
of O
PML B
. O

Disruption O
of O
PML B
subnuclear I
domains I
by O
the O
acidic B
IE1 I
protein I
of O
human O
cytomegalovirus O
is O
mediated O
through O
interaction O
with O
PML B
and O
may O
modulate O
a O
RING O
finger O
- O
dependent O
cryptic O
transactivator O
function O
of O
PML B
. O

Furthermore O
, O
the O
GC O
- O
rich O
sequences O
could O
confer O
Sp1 B
- O
dependent O
transactivation O
to O
a O
heterologous O
prolactin B
minimal I
promoter I
. O

Several O
reports O
assert O
that O
prolactin B
affects O
the O
delta O
5 O
and O
delta O
4 O
pathways O
through O
its O
effect O
on O
the O
activity O
of O
3beta B
- I
hydroxysteroid I
dehydrogenase I
( O
3beta B
- I
OHSD I
) O
. O

( O
i O
) O
p60 B
bound O
fast O
- O
migrating O
, O
underprocessed O
wild B
- I
type I
ICP22 I
and O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
24 O
amino O
acids O
but O
not O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
40 O
amino O
acids O
, O
whereas O
the O
previously O
identified O
cellular B
protein I
p78 I
( O
R O
. O

After O
a O
shift O
to O
37 O
degrees O
C O
, O
the O
mutant O
Rat7 B
- I
1p I
/ O
Nup159 B
- I
1p I
is O
lost O
from O
the O
nuclear O
rim O
of O
rat7 O
- O
1 O
cells O
and O
NPCs O
, O
which O
are O
clustered O
together O
in O
these O
cells O
grown O
under O
permissive O
conditions O
become O
substantially O
less O
clustered O
. O

After O
a O
shift O
to O
37 O
degrees O
C O
, O
the O
mutant O
Rat7 B
- I
1p I
/ O
Nup159 B
- I
1p I
is O
lost O
from O
the O
nuclear O
rim O
of O
rat7 O
- O
1 O
cells O
and O
NPCs O
, O
which O
are O
clustered O
together O
in O
these O
cells O
grown O
under O
permissive O
conditions O
become O
substantially O
less O
clustered O
. O

The O
mRNA O
for O
this O
protein O
is O
expressed O
in O
the O
T O
- O
ALL O
cell O
line O
Jurkat O
and O
has O
been O
designated O
HUG1 B
, O
for O
HOX11 B
Upstream I
Gene I
. O

The O
STS B
sequence I
WI I
- I
14920 I
is O
in O
fact O
derived O
from O
the O
3 O
' O
- O
untranslated O
region O
of O
the O
human B
PUNC I
gene I
. O

Here O
we O
examine O
the O
population O
of O
gammaS B
transcripts I
in O
adult O
human O
lens O
and O
the O
structure O
of O
the O
human B
CRYGS I
genes I
. O

Mouse B
macrophage I
beta I
subunit I
( I
CD11b I
) I
cDNA I
for O
the O
CR3 B
complement I
receptor I
/ O
Mac B
- I
1 I
antigen I
. O

Unconventional O
mRNA O
processing O
in O
the O
expression O
of O
two O
calcineurin B
B I
isoforms I
in O
Dictyostelium O
. O

The O
deduced O
amino O
acid O
sequence O
of O
this O
open O
reading O
frame O
is O
significantly O
homologous O
to O
the O
HSV B
1 I
UL49 I
. I
5 I
gene I
product I
, O
and O
as O
with O
UL49 B
. I
5 I
, O
it O
contains O
a O
potential O
signal O
sequence O
and O
transmembrane O
domain O
characteristic O
of O
membrane O
- O
associated O
proteins O
. O

Identification O
of O
a O
putative O
chromosomal O
replication O
origin O
from O
Helicobacter O
pylori O
and O
its O
interaction O
with O
the O
initiator B
protein I
DnaA I
. O

The O
primary O
structure O
of O
cholesterol B
esterase I
displayed O
no O
significant O
homology O
with O
other O
lipases B
, O
although O
the O
putative O
lipid O
interfacial O
recognition O
site O
of O
G O
- O
X O
- O
S O
- O
X O
- O
G O
is O
present O
in O
the O
cholesterol B
esterase I
sequence I
. O

Protein B
kinase I
C I
transiently O
activated O
heteromeric B
N I
- I
methyl I
- I
D I
- I
aspartate I
receptor I
channels I
independent O
of O
the O
phosphorylatable O
C O
- O
terminal O
splice O
domain O
and O
of O
consensus O
phosphorylation O
sites O
. O

Siglec B
- I
9 I
is O
predicted O
to O
contain O
three O
extracellular O
immunoglobulin B
- I
like I
domains I
that O
comprise O
an O
N B
- I
terminal I
V I
- I
set I
domain I
and O
two O
C2 B
- I
set I
domains I
, O
a O
transmembrane O
region O
and O
a O
cytoplasmic O
tail O
containing O
two O
putative O
tyrosine O
- O
based O
signaling O
motifs O
. O

Being O
implicated O
in O
insulin B
and O
GK B
gene I
regulations O
as O
a O
common O
transcription O
factor O
, O
IPF1 B
/ O
STF B
- I
1 I
/ O
PDX B
- I
1 I
is O
likely O
to O
play O
an O
essential O
role O
in O
maintaining O
normal O
beta O
- O
cell O
functions O
. O

Being O
implicated O
in O
insulin B
and O
GK B
gene I
regulations O
as O
a O
common O
transcription O
factor O
, O
IPF1 B
/ O
STF B
- I
1 I
/ O
PDX B
- I
1 I
is O
likely O
to O
play O
an O
essential O
role O
in O
maintaining O
normal O
beta O
- O
cell O
functions O
. O

We O
demonstrate O
that O
the O
WRM B
- I
1 I
protein I
binds O
to O
LIT B
- I
1 I
in O
vivo O
and O
that O
WRM B
- I
1 I
can O
activate O
the O
LIT B
- I
1 I
protein I
kinase I
when O
coexpressed O
in O
vertebrate O
tissue O
culture O
cells O
. O

We O
demonstrate O
that O
the O
WRM B
- I
1 I
protein I
binds O
to O
LIT B
- I
1 I
in O
vivo O
and O
that O
WRM B
- I
1 I
can O
activate O
the O
LIT B
- I
1 I
protein I
kinase I
when O
coexpressed O
in O
vertebrate O
tissue O
culture O
cells O
. O

RESULTS O
: O
All O
primary O
tumors O
were O
positive O
for O
CAM5 B
. I
2 I
. O

Recombinant B
Human I
Erythropoietin I
and O
Platinum O
- O
Based O
Chemotherapy O
In O
Advanced O
Ovarian O
Cancer O

Some O
of O
these O
physiological O
responses O
are O
regulated O
via O
activation O
of O
transcription O
factors O
such O
as O
activator B
protein I
1 I
( O
AP B
- I
1 I
) O
. O

Some O
of O
these O
physiological O
responses O
are O
regulated O
via O
activation O
of O
transcription O
factors O
such O
as O
activator B
protein I
1 I
( O
AP B
- I
1 I
) O
. O

To O
test O
the O
role O
of O
myb B
family I
members I
in O
progression O
through O
the O
cell O
cycle O
, O
we O
comicroinjected O
c B
- I
myc I
and O
myb B
expression O
vectors O
into O
serum O
- O
deprived O
quiescent O
SMCs O
. O

To O
test O
the O
role O
of O
myb B
family I
members I
in O
progression O
through O
the O
cell O
cycle O
, O
we O
comicroinjected O
c B
- I
myc I
and O
myb B
expression O
vectors O
into O
serum O
- O
deprived O
quiescent O
SMCs O
. O

The O
same O
high O
degree O
of O
sequence O
homology O
between O
the O
two O
F O
. O
diplosiphon O
PC B
alpha I
and O
PC B
beta I
sequences I
( O
85 O
and O
77 O
% O
, O
respectively O
) O
was O
found O
at O
both O
the O
nucleotide O
and O
amino O
acid O
levels O
, O
and O
similar O
results O
were O
obtained O
for O
interspecies O
comparisons O
. O

A O
wound O
model O
for O
decubitus O
and O
leg O
ulcers O
consisting O
of O
human O
dermal O
fibroblasts O
in O
type B
I I
collagen I
dermal O
" O
equivalent O
" O
matrix O
( O
DEM O
) O
was O
exposed O
in O
vitro O
to O
electric O
fields O
similar O
to O
postulated O
endogenous O
fields O
in O
wounds O
. O

A O
group O
of O
factors O
known O
as O
activating B
transcription I
factors I
( O
ATF B
) O
have O
been O
found O
to O
bind O
to O
the O
latter O
and O
related O
sequences O
found O
upstream O
of O
early O
adenovirus O
promoters O
induced O
by O
E1A B
, O
and O
these O
factors O
are O
highly O
homologous O
to O
the O
CREB B
protein I
. O

The O
vertebrate B
transcription I
factors I
TCF I
( O
T B
cell I
factor I
) O
and O
LEF B
( O
lymphocyte B
enhancer I
binding I
factor I
) O
interact O
with O
beta B
- I
catenin I
and O
are O
hypothesized O
to O
mediate O
Wingless B
/ O
Wnt B
signaling O
. O

The O
vertebrate B
transcription I
factors I
TCF I
( O
T B
cell I
factor I
) O
and O
LEF B
( O
lymphocyte B
enhancer I
binding I
factor I
) O
interact O
with O
beta B
- I
catenin I
and O
are O
hypothesized O
to O
mediate O
Wingless B
/ O
Wnt B
signaling O
. O

In O
seven O
patients O
( O
7 O
. O
8 O
% O
) O
with O
new O
Q O
- O
waves O
and O
a O
pathologic O
CK B
- I
MB I
profile O
( O
group O
II O
) O
troponin B
T I
reached O
median O
levels O
of O
10 O
. O
47 O
micrograms O
/ O
l O
( O
quartile O
6 O
. O
34 O
- O
12 O
. O
50 O
micrograms O
/ O
l O
) O
( O
P O
< O
0 O
. O
001 O
I O
vs O
II O
) O
. O

Plasmid O
subclones O
of O
recombinant O
phage O
lambda O
Asm152 O
were O
able O
to O
complement O
both O
Escherichia B
coli I
gltB I
and O
A O
. O
sesbaniae O
Asm O
- O
Vi O
mutants O
; O
NADPH B
- I
glutamate I
synthase I
activity O
was O
detected O
in O
all O
such O
strains O
complemented O
to O
Asm O
+ O
. O

The O
sequence O
of O
LZ321 B
matched O
that O
of O
RREB1 B
, O
a O
transcription O
factor O
that O
bound O
to O
a O
Ras B
responsive I
element I
( O
RRE B
) O
very O
different O
from O
the O
sequence O
with O
which O
we O
isolated O
LZ321 B
. O

Steady O
- O
state O
levels O
of O
murine B
MMR I
mRNA I
were O
measured O
in O
the O
macrophage O
cell O
line O
J774E O
, O
which O
is O
known O
to O
express O
the O
protein O
at O
the O
cell O
surface O
. O

In O
vitro O
, O
c B
- I
Src I
phosphorylated O
FAK B
Tyr I
- I
925 I
in O
a O
glutathione B
S I
- I
transferase I
- O
FAK B
C O
- O
terminal O
domain O
fusion O
protein O
, O
whereas O
FAK O
did O
not O
. O

Gel O
shift O
analysis O
of O
protein O
binding O
from O
nuclear O
extracts O
to O
these O
caveolin B
promoter I
DNA I
sequences I
, O
together O
with O
DNase B
I I
footprinting O
, O
confirmed O
nucleoprotein O
binding O
to O
the O
SRE O
- O
like O
elements O
as O
part O
of O
the O
transcriptional O
response O
to O
LDL B
- I
FC I
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

We O
report O
five O
of O
13 O
evaluable O
patients O
undergoing O
allogeneic O
sibling O
BM O
or O
PBSC O
transplantation O
for O
MM O
between O
1990 O
and O
1997 O
who O
met O
the O
criteria O
for O
adjuvant O
alpha B
- I
IFN I
therapy O
. O

Molecular O
cloning O
of O
cDNAs O
encoding O
alpha O
- O
subunits O
of O
guanine B
nucleotide I
- I
binding I
regulatory I
proteins I
( O
G B
- I
proteins I
) O
has O
revealed O
the O
existence O
of O
nine O
species O
of O
alpha O
- O
subunits O
. O

Pros O
and O
cons O
of O
selective O
inhibition O
of O
cyclooxygenase B
- I
2 I
versus O
dual O
lipoxygenase B
/ O
cyclooxygenase B
inhibition O
: O
is O
two O
better O
than O
one O
? O

TNF B
- I
alpha I
effect O
was O
eliminated O
by O
a O
2 O
- O
bp O
substitution O
mutation O
in O
the O
NF B
- I
kappa I
B1 I
binding I
half I
site I
of O
the O
NF B
- I
kappa I
B I
cis I
element I
. O

The O
M O
- O
phase O
induction O
activity O
of O
Cdc2 B
- O
Cdc13 B
is O
inhibited O
by O
Wee1 B
tyrosine I
kinase I
, O
which O
phosphorylates O
Cdc2 B
on O
tyrosine O
- O
15 O
. O

Single O
substitutions O
of O
three O
highly O
conserved O
phenylalanine O
residues O
( O
Phe O
- O
15 O
, O
Phe O
- O
17 O
, O
Phe O
- O
27 O
) O
by O
alanine O
and O
substitution O
of O
one O
histidine O
( O
His O
- O
29 O
) O
by O
glutamine O
, O
all O
located O
within O
the O
putative O
RNA O
- O
binding O
sites O
RNP B
- I
1 I
and O
RNP B
- I
2 I
, O
abolished O
the O
nucleic O
acid O
- O
binding O
activity O
of O
CspB B
. O

Single O
substitutions O
of O
three O
highly O
conserved O
phenylalanine O
residues O
( O
Phe O
- O
15 O
, O
Phe O
- O
17 O
, O
Phe O
- O
27 O
) O
by O
alanine O
and O
substitution O
of O
one O
histidine O
( O
His O
- O
29 O
) O
by O
glutamine O
, O
all O
located O
within O
the O
putative O
RNA O
- O
binding O
sites O
RNP B
- I
1 I
and O
RNP B
- I
2 I
, O
abolished O
the O
nucleic O
acid O
- O
binding O
activity O
of O
CspB B
. O

Using O
transgenic O
lines O
a O
detailed O
analysis O
of O
the O
Hoxa B
- I
7 I
enhancer O
- O
directed O
expression O
during O
embryogenesis O
was O
performed O
. O

Serum O
levels O
of O
angiotensin B
converting I
enzyme I
were O
well O
maintained O
. O

Characterization O
of O
a O
nuclear B
deformed I
epidermal I
autoregulatory I
factor I
- I
1 I
( O
DEAF B
- I
1 I
) O
- O
related O
( O
NUDR B
) O
transcriptional O
regulator O
protein O
. O

Cotransfection O
with O
C B
/ I
EBPbeta I
and O
GATA B
- I
1 I
expression O
vectors O
produced O
a O
5 O
- O
fold O
increase O
compared O
with O
cotransfection O
with O
the O
C B
/ I
EBPbeta I
or O
GATA B
- I
1 I
expression O
vectors O
individually O
. O

Cotransfection O
with O
C B
/ I
EBPbeta I
and O
GATA B
- I
1 I
expression O
vectors O
produced O
a O
5 O
- O
fold O
increase O
compared O
with O
cotransfection O
with O
the O
C B
/ I
EBPbeta I
or O
GATA B
- I
1 I
expression O
vectors O
individually O
. O

Cotransfection O
with O
C B
/ I
EBPbeta I
and O
GATA B
- I
1 I
expression O
vectors O
produced O
a O
5 O
- O
fold O
increase O
compared O
with O
cotransfection O
with O
the O
C B
/ I
EBPbeta I
or O
GATA B
- I
1 I
expression O
vectors O
individually O
. O

Cotransfection O
with O
C B
/ I
EBPbeta I
and O
GATA B
- I
1 I
expression O
vectors O
produced O
a O
5 O
- O
fold O
increase O
compared O
with O
cotransfection O
with O
the O
C B
/ I
EBPbeta I
or O
GATA B
- I
1 I
expression O
vectors O
individually O
. O

In O
contrast O
to O
the O
p16 B
- O
mediated O
G1 O
block O
, O
G1 O
arrest O
mediated O
by O
the O
cdk B
inhibitors O
p21Cip1 B
or O
p27Kip1 B
cannot O
be O
bypassed O
either O
by O
inactivation O
of O
pRb B
or O
overexpression O
of O
E2F B
family I
members I
. O

In O
addition O
, O
the O
authors O
found O
one O
an3 B
allele I
( O
an3 B
- I
W138A I
) O
in O
which O
a O
dTph1 B
element I
had O
inserted O
30 O
bp O
upstream O
the O
translation O
start O
, O
without O
inactivating O
the O
gene O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase B
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

In O
this O
study O
, O
we O
show O
that O
HNF B
- I
4 I
, O
a O
member O
of O
the O
steroid B
hormone I
receptor I
superfamily I
, O
binds O
the O
AF B
- I
1 I
site I
on O
the O
apoB B
promoter I
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

Our O
current O
study O
aims O
at O
clarifying O
the O
role O
of O
myristoylation O
in O
caveolar O
targeting O
using O
well O
- O
characterized O
acylation O
mutants O
of O
two O
model O
proteins O
, O
namely O
Gi1 B
alpha I
and O
c B
- I
Src I
. O

The O
Rep B
proteins I
of O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep B
recognition I
sequences I
( O
RRSs B
) O
in O
the O
AAV O
inverted O
terminal O
repeats O
( O
ITRs O
) O
, O
the O
AAV B
p5 I
promoter I
, O
and O
the O
preferred O
AAV O
integration O
site O
in O
human O
chromosome O
19 O
, O
called O
AAVS1 O
. O

The O
Rep B
proteins I
of O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep B
recognition I
sequences I
( O
RRSs B
) O
in O
the O
AAV O
inverted O
terminal O
repeats O
( O
ITRs O
) O
, O
the O
AAV B
p5 I
promoter I
, O
and O
the O
preferred O
AAV O
integration O
site O
in O
human O
chromosome O
19 O
, O
called O
AAVS1 O
. O

This O
deletion O
disrupts O
the O
PU B
. I
1 I
Ets B
domain I
. O

Overexpression O
of O
p50 B
in O
transient O
cotransfection O
studies O
using O
the O
proximal O
CRP B
promoter I
( O
- O
125 O
/ O
+ O
9 O
) O
linked O
to O
a O
luciferase B
reporter I
caused O
a O
3 O
- O
fold O
increase O
of O
luciferase B
activity O
, O
while O
C B
/ I
EBPbeta I
overexpression O
caused O
an O
18 O
- O
fold O
increase O
; O
simultaneous O
overexpression O
of O
both O
transcription O
factors O
increased O
luciferase B
activity O
approximately O
600 O
- O
fold O
. O

Immunological O
studies O
also O
failed O
to O
demonstrate O
any O
significant O
change O
except O
for O
a O
significant O
increase O
of O
natural O
killer O
( O
NK O
) O
cell O
activity O
after O
IFN B
- I
gamma I
infusion O
. O

Rat B
cholesterol I
side I
- I
chain I
cleavage I
cytochrome I
P I
- I
450 I
( O
P B
- I
450scc I
) O
gene O
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
, O
by O
interacting O
with O
cellular O
transcription O
factors O
and O
cofactors O
, O
vIRF B
- I
2 I
may O
modulate O
the O
expression O
of O
the O
early O
inflammatory O
genes O
and O
potentially O
deregulate O
the O
immune O
system O
. O

We O
report O
that O
Gcn5 B
, O
a O
histone B
H3 I
acetylase I
, O
plays O
a O
central O
role O
in O
initiation O
of O
meiosis O
via O
effects O
on O
IME2 B
expression O
. O

Interferon B
- I
alpha I
inducibility O
of O
IFI16 B
may O
be O
regulated O
by O
an O
interferon B
- I
alpha I
/ I
beta I
- O
stimulated O
response O
consensus O
element O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
position O
in O
the O
related O
myeloid B
cell I
nuclear I
differentiation I
antigen I
gene O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Overexpression O
of O
a O
HIF B
- I
1alpha I
construct O
with O
deletions O
of O
the O
basic O
domain O
and O
carboxy O
terminus O
blocked O
reporter O
gene O
activation O
by O
endogenous O
HIF B
- I
1 I
in O
hypoxic O
cells O
. O

Overexpression O
of O
a O
HIF B
- I
1alpha I
construct O
with O
deletions O
of O
the O
basic O
domain O
and O
carboxy O
terminus O
blocked O
reporter O
gene O
activation O
by O
endogenous O
HIF B
- I
1 I
in O
hypoxic O
cells O
. O

In O
serum O
- O
starved O
NIH O
3T3 O
cells O
, O
v B
- I
raf I
increased O
mdr1 B
promoter I
activity O
approximately O
10 O
- O
fold O
compared O
to O
a O
v B
- I
raf I
frame O
- O
shift O
control O
. O

In O
serum O
- O
starved O
NIH O
3T3 O
cells O
, O
v B
- I
raf I
increased O
mdr1 B
promoter I
activity O
approximately O
10 O
- O
fold O
compared O
to O
a O
v B
- I
raf I
frame O
- O
shift O
control O
. O

To O
determine O
cis O
- O
acting O
elements O
controlling O
the O
rat O
B B
- I
50 I
/ O
GAP B
- I
43 I
gene O
expression O
, O
the O
genomic O
DNA O
encoding O
exon O
1 O
and O
the O
5 O
' O
flanking O
sequence O
was O
isolated O
. O

To O
determine O
cis O
- O
acting O
elements O
controlling O
the O
rat O
B B
- I
50 I
/ O
GAP B
- I
43 I
gene O
expression O
, O
the O
genomic O
DNA O
encoding O
exon O
1 O
and O
the O
5 O
' O
flanking O
sequence O
was O
isolated O
. O

TNF B
- I
alpha I
stimulated O
these O
changes O
in O
part O
by O
increasing O
transcription O
and O
stabilization O
of O
RNA O
for O
amphiregulin B
, O
an O
EGF B
receptor I
ligand O
, O
and O
amphiregulin B
directly O
increased O
HPV O
- O
16 O
E6 B
/ O
E7 B
and O
cyclin B
A I
RNAs I
. O

TNF B
- I
alpha I
stimulated O
these O
changes O
in O
part O
by O
increasing O
transcription O
and O
stabilization O
of O
RNA O
for O
amphiregulin B
, O
an O
EGF B
receptor I
ligand O
, O
and O
amphiregulin B
directly O
increased O
HPV O
- O
16 O
E6 B
/ O
E7 B
and O
cyclin B
A I
RNAs I
. O

Antibodies O
against O
REAP B
- I
1 I
inhibit O
in O
vitro O
RNA O
editing O
reactions O
confirming O
its O
role O
in O
RNA O
editing O
. O

BAG B
- I
1 I
also O
prevented O
growth O
arrest O
following O
UV O
- O
irradiation O
- O
induced O
genotoxic O
injury O
without O
interfering O
with O
accumulation O
of O
p53 B
protein I
or O
p21 B
( O
waf B
- I
1 I
) O
expression O
. O

BAG B
- I
1 I
also O
prevented O
growth O
arrest O
following O
UV O
- O
irradiation O
- O
induced O
genotoxic O
injury O
without O
interfering O
with O
accumulation O
of O
p53 B
protein I
or O
p21 B
( O
waf B
- I
1 I
) O
expression O
. O

We O
have O
isolated O
a O
unique O
murine B
FLT3 I
cDNA I
that O
codes O
for O
a O
variant O
isoform O
of O
FLT3 B
, O
devoid O
of O
the O
fifth O
Ig B
- I
like I
domain I
, O
by O
comparison O
with O
the O
prototypic O
form O
. O

Particle O
bombardment O
of O
barley O
aleurone O
with O
a O
B22EL8 B
promoter I
- O
GUS B
( O
beta B
- I
glucuronidase I
) O
construct O
demonstrates O
that O
the O
promoter O
( O
3 O
kb O
) O
is O
active O
in O
developing O
barley O
grains O
. O

Elements O
regulating O
cell O
- O
and O
stage O
- O
specific O
expression O
of O
the O
C O
. O
elegans O
MyoD B
family O
homolog O
hlh B
- I
1 I
. O

After O
5 O
days O
stimulation O
with O
G B
- I
CSF I
( O
10 O
micrograms O
/ O
kg O
) O
1l O
of O
blood O
was O
drawn O
, O
kept O
unprocessed O
for O
3 O
days O
and O
reinfused O
24 O
h O
after O
completion O
of O
chemotherapy O
. O

Our O
data O
indicate O
that O
the O
various O
subunits O
of O
the O
human O
P B
- I
TEFb I
complex O
may O
play O
distinct O
roles O
at O
multiple O
stages O
to O
mediate O
Tat B
activation O
of O
HIV O
- O
1 O
transcription O
elongation O
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

Recently O
, O
we O
demonstrated O
that O
platelet B
- I
derived I
growth I
factor I
( I
PDGF I
) I
- I
beta I
receptor I
stimulation O
, O
but O
not O
various O
other O
growth O
factors O
, O
inhibits O
transcription O
of O
alpha1D B
- O
, O
but O
not O
alpha1A B
- O
or O
alpha1B B
- I
ARs I
, O
resulting O
in O
reduced O
norepinephrine O
- O
mediated O
SMC O
growth O
. O

The O
results O
indicate O
that O
the O
RNA O
in O
T7 B
RNA I
polymerase I
is O
not O
free O
of O
steric O
interactions O
in O
the O
ternary O
complex O
and O
not O
available O
for O
structure O
formation O
until O
it O
is O
at O
least O
10 O
bases O
away O
from O
the O
site O
of O
polymerization O
. O

The O
two O
complexes O
were O
detected O
with O
a O
similar O
activation O
kinetics O
upon O
IL B
- I
4 I
stimulation O
. O

Consistently O
, O
we O
show O
that O
phosphorylation O
by O
protein B
kinase I
A I
inhibits O
Sfl1 B
DNA O
binding O
in O
vitro O
, O
and O
that O
a O
tpk2Delta B
mutation O
increases O
the O
levels O
of O
Sfl1 B
protein I
associated O
with O
specific O
promoter O
elements O
in O
vivo O
. O

The O
response O
sequences O
were O
localized O
between O
- O
67 O
and O
+ O
30 O
in O
the O
simian O
cytomegalovirus O
IE94 B
promoter I
and O
upstream O
of O
position O
+ O
9 O
in O
the O
HCMV B
IE68 I
promoter I
. O

Some O
CHOP B
- O
C B
/ I
EBP I
heterodimers O
apparently O
bind O
to O
alternative O
DNA O
sequence O
and O
thereby O
regulate O
the O
transcription O
of O
other O
genes O
. O

To O
identify O
and O
determine O
the O
function O
of O
Ino2p B
in O
yeast O
cells O
, O
we O
raised O
antibodies O
to O
a O
beta B
- I
galactosidase I
/ O
Ino2 B
fusion O
protein O
. O

The O
arrangement O
of O
amino O
acids O
in O
the O
helix O
1 O
and O
helix O
2 O
regions O
is O
quite O
similar O
to O
those O
of O
Mxi B
and O
Mad B
, O
but O
different O
from O
those O
of O
E2F B
- I
1 I
and O
DP B
- I
1 I
. O

The O
arrangement O
of O
amino O
acids O
in O
the O
helix O
1 O
and O
helix O
2 O
regions O
is O
quite O
similar O
to O
those O
of O
Mxi B
and O
Mad B
, O
but O
different O
from O
those O
of O
E2F B
- I
1 I
and O
DP B
- I
1 I
. O

The O
present O
study O
also O
emphasizes O
the O
need O
of O
establishing O
dose O
- O
response O
curves O
to O
correctly O
assess O
the O
relative O
contribution O
of O
the O
different O
regions O
of O
steroid B
hormone I
receptors I
in O
activation O
of O
transcription O
. O

By O
contrast O
with O
ama B
- I
1 I
, O
rpc B
- I
1 I
was O
not O
deleted O
by O
mDf4 O
or O
larger O
deficiencies O
examined O
, O
indicating O
that O
these O
genes O
are O
no O
closer O
than O
150 O
kb O
. O

By O
contrast O
with O
ama B
- I
1 I
, O
rpc B
- I
1 I
was O
not O
deleted O
by O
mDf4 O
or O
larger O
deficiencies O
examined O
, O
indicating O
that O
these O
genes O
are O
no O
closer O
than O
150 O
kb O
. O

The O
reconstituted O
RNA B
polymerases I
containing O
the O
mutant O
alpha O
subunits O
were O
examined O
for O
their O
response O
to O
transcription O
activation O
by O
cAMP B
- I
CRP I
and O
the O
rrnBP1 B
UP I
element I
. O

The O
reconstituted O
RNA B
polymerases I
containing O
the O
mutant O
alpha O
subunits O
were O
examined O
for O
their O
response O
to O
transcription O
activation O
by O
cAMP B
- I
CRP I
and O
the O
rrnBP1 B
UP I
element I
. O

We O
also O
demonstrate O
that O
a O
p110RB1 B
mutant I
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a B
/ O
large B
T I
antigen I
- O
binding O
properties O
, O
represses O
EIIaE B
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild B
- I
type I
p110RB1 I
. O

The O
IGFBP B
- I
1 I
IRS B
and O
PEPCK B
IRS B
both O
bind O
the O
alpha O
and O
beta O
forms O
of O
hepatic B
nuclear I
factor I
3 I
( O
HNF B
- I
3 I
) O
, O
although O
the O
latter O
does O
so O
with O
a O
sixfold O
- O
lower O
relative O
affinity O
. O

The O
IGFBP B
- I
1 I
IRS B
and O
PEPCK B
IRS B
both O
bind O
the O
alpha O
and O
beta O
forms O
of O
hepatic B
nuclear I
factor I
3 I
( O
HNF B
- I
3 I
) O
, O
although O
the O
latter O
does O
so O
with O
a O
sixfold O
- O
lower O
relative O
affinity O
. O

The O
effect O
of O
the O
NMDA B
- I
receptor I
antagonist O
( O
+ O
/ O
- O
) O
- O
CPP O
on O
the O
conditioned O
- O
reflex O
activation O
of O
an O
operant O
reaction O
in O
the O
brain O
electrical O
self O
- O
stimulation O
test O
in O
rats O

Our O
data O
suggest O
that O
the O
ZF B
- I
HD I
class O
of O
homeodomain B
proteins I
may O
be O
involved O
in O
the O
establishment O
of O
the O
characteristic O
expression O
pattern O
of O
the O
C4 B
PEPCase I
gene I
. O

Our O
data O
suggest O
that O
the O
ZF B
- I
HD I
class O
of O
homeodomain B
proteins I
may O
be O
involved O
in O
the O
establishment O
of O
the O
characteristic O
expression O
pattern O
of O
the O
C4 B
PEPCase I
gene I
. O

We O
investigated O
whether O
two O
WT1 B
splice I
variants I
lacking O
or O
including O
a O
three O
- O
amino O
- O
acid O
( O
KTS O
) O
insertion O
between O
the O
third O
and O
fourth O
zinc O
finger O
in O
the O
DNA O
- O
binding O
domain O
could O
repress O
the O
IR B
promoter I
in O
vitro O
. O

We O
further O
showed O
a O
significant O
repression O
of O
promoter O
activity O
( O
> O
40 O
fold O
) O
by O
E2 B
- I
2 I
( O
lacking O
the O
amino O
acid O
sequence O
RSRS O
) O
when O
the O
E47 B
reporter I
construct I
, O
containing O
a O
hexameric O
E O
- O
box O
site O
, O
was O
used O
. O

We O
further O
showed O
a O
significant O
repression O
of O
promoter O
activity O
( O
> O
40 O
fold O
) O
by O
E2 B
- I
2 I
( O
lacking O
the O
amino O
acid O
sequence O
RSRS O
) O
when O
the O
E47 B
reporter I
construct I
, O
containing O
a O
hexameric O
E O
- O
box O
site O
, O
was O
used O
. O

A O
400 O
- O
bp O
fragment O
( O
bp O
- O
339 O
through O
+ O
71 O
) O
of O
the O
CD22 B
promoter I
region I
was O
subcloned O
into O
a O
pGEM O
- O
chloramphenicol B
acetyltransferase I
vector O
and O
after O
transfection O
into O
B O
and O
T O
cells O
was O
found O
to O
be O
active O
in O
both O
B O
and O
T O
cells O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
between O
viral O
RNA O
and O
BMV B
CP I
peptides I
with O
either O
proline O
or O
alanine O
substitutions O
revealed O
that O
the O
interaction O
is O
nonspecific O
. O

Inhibition O
of O
DNA B
topoisomerase I
II I
alpha I
gene I
expression O
by O
the O
p53 B
tumor I
suppressor I
. O

Treatments O
were O
two O
adrenocorticotrophin B
( O
ACTH B
) O
preparations O
given O
intramuscularly O
at O
2 O
. O
2 O
U O
/ O
kg O
, O
one O
of O
the O
ACTH B
preparations O
given O
intramuscularly O
at O
1 O
U O
/ O
kg O
and O
a O
synthetic O
polypeptide O
with O
ACTH B
- I
like I
activity O
( O
tetracosactrin O
, O
cosyntropin O
) O
given O
intravenously O
at O
5 O
micrograms O
/ O
kg O
. O

Recombinant O
propeptides O
containing O
mutations O
of O
one O
of O
the O
three O
tryptophan O
residues O
were O
three O
orders O
of O
magnitude O
less O
effective O
as O
inhibitors O
of O
mature B
cathepsin I
S I
than O
the O
wild O
- O
type O
propeptide O
. O

In O
patients O
with O
active O
TB O
, O
cytokines O
that O
were O
elevated O
in O
serum O
were O
IFN B
- I
gamma I
, O
IL B
- I
6 I
and O
IL B
- I
10 I
. O

In O
patients O
with O
active O
TB O
, O
cytokines O
that O
were O
elevated O
in O
serum O
were O
IFN B
- I
gamma I
, O
IL B
- I
6 I
and O
IL B
- I
10 I
. O

In O
patients O
with O
active O
TB O
, O
cytokines O
that O
were O
elevated O
in O
serum O
were O
IFN B
- I
gamma I
, O
IL B
- I
6 I
and O
IL B
- I
10 I
. O

Isolation O
and O
properties O
of O
Drosophila B
melanogaster I
ferritin I
- O
- O
molecular O
cloning O
of O
a O
cDNA O
that O
encodes O
one O
subunit O
, O
and O
localization O
of O
the O
gene O
on O
the O
third O
chromosome O
. O

We O
show O
that O
Fos B
down O
regulates O
several O
immediate B
- I
early I
genes I
( O
c B
- I
fos I
, O
Egr B
- I
1 I
, O
and O
Egr B
- I
2 I
) O
after O
mitogenic O
stimulation O
. O

We O
show O
that O
Fos B
down O
regulates O
several O
immediate B
- I
early I
genes I
( O
c B
- I
fos I
, O
Egr B
- I
1 I
, O
and O
Egr B
- I
2 I
) O
after O
mitogenic O
stimulation O
. O

We O
show O
that O
Fos B
down O
regulates O
several O
immediate B
- I
early I
genes I
( O
c B
- I
fos I
, O
Egr B
- I
1 I
, O
and O
Egr B
- I
2 I
) O
after O
mitogenic O
stimulation O
. O

The O
human B
IFI16 I
gene I
is O
a O
member O
of O
an O
interferon B
- O
inducible O
family O
of O
mouse O
and O
human O
genes O
closely O
linked O
on O
syntenic O
regions O
of O
chromosome O
1 O
. O

In O
agreement O
with O
this O
model O
, O
elimination O
of O
the O
ADAM13 B
cytoplasmic I
domain I
increased O
developmental O
alterations O
attributable O
to O
ADAM13 B
proteolytic O
activity O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

After O
3 O
months O
of O
intervention O
, O
sustained O
physical O
training O
was O
associated O
with O
the O
decrease O
of O
FVII B
and O
PAI B
- I
1 I
levels O
. O

This O
cDNA O
corresponded O
to O
FGF B
- I
binding I
protein I
( O
FGF B
- I
BP I
) O
, O
a O
secreted O
protein O
previously O
shown O
to O
bind O
acidic O
and O
basic B
FGF I
and O
to O
modulate O
their O
activities O
. O

However O
the O
precise O
function O
of O
DNA B
- I
PK I
in O
DNA O
double O
- O
strand O
break O
repair O
is O
not O
known O
. O

This O
new O
receptor O
, O
TOR B
( O
thymus B
orphan I
receptor I
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR B
alpha I
/ O
RZR B
alpha I
and O
clusters O
with O
these O
two O
receptors O
and O
RZR B
beta I
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

Rottlerin O
also O
inhibited O
the O
activation O
of O
MAP B
kinase I
kinase I
( O
MEK B
) O
in O
response O
to O
activated O
Raf B
, O
but O
had O
no O
effect O
upon O
c B
- I
Raf I
activity O
or O
ERK B
activation O
by O
activated O
MEK B
. O

Rottlerin O
also O
inhibited O
the O
activation O
of O
MAP B
kinase I
kinase I
( O
MEK B
) O
in O
response O
to O
activated O
Raf B
, O
but O
had O
no O
effect O
upon O
c B
- I
Raf I
activity O
or O
ERK B
activation O
by O
activated O
MEK B
. O

The O
isolation O
of O
crt5 B
- I
262 I
, O
an O
additional O
cdc B
allele I
of O
POL1 B
/ O
CDC17 B
, O
suggests O
for O
the O
first O
time O
that O
directly O
blocking O
DNA O
replication O
can O
provide O
a O
signal O
to O
induce O
the O
DNA O
damage O
response O
. O

The O
NF B
- I
kappa I
B I
precursor O
p100 B
( O
lyt B
- I
10 I
, O
p97 B
, O
p98 B
) O
generates O
after O
proteolytic O
processing O
a O
52 O
kDa O
subunit O
, O
which O
can O
bind O
to O
kappa B
B I
- I
motifs I
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

The O
RsmA B
- I
mutant I
, O
like O
its O
parent O
, O
produces O
N O
- O
( O
3 O
- O
oxohexanoyl O
) O
- O
L O
- O
homoserine O
lactone O
( O
HSL O
) O
, O
a O
starvation O
/ O
cell O
density O
- O
sensing O
signal O
required O
for O
extracellular O
enzyme O
production O
. O

The O
N O
- O
terminal O
exon1 O
had O
no O
homology O
at O
the O
amino O
acid O
level O
with O
NGFI B
- I
B I
, O
the O
mammalian O
homologue O
. O

We O
identified O
Tyr O
( O
112 O
) O
and O
Leu O
( O
175 O
) O
within O
the O
RNA O
- O
binding O
domain O
of O
the O
U1 B
70K I
protein I
to O
be O
cross O
- O
linked O
to O
G O
( O
28 O
) O
and O
U O
( O
30 O
) O
in O
stem O
- O
loop O
I O
, O
respectively O
. O

Here O
, O
we O
provide O
direct O
evidence O
that O
the O
meiotic O
defect O
caused O
by O
either O
unregulated O
cAPK B
activity O
or O
unregulated O
ran1 B
+ I
kinase I
activity O
is O
due O
to O
inability O
to O
induce O
transcription O
of O
the O
mei2 B
+ I
gene I
, O
which O
is O
required O
for O
meiotic O
initiation O
. O

Here O
, O
we O
provide O
direct O
evidence O
that O
the O
meiotic O
defect O
caused O
by O
either O
unregulated O
cAPK B
activity O
or O
unregulated O
ran1 B
+ I
kinase I
activity O
is O
due O
to O
inability O
to O
induce O
transcription O
of O
the O
mei2 B
+ I
gene I
, O
which O
is O
required O
for O
meiotic O
initiation O
. O

In O
K562 O
cells O
, O
using O
the O
bicistronic O
vector O
, O
selection O
with O
colchicine O
led O
to O
at O
least O
20 O
- O
fold O
higher O
expression O
of O
the O
MDR1 B
gene I
product I
than O
did O
selection O
with O
G418 O
, O
suggesting O
that O
the O
stringent O
MDR1 B
selection O
system O
is O
very O
efficient O
for O
obtaining O
overexpression O
of O
foreign O
genes O
. O

Structure O
and O
regulation O
of O
KGD2 B
, O
the O
structural O
gene O
for O
yeast B
dihydrolipoyl I
transsuccinylase I
. O

Point O
mutations O
of O
Stat3 B
within O
the O
interacting O
domains O
blocked O
both O
physical O
interaction O
of O
Stat3 B
with O
c B
- I
Jun I
and O
their O
cooperation O
in O
IL B
- I
6 I
- O
induced O
transcription O
directed O
by O
the O
alpha B
( I
2 I
) I
- I
macroglobulin I
enhancer I
. O

Point O
mutations O
of O
Stat3 B
within O
the O
interacting O
domains O
blocked O
both O
physical O
interaction O
of O
Stat3 B
with O
c B
- I
Jun I
and O
their O
cooperation O
in O
IL B
- I
6 I
- O
induced O
transcription O
directed O
by O
the O
alpha B
( I
2 I
) I
- I
macroglobulin I
enhancer I
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

Cellular O
lysates O
were O
analyzed O
for O
luciferase B
and O
beta B
- I
galactosidase I
activities O
. O

Homology O
is O
much O
higher O
( O
64 O
% O
) O
between O
the O
28 O
- O
kDa O
protein O
and O
regions O
that O
are O
strongly O
conserved O
among O
the O
members O
of O
the O
serine B
protease I
family I
. O

Thus O
integration B
host I
factor I
is O
required O
for O
normal O
type B
1 I
fimbriae I
phase O
variation O
in O
E O
. O
coli O
. O

Thus O
integration B
host I
factor I
is O
required O
for O
normal O
type B
1 I
fimbriae I
phase O
variation O
in O
E O
. O
coli O
. O

We O
examined O
the O
mechanisms O
by O
which O
two O
different O
types O
of O
photonic O
radiation O
, O
short O
wavelength O
UV O
( O
UV O
- O
C O
) O
and O
gamma O
radiation O
, O
activate O
transcription O
factor O
NF B
- I
kappaB I
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

Both O
PMP20 B
gene I
products I
contain O
the O
carboxyl O
- O
terminal O
sequence O
AKL O
, O
similar O
to O
the O
putative O
SKL O
peroxisomal O
sorting O
sequence O
( O
Gould O
, O
S O
. O

The O
corresponding O
tetrapeptide O
sequences O
SSPD O
and O
SATD O
for O
human B
and I
mouse I
PKC I
- I
epsilon I
, O
respectively O
, O
are O
unusual O
for O
caspase B
- I
3 I
. O

The O
lipopolysaccharide O
- O
binding O
protein O
is O
a O
secretory B
class I
1 I
acute I
- I
phase I
protein I
whose O
gene O
is O
transcriptionally O
activated O
by O
APRF B
/ O
STAT B
/ I
3 I
and O
other O
cytokine O
- O
inducible O
nuclear O
proteins O
. O

These O
proteins O
, O
called O
variant B
surface I
glycoproteins I
( O
VSGs B
) O
, O
are O
expressed O
from O
a O
specific O
locus O
, O
the O
VSG B
gene I
expression I
site I
( I
ES I
) I
. O

The O
homeodomain B
transcription I
factor I
CDP B
/ O
cut B
interacts O
with O
the O
cell O
cycle O
regulatory O
element O
of O
histone B
H4 I
genes I
packaged O
into O
nucleosomes O
. O

The O
homeodomain B
transcription I
factor I
CDP B
/ O
cut B
interacts O
with O
the O
cell O
cycle O
regulatory O
element O
of O
histone B
H4 I
genes I
packaged O
into O
nucleosomes O
. O

Cotransfection O
of O
pINV O
- O
2473 O
, O
a O
construct O
containing O
2473 O
base O
pairs O
of O
hINV B
upstream I
sequence I
linked O
to O
luciferase B
, O
with O
POU B
homeodomain I
transcription I
factors I
Oct1 B
, O
Oct2 B
, O
Brn4 B
, O
SCIP B
, O
Skn1a B
or O
Skn1i B
, O
results O
in O
a O
strong O
suppression O
of O
basal O
promoter O
activity O
. O

Genomic O
DNA O
blot O
analysis O
indicates O
that O
the O
trout B
L2 I
locus I
has O
a O
cluster O
- O
like O
organization O
similar O
to O
the O
trout B
L1 I
locus I
and O
the O
IgL B
locus I
of O
several O
teleost O
fish O
. O

Genomic O
DNA O
blot O
analysis O
indicates O
that O
the O
trout B
L2 I
locus I
has O
a O
cluster O
- O
like O
organization O
similar O
to O
the O
trout B
L1 I
locus I
and O
the O
IgL B
locus I
of O
several O
teleost O
fish O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Ligand O
binding O
of O
multi O
- O
chain O
antigen O
receptors O
and O
hematopoietin B
/ O
cytokine O
receptors O
results O
in O
rapid O
activation O
of O
protein B
tyrosine I
kinase I
( O
PTK B
) O
- O
dependent O
signalling O
molecules O
such O
as O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Previous O
data O
suggested O
a O
subtle O
increase O
in O
serum O
P O
at O
the O
time O
of O
hCG B
injection O
without O
LH B
surge O
reduces O
the O
PR O
of O
women O
having O
oocyte O
retrievals O
for O
IVF O
; O
this O
study O
compared O
PRs O
of O
recipients O
in O
a O
shared O
oocyte O
program O
according O
to O
the O
donors O
' O
pre B
- I
hCG I
P O
level O
. O

The O
architecture O
of O
the O
hRap1 B
Myb B
domain I
is O
very O
close O
to O
that O
of O
each O
of O
the O
Myb B
domains I
from O
TRF1 B
, O
scRap1p B
and O
c B
- I
Myb I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

Previous O
studies O
have O
shown O
that O
TGFbeta1 B
expression O
is O
upregulated O
in O
mouse O
keratinocytes O
infected O
with O
a O
v B
- I
rasHa I
retrovirus O
, O
although O
the O
functional O
significance O
of O
this O
has O
not O
been O
clear O
. O

Using O
a O
GTP O
- O
dependent O
, O
brefeldin O
A O
- O
sensitive O
in O
vitro O
AP B
- I
1 I
binding O
assay O
, O
we O
have O
determined O
here O
the O
parameters O
of O
the O
AP B
- I
1 I
binding O
reaction O
. O

Using O
a O
GTP O
- O
dependent O
, O
brefeldin O
A O
- O
sensitive O
in O
vitro O
AP B
- I
1 I
binding O
assay O
, O
we O
have O
determined O
here O
the O
parameters O
of O
the O
AP B
- I
1 I
binding O
reaction O
. O

The O
psi B
zeta I
gene I
has O
a O
nonsense O
mutation O
in O
exon O
1 O
but O
has O
identical O
promoter O
sequence O
and O
RNA O
processing O
sites O
to O
the O
zeta B
gene I
, O
raising O
the O
possibility O
that O
both O
psi B
zeta I
and O
zeta B
are O
transcriptionally O
active O
. O

Heterodimerization B
mutant I
RXR I
failed O
to O
alter O
GFP B
- O
VDR B
and O
nlsGFP B
- O
VDR B
distribution O
or O
activity O
. O

Biochemical O
studies O
and O
studies O
of O
cells O
expressing O
mutant O
IL B
- I
2 I
receptors I
indicate O
that O
IL B
- I
2 I
- O
induced O
tyrosine B
kinase I
activation O
initiates O
a O
complex O
signaling O
cascade O
. O

The O
Synechococcus B
gene I
rps1 I
encoding O
S1 B
is O
located O
1 O
. O
1 O
kb O
downstream O
from O
psbB B
, O
which O
encodes O
the O
photosystem B
II I
P680 I
chlorophyll I
a I
apoprotein I
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 B
antibodies I
, O
demonstrated O
that O
the O
Sp1 B
- I
binding I
site I
in O
the O
CDK6 B
promoter I
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 B
transcription I
factor I
. O

Untransformed O
3T3 O
cells O
carry O
abundant O
1 O
. O
9 O
kb O
Hox B
1 I
. I
3 I
RNA O
, O
whereas O
the O
methylcholanthrene O
- O
transformed O
MB66 O
and O
LTK O
- O
cells O
or O
3T3 O
cells O
transformed O
by O
the O
oncogenes O
src B
, O
fos B
or O
SV40 B
T I
antigen I
express O
only O
low O
levels O
. O

Although O
analysis O
of O
the O
similarity O
between O
the O
44 O
- O
kDa O
protein O
and O
the O
E B
. I
coli I
RecA I
protein I
did O
not O
show O
any O
significant O
homology O
between O
them O
, O
it O
revealed O
their O
identity O
by O
five O
amino O
- O
acid O
residues O
involved O
in O
the O
formation O
of O
the O
epitope O
that O
recognized O
the O
paratope O
of O
the O
RecA B
protein I
antibody I
for O
subsequent O
epitope O
- O
paratope O
binding O
of O
these O
proteins O
. O

Recently O
, O
we O
have O
demonstrated O
that O
mouse O
microglial O
cells O
, O
the O
brain O
macrophages O
, O
express O
both O
IL B
- I
15 I
and O
IL B
- I
15 I
/ I
IL I
- I
2 I
receptors I
. O

These O
results O
suggest O
that O
camptothecin O
resistance O
in O
CEM O
/ O
DOX O
cells O
is O
due O
to O
different O
mechanism O
( O
s O
) O
than O
topoisomerase B
- O
or O
P B
- I
glycoprotein I
- O
associated O
multidrug O
resistance O
. O

The O
pattern O
of O
expression O
of O
this O
and O
other O
Chi26 B
/ O
Chi33 B
chimeric O
promoters O
suggest O
that O
the O
E B
- I
region I
contains O
cis O
- O
acting O
sequences O
which O
activate O
transcription O
in O
aleurone O
and O
silence O
transcription O
in O
leaves O
. O

These O
data O
suggest O
that O
reduction O
in O
PRA O
may O
have O
contributed O
to O
the O
hemodynamic O
effects O
of O
this O
peak B
III I
PDE I
inhibitor O
. O

Binding O
of O
C B
/ I
EBPs I
to O
all O
three O
spi B
2 I
. I
3 I
3 I
' I
UTR I
repressor I
sites I
, O
although O
rather O
weak O
, O
was O
confirmed O
by O
electrophoretic O
mobility O
shift O
assays O
that O
otherwise O
failed O
to O
reveal O
specific O
interactions O
with O
other O
liver O
nuclear O
proteins O
in O
vitro O
. O

PC12 O
cultures O
that O
had O
been O
" O
primed O
" O
in O
this O
way O
showed O
an O
accelerated O
and O
augmented O
differentiation O
response O
to O
nerve B
growth I
factor I
. O

The O
leucine O
zipper O
region O
of O
ATF B
proteins I
is O
also O
similar O
to O
that O
of O
the O
AP B
- I
1 I
/ O
c B
- I
jun I
family O
of O
transcription O
factors O
, O
whose O
DNA O
- O
binding O
site O
differs O
from O
the O
ATF B
- O
binding O
site O
at O
a O
single O
position O
. O

The O
leucine O
zipper O
region O
of O
ATF B
proteins I
is O
also O
similar O
to O
that O
of O
the O
AP B
- I
1 I
/ O
c B
- I
jun I
family O
of O
transcription O
factors O
, O
whose O
DNA O
- O
binding O
site O
differs O
from O
the O
ATF B
- O
binding O
site O
at O
a O
single O
position O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

When O
the O
measured O
beta B
- I
galactosidase I
activity O
in O
the O
pWP O
- O
transfected O
cells O
was O
normalized O
to O
the O
pCH110 O
- O
transfected O
cells O
( O
an O
appropriate O
control O
if O
the O
SV40 B
early I
region I
promoter I
functions O
constitutively O
in O
various O
cell O
lines O
) O
, O
the O
results O
suggested O
that O
the O
promoter O
region O
of O
the O
PLP B
gene I
contains O
the O
information O
necessary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specific O
manner O
. O

The O
P B
- I
ITIM I
- I
compelled I
multi I
- I
phosphoprotein I
complex I
binds O
to O
and O
activates O
SHP B
- I
2 I
, O
which O
in O
turn O
dephosphorylates O
SHIP B
and O
Shc B
and O
probably O
other O
substrates O
. O

We O
propose O
that O
U73 B
is O
involved O
in O
methylation O
of O
the O
G1739 O
residue O
of O
the O
human B
28S I
rRNA I
. O

Lysates O
of O
COS O
cells O
transfected O
with O
modified B
hGrzB I
cDNA I
were O
able O
to O
hydrolyze O
tert O
- O
butyloxycarbonyl O
- O
Ala O
- O
Ala O
- O
Asp O
- O
thiobenzyl O
ester O
( O
Boc O
- O
Ala O
- O
Ala O
- O
Asp O
- O
SBzl O
) O
, O
whereas O
lysates O
transfected O
with O
unmodified B
hGrzB I
cDNA I
were O
inactive O
. O

Lysates O
of O
COS O
cells O
transfected O
with O
modified B
hGrzB I
cDNA I
were O
able O
to O
hydrolyze O
tert O
- O
butyloxycarbonyl O
- O
Ala O
- O
Ala O
- O
Asp O
- O
thiobenzyl O
ester O
( O
Boc O
- O
Ala O
- O
Ala O
- O
Asp O
- O
SBzl O
) O
, O
whereas O
lysates O
transfected O
with O
unmodified B
hGrzB I
cDNA I
were O
inactive O
. O

Proteins O
PBP B
- I
1 I
and O
PBP B
- I
2 I
bind O
to O
two O
of O
the O
three O
promoter O
elements O
in O
the O
trypanosomatid O
Leptomonas O
seymouri O
. O

Proteins O
PBP B
- I
1 I
and O
PBP B
- I
2 I
bind O
to O
two O
of O
the O
three O
promoter O
elements O
in O
the O
trypanosomatid O
Leptomonas O
seymouri O
. O

There O
is O
an O
overall O
functional O
similarity O
between O
IL B
- I
6 I
and O
c B
- I
fos I
promoters I
, O
since O
transfection O
of O
excess O
amounts O
of O
either O
promoter O
DNA O
into O
intact O
HeLa O
cells O
modulates O
the O
function O
of O
the O
heterologous O
promoter O
construct O
. O

To O
determine O
whether O
the O
transcript O
encodes O
an O
active O
enzyme O
, O
we O
developed O
a O
novel O
transient O
embryonic O
excision O
assay O
in O
which O
zebrafish O
fertilized O
eggs O
were O
co O
- O
injected O
with O
RNA O
transcribed O
in O
vitro O
using O
the O
Tol2 B
cDNA I
as O
a O
template O
and O
a O
plasmid O
DNA O
harboring O
a O
nonautonomous O
Tol2 B
element I
, O
which O
has O
a O
deletion O
in O
the O
transposase B
coding I
region I
. O

Signal O
transduction O
in O
fibroblasts O
stably O
transformed O
by O
[ O
Val12 O
] O
Ras O
- O
- O
the O
activities O
of O
extracellular B
- I
signal I
- I
regulated I
kinase I
and O
Jun B
N I
- I
terminal I
kinase I
are O
only O
moderately O
increased O
, O
and O
the O
activity O
of O
the O
delta O
- O
inhibitor O
of O
c B
- I
Jun I
is O
not O
alleviated O
. O

The O
present O
study O
demonstrates O
that O
the O
proto B
- I
oncogene I
c I
- I
jun I
represses O
transcription O
of O
the O
human B
CG I
alpha I
and O
CG B
beta I
promoters I
. O

The O
present O
study O
demonstrates O
that O
the O
proto B
- I
oncogene I
c I
- I
jun I
represses O
transcription O
of O
the O
human B
CG I
alpha I
and O
CG B
beta I
promoters I
. O

c B
- I
Jun I
repressed O
the O
CG B
alpha I
promoter I
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c B
- I
Jun I
and O
other O
members O
of O
the O
B B
- I
Zip I
transcription I
factor I
family I
. O

c B
- I
Jun I
repressed O
the O
CG B
alpha I
promoter I
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c B
- I
Jun I
and O
other O
members O
of O
the O
B B
- I
Zip I
transcription I
factor I
family I
. O

c B
- I
Jun I
repressed O
the O
CG B
alpha I
promoter I
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c B
- I
Jun I
and O
other O
members O
of O
the O
B B
- I
Zip I
transcription I
factor I
family I
. O

Previous O
studies O
using O
partial O
sequences O
have O
suggested O
the O
potential O
of O
26S B
or O
large B
- I
subunit I
( O
LSU B
) O
rDNA O
for O
phylogeny O
retrieval O
at O
taxonomic O
levels O
comparable O
to O
those O
investigated O
with O
18S B
rDNA I
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD B
fragment I
downstream O
of O
the O
lac B
promoter I
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc B
coding I
regions I
with O
the O
efficient O
atpE B
ribosome I
- I
binding I
site I
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

Fas B
( O
APO B
- I
1 I
/ O
CD95 B
) O
, O
which O
is O
a O
member O
of O
the O
tumor B
necrosis I
factor I
receptor I
superfamily I
, O
is O
a O
cell O
surface O
receptor O
that O
induces O
apoptosis O
. O

Viral O
complementary O
15 B
S I
mRNA I
that O
directs O
the O
synthesis O
of O
N B
protein I
and O
hybridizes O
to O
the O
predicted O
N B
gene I
DNA O
has O
been O
identified O
in O
infected O
cell O
extracts O
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase B
I I
protection O
analyses O
revealed O
that O
FP B
I I
was O
bound O
by O
the O
transcription O
factor O
PU B
. I
1 I
/ O
Spi B
- I
1 I
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase B
I I
protection O
analyses O
revealed O
that O
FP B
I I
was O
bound O
by O
the O
transcription O
factor O
PU B
. I
1 I
/ O
Spi B
- I
1 I
. O

NF B
- I
kappaB I
DNA O
- O
protein O
binding O
and O
ICAM B
- I
1 I
promoter I
activity O
were O
enhanced O
by O
IL B
- I
1beta I
and O
these O
effects O
were O
inhibited O
by O
tyrphostin O
23 O
, O
but O
not O
by O
PD O
98059 O
or O
SB O
203580 O
. O

NF B
- I
kappaB I
DNA O
- O
protein O
binding O
and O
ICAM B
- I
1 I
promoter I
activity O
were O
enhanced O
by O
IL B
- I
1beta I
and O
these O
effects O
were O
inhibited O
by O
tyrphostin O
23 O
, O
but O
not O
by O
PD O
98059 O
or O
SB O
203580 O
. O

The O
myb B
proto I
oncogene I
product I
( O
c B
- I
Myb I
) O
is O
a O
transcriptional O
regulator O
and O
its O
expression O
and O
function O
are O
tightly O
linked O
to O
the O
cellular O
entry O
into O
S O
phase O
and O
DNA O
synthesis O
. O

Both O
the O
p38 B
kinase I
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 B
kinase I
reduced O
IL B
- I
1beta I
stimulation O
of O
the O
hBNP B
promoter I
. O

Ptx1 B
belongs O
to O
an O
expanding O
family O
of O
bicoid B
- I
related I
vertebrate O
homeobox O
genes O
. O

Inspection O
of O
X B
. I
tropicalis I
, I
mouse I
and I
human I
U6 I
DNA I
upstream I
sequences I
revealed O
the O
presence O
of O
a O
TATA O
box O
as O
well O
as O
of O
the O
proximal O
and O
enhancer O
( O
octamer O
motif O
) O
elements O
contained O
in O
snRNA O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

The O
human B
PAX8 I
gene I
generates O
at O
least O
five O
different O
alternatively O
spliced O
transcripts O
encoding O
different O
PAX8 B
isoforms I
. O

These O
data O
show O
that O
both O
Sp1 B
and O
Sp3 B
transcription I
factors I
upregulate O
HGF B
promoter I
activity O
by O
binding O
to O
the O
Sp1 B
binding I
site I
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B
gene I
promoter I
. O

These O
data O
show O
that O
both O
Sp1 B
and O
Sp3 B
transcription I
factors I
upregulate O
HGF B
promoter I
activity O
by O
binding O
to O
the O
Sp1 B
binding I
site I
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B
gene I
promoter I
. O

These O
data O
show O
that O
both O
Sp1 B
and O
Sp3 B
transcription I
factors I
upregulate O
HGF B
promoter I
activity O
by O
binding O
to O
the O
Sp1 B
binding I
site I
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B
gene I
promoter I
. O

Mammalian O
homologues O
of O
the O
Polycomb B
- I
group I
gene I
Enhancer B
of I
zeste I
mediate O
gene O
silencing O
in O
Drosophila O
heterochromatin O
and O
at O
S O
. O
cerevisiae O
telomeres O
. O

The O
S3 B
protein I
also O
contains O
a O
DNA O
repair O
activity O
, O
efficiently O
processing O
8 O
- O
oxoguanine O
residues O
in O
DNA O
via O
an O
N B
- I
glycosylase I
/ O
apurinic B
- I
apyrimidinic I
( I
AP I
) I
lyase I
activity O
. O

The O
nucleoporin B
98 I
gene I
( O
NUP98 B
) O
, O
which O
is O
rearranged O
in O
several O
acute O
myeloid O
leukemia O
translocations O
, O
is O
located O
within O
this O
region O
. O

The O
encoded O
Arabidopsis B
U3 I
snRNAs I
can O
be O
folded O
into O
a O
secondary O
structure O
which O
is O
more O
similar O
to O
that O
of O
U3 B
RNAs I
from O
lower O
eukaryotes O
rather O
than O
from O
metazoa O
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF B
- I
kappa I
B I
element I
and O
additional O
regions O
such O
as O
the O
CAAT B
/ I
enhancer I
binding I
protein I
( O
C B
/ I
EBP I
) O
element O
of O
the O
IL B
- I
8 I
promoter I
. O

Cells O
were O
co O
- O
infected O
simultaneously O
with O
IBV O
, O
the O
recombinant O
FPV O
( O
rFPV O
) O
containing O
the O
D O
- O
RNA O
sequence O
and O
a O
second O
rFPV O
expressing O
T7 B
RNA I
polymerase I
for O
the O
initial O
expression O
of O
the O
D O
- O
RNA O
transcript O
, O
subsequently O
rescued O
by O
helper O
IBV O
. O

The O
AP B
- I
1 I
recruited O
by O
ARF1 B
. I
GTP I
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP B
- I
1 I
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 B
( I
Q71L I
) I
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

The O
AP B
- I
1 I
recruited O
by O
ARF1 B
. I
GTP I
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP B
- I
1 I
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 B
( I
Q71L I
) I
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

The O
AP B
- I
1 I
recruited O
by O
ARF1 B
. I
GTP I
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP B
- I
1 I
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 B
( I
Q71L I
) I
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

To O
investigate O
its O
transcription O
, O
1 O
. O
1 O
kilobases O
of O
the O
5 O
' O
- O
flanking O
sequence O
were O
fused O
to O
a O
luciferase B
reporter I
gene I
. O

In O
contrast O
, O
corticotropin B
releasing I
factor I
( O
CRF B
) O
, O
injected O
centrally O
produces O
a O
suppression O
of O
punished O
and O
non O
- O
punished O
responding O
in O
the O
conflict O
test O
consistent O
with O
its O
hypothesized O
role O
in O
mediating O
behavioral O
responses O
to O
stress O
. O

Temporal O
recruitment O
of O
the O
mSin3A B
- O
histone B
deacetylase I
corepressor O
complex O
to O
the O
ETS B
domain I
transcription I
factor I
Elk B
- I
1 I
. O

In O
addition O
, O
FOP B
- O
FGFR1 B
- O
expressing O
cells O
show O
constitutive O
phosphorylation O
of O
the O
positive O
regulator O
of O
translation O
p70S6 B
kinase I
; O
this O
phosphorylation O
is O
inhibited O
by O
PI3 B
- I
kinase I
and O
mTOR B
( O
mammalian B
target I
of I
rapamycin I
) O
inhibitors O
. O

This O
is O
similar O
to O
previous O
reports O
of O
muscle B
creatine I
phosphokinase I
release O
in O
psychiatric O
patients O
. O

We O
found O
that O
the O
PRP20 B
gene I
is O
identical O
to O
the O
yeast B
SRM1 I
gene I
( O
Clark O
and O
Sprague O
1989 O
) O
. O

Basal O
JNK B
MAPK I
kinase I
activity O
was O
also O
specifically O
induced O
by O
deltaEGFR B
, O
which O
correlated O
with O
increased O
phosphorylation O
of O
a O
54 B
- I
kDa I
JNK2 I
protein I
observed O
in O
deltaEGFR B
- O
containing O
cells O
. O

Deletion O
analysis O
defines O
distinct O
functional O
domains O
for O
protein O
- O
protein O
and O
nucleic O
acid O
interactions O
in O
the O
ORF1 B
protein I
of O
mouse O
LINE B
- I
1 I
. O

PMA O
produced O
similar O
results O
, O
but O
the O
induction O
of O
the O
WT B
AP1 I
c B
- I
jun I
promoter O
- O
CAT O
plasmid O
was O
smaller O
. O

As O
a O
test O
of O
this O
hypothesis O
, O
we O
predicted O
that O
mice O
which O
have O
altered O
expression O
of O
class O
I O
gene O
products O
, O
the O
beta2 B
- I
microglobulin I
knockout O
mice O
, O
[ B
beta2m I
( I
- I
/ I
- I
) I
] I
, O
would O
develop O
Fe O
overload O
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN B
- I
gamma I
- O
activated O
transcription O
factors O
, O
STAT B
- I
1alpha I
and O
IRF B
- I
1 I
, O
bind O
the O
GAS B
and O
IRF B
elements I
, O
respectively O
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN B
- I
gamma I
- O
activated O
transcription O
factors O
, O
STAT B
- I
1alpha I
and O
IRF B
- I
1 I
, O
bind O
the O
GAS B
and O
IRF B
elements I
, O
respectively O
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN B
- I
gamma I
- O
activated O
transcription O
factors O
, O
STAT B
- I
1alpha I
and O
IRF B
- I
1 I
, O
bind O
the O
GAS B
and O
IRF B
elements I
, O
respectively O
. O

Helenalin O
triggers O
a O
CD95 B
death I
receptor I
- O
independent O
apoptosis O
that O
is O
not O
affected O
by O
overexpression O
of O
Bcl B
- I
x I
( I
L I
) I
or O
Bcl B
- I
2 I
. O

Helenalin O
triggers O
a O
CD95 B
death I
receptor I
- O
independent O
apoptosis O
that O
is O
not O
affected O
by O
overexpression O
of O
Bcl B
- I
x I
( I
L I
) I
or O
Bcl B
- I
2 I
. O

Sequence O
analysis O
and O
electrophoretic O
mobility O
shift O
experiments O
suggest O
that O
GnSE B
response I
elements I
interact O
, O
in O
these O
two O
regions O
, O
with O
GATA B
- I
and I
LIM I
- I
related I
factors I
, O
respectively O
. O

Wild O
type O
MEKK1 B
enhances O
promoter O
activity O
and O
the O
activity O
can O
be O
inhibited O
by O
dominant O
negative O
MEKK1 B
, O
MEK1 B
, O
MEK7 B
, O
MEK3 B
, O
p38 B
/ O
RK B
, O
and O
c B
- I
Jun I
. O

An O
scrR B
promoter I
fragment I
, O
which O
dose O
not O
contain O
a O
sequence O
resembling O
OB B
, O
was O
not O
shifted O
by O
the O
fusion O
protein O
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta B
- I
adrenoceptor I
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 B
- I
HT1A I
and I
5 I
- I
HT1B I
receptors I
, O
and O
of O
the O
selective O
beta B
1 I
- I
and I
beta I
2 I
- I
adrenoceptor I
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 B
- I
HT I
receptors I
. O

Indeed O
, O
after O
a O
single O
oral O
dose O
, O
the O
role O
of O
the O
mu B
- I
receptor I
agonist O
component O
of O
the O
antinociceptive O
effect O
of O
tramadol O
appears O
to O
be O
minor O
, O
with O
most O
of O
the O
analgesic O
effect O
being O
attributable O
to O
nonopioid O
properties O
of O
the O
parent O
compound O
. O

Organization O
of O
exons O
suggests O
that O
, O
similar O
to O
the O
human B
VEGF I
gene I
, O
alternative O
splicing O
generates O
the O
120 O
- O
, O
164 O
- O
, O
and O
188 O
- O
amino O
acid O
isoforms O
, O
but O
does O
not O
predict O
a O
fourth O
VEGF B
isoform I
corresponding O
to O
human B
VEGF206 I
. O

Genomic O
organization O
of O
the O
human B
multidrug I
resistance I
( I
MDR1 I
) I
gene I
and O
origin O
of O
P B
- I
glycoproteins I
. O

Serum B
alkaline I
phosphatase I
and O
creatine B
kinase I
activities O
were O
significantly O
increased O
in O
the O
A O
praelongus O
- O
fed O
pigs O
and O
significantly O
decreased O
in O
Na2SeO4 O
- O
fed O
pigs O
. O

Phosphorylation O
of O
the O
ras B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
by O
the O
p93c B
- I
fes I
protein B
- I
tyrosine I
kinase I
in O
vitro O
and O
formation O
of O
GAP B
- O
fes B
complexes O
via O
an O
SH2 B
domain O
- O
dependent O
mechanism O
. O

RET B
/ O
PTC B
oncogenes O
, O
generated O
by O
chromosomal O
rearrangements O
in O
papillary O
thyroid O
carcinomas O
, O
are O
constitutively O
activated O
versions O
of O
proto B
- I
RET I
, O
a O
gene O
coding O
for O
a O
receptor B
- I
type I
tyrosine I
kinase I
( O
TK B
) O
whose O
ligand O
is O
still O
unknown O
. O

By O
deletion O
analysis O
, O
we O
identified O
the O
regions O
of O
c B
- I
Jun I
encoding O
transformation O
and O
transactivation O
functions O
. O

Fli B
- I
1 I
is O
a O
proto O
- O
oncogene O
which O
is O
rearranged O
in O
tumors O
induced O
by O
three O
different O
retroviruses O
, O
Cas O
- O
Br O
- O
E O
, O
F O
- O
MuLV O
, O
and O
10A1 O
. O

Analysis O
of O
WT1 B
target I
gene I
expression O
in O
stably O
transfected O
cell O
lines O
. O

Our O
results O
showed O
that O
the O
5 O
- O
hydroxytryptamine O
( O
5 O
- O
HT O
) O
content O
in O
platelets O
was O
: O
( O
1 O
) O
increased O
in O
the O
subgroup O
of O
anti O
- O
social O
alcoholics O
; O
( O
2 O
) O
transiently O
and O
differently O
altered O
in O
alcoholics O
compared O
to O
opiate O
addicts O
; O
and O
( O
3 O
) O
lowered O
in O
drinking O
alcoholics O
and O
normal O
in O
alcoholics O
who O
were O
drinking O
as O
well O
as O
smoking O
( O
that O
may O
occur O
via O
MAO B
- I
B I
inhibition O
by O
smoke O
) O
. O

This O
sequence O
can O
interact O
with O
at O
least O
two O
proteins O
in O
a O
fibroblast O
nuclear O
extract O
that O
have O
binding O
characteristics O
of O
an O
Ets B
family I
protein I
and O
a O
serum B
response I
factor I
- I
like I
protein I
. O

Several O
positive O
clones O
were O
isolated O
, O
one O
of O
which O
encoded O
the O
C O
- O
terminal O
253 O
amino O
acids O
of O
a O
putative O
RNA B
helicase I
, O
a O
DEAD B
box I
protein I
designated O
DDX3 B
. O

To O
investigate O
whether O
the O
two O
RPG B
- I
boxes I
mediate O
transcription O
activation O
of O
both O
the O
L46 B
and O
S24 B
gene I
, O
two O
experimental O
strategies O
were O
followed O
: O
cloning O
of O
the O
respective O
genes O
on O
multicopy O
vectors O
and O
construction O
of O
fusion O
genes O
. O

This O
was O
further O
suggested O
by O
transactivation O
assays O
in O
which O
mouse O
fibroblasts O
were O
transiently O
transfected O
with O
a O
human B
beta I
- I
globin I
reporter I
gene I
in O
the O
absence O
and O
presence O
of O
an O
LKLF B
cDNA I
construct I
. O

Sequence O
analysis O
identifies O
a O
ras B
- I
associating I
( O
RA B
) O
- O
like O
domain O
in O
the O
N O
- O
termini O
of O
band B
4 I
. I
1 I
/ I
JEF I
domains I
and O
in O
the O
Grb7 B
/ I
10 I
/ I
14 I
adapter I
family I
. O

Rhinovirus B
2A I
protease I
and O
foot B
- I
and I
- I
mouth I
- I
disease I
virus I
L I
protease I
were O
used O
to O
analyze O
the O
association O
of O
eIF4G B
with O
eIF4A B
, O
eIF4E B
, O
and O
eIF3 B
. O

Furthermore O
, O
it O
was O
found O
that O
the O
Shb B
- O
overexpressing O
cells O
extended O
neurites O
in O
response O
to O
epidermal B
growth I
factor I
. O

In O
cases O
of O
intracapsular O
prostatic O
cancer O
the O
level O
of O
prostatic B
acid I
phosphatase I
( O
PAP B
) O
measured O
by O
radioimmunoassay O
was O
1 O
. O
4 O
+ O
/ O
- O
0 O
. O
8 O
micrograms O
/ O
l O
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Immunoprecipitation O
of O
cell O
lysates O
with O
anti B
- I
phosphotyrosine I
and O
immunoblotting O
showed O
phosphorylated O
forms O
of O
the O
mitogenic O
pathway O
proteins O
Shc B
and O
MAPK B
in O
addition O
to O
p185 B
( O
neu B
) O
, O
suggesting O
that O
the O
Ras B
to O
MAPK B
mitogenic O
pathway O
is O
activated O
. O

Molecular O
analysis O
indicated O
that O
inactivation O
of O
H B
- I
2L I
expression O
in O
nearly O
every O
null O
clone O
resulted O
from O
an O
apparent O
deletion O
or O
rearrangement O
of O
5 B
' I
- I
flanking I
and I
5 I
' I
- I
coding I
H I
- I
2L I
sequences I
, O
with O
breakpoints O
consistently O
mapping O
to O
within O
a O
550 O
bp O
GC O
- O
rich O
region O
between O
exon O
1 O
and O
the O
middle O
of O
intron O
2 O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk B
- I
1 I
in O
GH4 O
cells O
decreased O
insulin B
- O
increased O
prolactin B
gene I
expression O
and O
confirmed O
the O
requirement O
for O
Elk B
- I
1 I
for O
insulin B
- O
increased O
prolactin B
gene I
expression O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk B
- I
1 I
in O
GH4 O
cells O
decreased O
insulin B
- O
increased O
prolactin B
gene I
expression O
and O
confirmed O
the O
requirement O
for O
Elk B
- I
1 I
for O
insulin B
- O
increased O
prolactin B
gene I
expression O
. O

The O
aromatic B
hydrocarbon I
receptor I
( O
AHR B
) O
is O
a O
ligand O
- O
activated O
transcription O
factor O
that O
regulates O
the O
expression O
of O
several O
drug O
- O
metabolizing O
enzymes O
and O
has O
been O
implicated O
in O
immunosuppression O
, O
teratogenesis O
, O
cell O
- O
specific O
hyperplasia O
, O
and O
certain O
types O
of O
malignancies O
and O
toxicities O
. O

ER O
and O
DR O
were O
significantly O
correlated O
with O
MIB B
- I
1 I
LI O
( O
P O
< O
0 O
. O
01 O
and O
P O
< O
0 O
. O
05 O
, O
respectively O
) O
, O
but O
RI O
and O
Td O
/ O
Te O
were O
not O
. O

Mutation O
of O
the O
distal O
E2F B
binding I
site I
in O
the O
cdc25A B
promoter I
abolished O
E2 B
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F B
site I
or O
the O
E2 B
site I
had O
no O
effect O
. O

Plasmid O
pNK21 O
, O
in O
which O
2 O
. O
05 O
- O
kb O
sequence O
covering O
the O
region O
encoding O
the O
nitrilase B
was O
was O
placed O
under O
the O
control O
of O
the O
lac B
promoter I
, O
directed O
overproduction O
of O
enzymatically B
active I
nitrilase I
in O
response O
to O
addition O
of O
isopropyl O
beta O
- O
D O
- O
thiogalactopyranoside O
in O
Escherichia O
coli O
. O

Insertion O
of O
alternatively O
spliced O
exon O
W O
into O
CREB B
mRNA I
during O
spermatogenesis O
results O
in O
a O
polycistronic O
RNA O
that O
encodes O
two O
novel O
internally O
translated O
CREB B
repressor I
isoforms I
called O
I B
- I
CREBs I
, O
consisting O
of O
the O
carboxy O
- O
terminal O
DNA O
- O
binding O
domain O
devoid O
of O
the O
transactivation O
domains O
. O

Insertion O
of O
alternatively O
spliced O
exon O
W O
into O
CREB B
mRNA I
during O
spermatogenesis O
results O
in O
a O
polycistronic O
RNA O
that O
encodes O
two O
novel O
internally O
translated O
CREB B
repressor I
isoforms I
called O
I B
- I
CREBs I
, O
consisting O
of O
the O
carboxy O
- O
terminal O
DNA O
- O
binding O
domain O
devoid O
of O
the O
transactivation O
domains O
. O

Consistent O
with O
this O
hypothesis O
, O
alpha1 B
- I
PDX I
prevents O
cleavage O
of O
BMP B
- I
4 I
in O
an O
oocyte O
translation O
assay O
. O

Consistent O
with O
this O
hypothesis O
, O
alpha1 B
- I
PDX I
prevents O
cleavage O
of O
BMP B
- I
4 I
in O
an O
oocyte O
translation O
assay O
. O

Platelet B
factor I
4 I
levels O
in O
patients O
with O
coronary O
artery O
disease O
. O

The O
glucose O
effect O
on O
the O
pyruvate B
kinase I
gene I
is O
reversibly O
antagonized O
by O
agents O
increasing O
intracellular O
cAMP O
. O

Coexpression O
of O
CREB B
- I
binding I
protein I
( O
CBP B
) O
/ O
p300 B
with O
TReP B
- I
132 I
has O
an O
additive O
effect O
on O
promoter O
activity O
, O
and O
the O
proteins O
were O
demonstrated O
to O
interact O
physically O
. O

Each O
fusion O
leads O
, O
in O
principle O
, O
to O
the O
same O
effect O
: O
The O
ret B
tyrosine I
kinase I
is O
uncoupled O
from O
its O
stringent O
physiological O
regulation O
by O
replacement O
of O
its O
5 O
' O
end O
and O
is O
aberrantly O
activated O
by O
the O
5 O
' O
parts O
of O
fused O
genes O
in O
thyrocytes O
that O
do O
not O
normally O
express O
ret B
tyrosine I
kinase I
. O

Each O
fusion O
leads O
, O
in O
principle O
, O
to O
the O
same O
effect O
: O
The O
ret B
tyrosine I
kinase I
is O
uncoupled O
from O
its O
stringent O
physiological O
regulation O
by O
replacement O
of O
its O
5 O
' O
end O
and O
is O
aberrantly O
activated O
by O
the O
5 O
' O
parts O
of O
fused O
genes O
in O
thyrocytes O
that O
do O
not O
normally O
express O
ret B
tyrosine I
kinase I
. O

Nine O
months O
after O
the O
end O
of O
the O
vaccination O
anti B
- I
HBsAg I
levels O
had O
dropped O
to O
9 O
+ O
/ O
- O
4 O
IU O
/ O
1 O
( O
M O
+ O
/ O
- O
SE O
) O
, O
with O
a O
geometric O
mean O
of O
5 O
IU O
/ O
1 O
, O
in O
the O
nine O
remaining O
evaluable O
patients O
. O

Control O
oligomers O
of O
scrambled O
sequence O
but O
identical O
base O
composition O
were O
ineffective O
, O
and O
no O
TFO O
- O
induced O
recombination O
was O
seen O
in O
a O
control O
LTK O
( O
- O
) O
cell O
line O
carrying O
an O
otherwise O
identical O
dual O
TK B
gene I
construct I
lacking O
the O
30 O
- O
bp O
polypurine O
target O
site O
. O

One O
cytoplasmic O
target O
which O
reflects O
the O
functional O
state O
of O
the O
plastids O
is O
protein B
kinase I
C I
. O

These O
three O
chromosomes O
share O
the O
transferrin B
gene I
( O
TF B
) O
, O
the O
myosin B
light I
polypeptide I
3 I
gene I
( O
MYL3 B
) O
, O
and O
the O
acylpeptide B
hydrolase I
gene I
( O
APEH B
) O
. O

These O
data O
indicate O
that O
SB O
203580 O
sensitive O
p38 B
MAP I
kinases I
are O
not O
involved O
in O
okadaic O
acid O
mediated O
increases O
in O
TRE O
DNA O
binding O
and O
transactivation O
. O

Sgs B
- I
4 I
is O
one O
of O
the O
eight O
known O
genes O
coding O
for O
larval O
secretion O
proteins O
in O
Drosophila O
melanogaster O
. O

The O
human B
BRCA1 I
promoter I
also O
contains O
a O
conserved O
E2F B
site I
and O
is O
similarly O
regulated O
by O
E2F1 B
and O
Rb B
. O

Using O
unidirectional O
PCR O
we O
isolated O
a O
361 O
- O
bp O
5 O
' O
promoter O
region O
and O
delineated O
the O
intronic O
/ O
exonic O
boundaries O
which O
include O
a O
non O
- O
coding O
exon O
1 O
, O
a O
single O
intron O
, O
and O
a O
coding O
exon O
2 O
, O
a O
structure O
that O
is O
typical O
of O
genes O
of O
the O
RNase B
A I
superfamily I
. O

This O
C O
- O
terminal O
domain O
contains O
several O
YxxI O
/ O
L O
motifs O
reminiscent O
of O
LMP2A B
and O
a O
putative O
TRAF B
binding I
site I
as O
in O
LMP1 B
. O

SCAN B
boxes O
are O
found O
in O
eight O
other O
genes O
in O
the O
GenBank O
database O
, O
five O
of O
which O
are O
also O
in O
the O
Kruppel B
family I
of O
zinc B
finger I
proteins I
lacking O
KRAB B
A I
and I
B I
domains O
and O
thereby O
define O
a O
new O
subclass O
of O
zinc B
finger I
proteins I
. O

SCAN B
boxes O
are O
found O
in O
eight O
other O
genes O
in O
the O
GenBank O
database O
, O
five O
of O
which O
are O
also O
in O
the O
Kruppel B
family I
of O
zinc B
finger I
proteins I
lacking O
KRAB B
A I
and I
B I
domains O
and O
thereby O
define O
a O
new O
subclass O
of O
zinc B
finger I
proteins I
. O

In O
the O
plant B
malate I
synthases I
, O
the O
extension O
is O
probably O
involved O
in O
routing O
to O
the O
microbodies O
, O
since O
it O
contains O
the O
potential O
peroxisomal O
targeting O
signal O
, O
Ser O
- O
Arg O
/ O
Lys O
- O
Leu O
, O
at O
the O
carboxy O
terminus O
. O

Screening O
of O
human O
cDNA O
libraries O
has O
identified O
two O
different O
5 O
' O
- O
termini O
and O
alternatively O
spliced O
forms O
of O
the O
human B
Fli I
- I
1 I
gene I
( O
Fli B
- I
1b I
) O
, O
suggesting O
the O
possible O
existence O
of O
two O
independent O
promoters O
. O

We O
suggest O
that O
the O
induction O
of O
IFNA B
promoter I
region I
requires O
cooperation O
between O
alpha B
F1 I
binding I
proteins I
and O
IRF B
- I
1 I
. O

We O
suggest O
that O
the O
induction O
of O
IFNA B
promoter I
region I
requires O
cooperation O
between O
alpha B
F1 I
binding I
proteins I
and O
IRF B
- I
1 I
. O

Heterologous O
hybridization O
with O
a O
rps12 B
gene I
specific O
probe O
from O
Euglena O
has O
revealed O
the O
presence O
of O
rps12 B
homologous I
sequences I
within O
the O
inverted O
repeat O
of O
Spirodela O
chloroplast O
DNA O
on O
the O
fragment B
BamHI I
- I
V I
. O

Plasmid O
subclones O
of O
the O
hr1a B
- O
containing O
AcMNPV O
HindIII B
- O
N O
fragment O
were O
examined O
for O
their O
ability O
to O
replicate O
in O
virus O
- O
infected O
( O
Spodoptera O
frugiperda O
) O
Sf9 O
cells O
, O
and O
to O
stimulate O
transcription O
when O
linked O
in O
cis O
with O
a O
39K B
gene I
promoter I
- I
beta I
- I
glucuronidase I
fusion I
and O
cotransfected O
into O
cells O
along O
with O
a O
plasmid O
( O
ple O
- O
1 O
) O
containing O
the O
gene O
encoding O
the O
trans O
- O
acting O
factor O
IE B
- I
1 I
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

In O
normal O
B O
cells O
stimulated O
by O
LPS O
or O
IL B
- I
4 I
, O
new O
complexes O
appear O
that O
bind O
to O
C B
/ I
EBP I
and O
NF B
- I
IL I
- I
4 I
elements I
, O
respectively O
, O
located O
within O
the O
- O
125 O
/ O
- O
101 O
region O
. O

In O
normal O
B O
cells O
stimulated O
by O
LPS O
or O
IL B
- I
4 I
, O
new O
complexes O
appear O
that O
bind O
to O
C B
/ I
EBP I
and O
NF B
- I
IL I
- I
4 I
elements I
, O
respectively O
, O
located O
within O
the O
- O
125 O
/ O
- O
101 O
region O
. O

Treatment O
of O
cells O
for O
10 O
min O
with O
TNF B
- I
alpha I
resulted O
in O
activation O
of O
p44 B
/ I
42 I
MAPK O
, O
p38 B
, O
and O
JNK B
. O

Treatment O
of O
cells O
for O
10 O
min O
with O
TNF B
- I
alpha I
resulted O
in O
activation O
of O
p44 B
/ I
42 I
MAPK O
, O
p38 B
, O
and O
JNK B
. O

A O
child O
presumed O
to O
have O
the O
21 B
- I
hydroxylase I
deficiency O
form O
of O
congenital O
adrenal O
hyperplasia O
was O
studied O
extensively O
as O
an O
infant O
. O

Following O
EGF B
or O
NGF B
stimulation O
of O
the O
v O
- O
CrkPC12 O
cells O
, O
the O
v B
- I
Crk I
protein O
itself O
became O
tyrosine O
phosphorylated O
within O
1 O
min O
. O

Deletion O
analysis O
of O
the O
3 O
. O
5kb O
DNA O
fragment O
revealed O
that O
the O
region O
between O
- O
125 O
to O
+ O
1 O
, O
containing O
a O
single O
Sp1 B
binding I
site I
, O
is O
essential O
for O
transcription O
of O
the O
embigin B
gene I
. O

The O
protein B
kinase I
C I
inhibitor O
GF O
- O
109203X O
abolished O
the O
activation O
by O
phorbol O
ester O
and O
inhibited O
the O
effect O
of O
CCK B
by O
78 O
% O
but O
had O
no O
effect O
on O
EGF B
- O
activated O
MAPK B
activity O
. O

Activated O
FGFR3 B
predominantly O
interacts O
with O
GRB2 B
. I
Sos I
in O
complex O
with O
a O
previously O
identified O
90 O
- O
kDa O
protein O
and O
designated O
protein B
80K I
- I
H I
. O

Co O
- O
expression O
of O
PLD1 B
in O
COS O
- O
7 O
cells O
with O
the O
two O
recombinant B
CK2 I
subunits I
, O
alpha O
or O
beta O
, O
suggests O
that O
the O
association O
of O
PLD1 B
with O
the O
kinase O
is O
through O
the O
beta O
subunit O
. O

Human B
recombinant I
erythropoietin I
( O
r B
- I
HuEPO I
, O
EprexR B
) O
was O
administered O
to O
8 O
children O
with O
chronic O
renal O
failure O
and O
high O
transfusion O
requirement O
. O

Human B
recombinant I
erythropoietin I
( O
r B
- I
HuEPO I
, O
EprexR B
) O
was O
administered O
to O
8 O
children O
with O
chronic O
renal O
failure O
and O
high O
transfusion O
requirement O
. O

Northern O
analyses O
further O
confirm O
that O
the O
expression O
of O
endogenous O
alpha B
- I
ENaC I
gene I
in O
salivary O
Pa O
- O
4 O
cells O
is O
suppressed O
by O
an O
ectopic O
HMGI B
- I
C I
overexpression O
. O

Gel O
mobility O
shift O
analyses O
reveal O
that O
FRTL O
- O
5 O
thyroid O
cell O
nuclear O
extracts O
form O
a O
specific O
protein O
/ O
DNA O
complex O
with O
this O
region O
, O
which O
is O
prevented O
by O
the O
TTF B
- I
1 I
binding I
element I
from O
the O
TG B
promoter I
; O
FRT O
and O
BRL O
cell O
nuclear O
extracts O
do O
not O
have O
TTF B
- I
1 I
and O
do O
not O
form O
this O
complex O
. O

Characterization O
of O
a O
DEAD B
box I
ATPase I
/ O
RNA B
helicase I
protein O
of O
Arabidopsis O
thaliana O
. O

In O
the O
studies O
described O
in O
this O
report O
, O
we O
have O
identified O
two O
potential O
Ets B
binding O
sites O
, O
EBS1 B
and O
EBS2 B
, O
which O
are O
conserved O
in O
both O
the O
human O
and O
murine O
interleukin B
- I
2 I
enhancers O
. O

The O
distinct O
spatial O
pattern O
of O
expression O
, O
and O
unusual O
amino O
acid O
sequence O
in O
its O
DNA O
binding O
domain O
, O
may O
indicate O
a O
particular O
role O
for O
DTEF B
- I
1 I
in O
cell O
- O
specific O
gene O
regulation O
. O

As O
anticipated O
, O
both O
intracellular O
p54 B
- O
SAPKbeta B
activation O
and O
Bcl B
- I
2 I
phosphorylation O
are O
blocked O
by O
co O
- O
transfection O
with O
the O
MAP B
kinase I
specific O
phosphatase O
MKP3 B
/ O
PYST1 B
. O

To O
assess O
the O
safety O
of O
the O
angiotensin B
converting I
enzyme I
inhibitor O
enalapril O
a O
multicenter O
, O
open O
, O
randomized O
, O
prazosin O
- O
controlled O
trial O
was O
designed O
comparing O
the O
incidence O
and O
severity O
of O
symptomatic O
hypotension O
on O
the O
first O
day O
of O
treatment O
. O

Oct B
- I
1 I
is O
a O
ubiquitously O
expressed O
regulatory O
gene O
of O
the O
POU B
domain I
family I
. O

Oct B
- I
1 I
is O
a O
ubiquitously O
expressed O
regulatory O
gene O
of O
the O
POU B
domain I
family I
. O

This O
is O
a O
consensus O
casein B
kinase I
II I
( O
CKII B
) O
site O
and O
, O
using O
purified O
wild O
- O
type O
and O
mutant O
proteins O
, O
we O
show O
that O
it O
is O
the O
main O
CKII B
site I
in O
the O
body O
of O
the O
N O
- O
terminal O
complex O
- O
forming O
region O
. O

Treatment O
with O
polyinosinic O
- O
polycytidylic O
acid O
to O
induce O
expression O
of O
Cre B
resulted O
in O
complete O
disruption O
of O
the O
Arnt B
gene I
and O
loss O
of O
ARNT B
messenger I
RNA I
( O
mRNA O
) O
expression O
in O
liver O
. O

Tubular O
dysfunction O
in O
renal O
lithiasis O
: O
cause O
or O
consequence O
? O
] O
To O
investigate O
whether O
overall O
tubular O
dysfunction O
is O
encountered O
in O
a O
particular O
subgroup O
of O
patients O
with O
urolithiasis O
, O
the O
following O
parameters O
of O
renal O
tubular O
function O
have O
been O
measured O
in O
fasting O
morning O
urine O
in O
124 O
male O
stone O
formers O
: O
excretion O
of O
lysozyme B
and O
gamma B
- I
glutamyl I
transpeptidase I
( O
gamma B
- I
GT I
) O
, O
fractional O
excretion O
( O
FE O
) O
or O
glucose O
, O
insulin B
, O
bicarbonate O
after O
an O
alkali O
load O
, O
and O
theoretical O
phosphate O
threshold O
( O
TmP O
/ O

Interaction O
between O
the O
tobacco O
DNA O
- O
binding O
activity O
CBF B
and O
the O
cyt B
- I
1 I
promoter I
element I
of O
the O
Agrobacterium O
tumefaciens O
T O
- O
DNA O
gene O
T B
- I
CYT I
correlates O
with O
cyt B
- I
1 I
directed O
gene O
expression O
in O
multiple O
tobacco O
tissue O
types O
. O

Interaction O
between O
the O
tobacco O
DNA O
- O
binding O
activity O
CBF B
and O
the O
cyt B
- I
1 I
promoter I
element I
of O
the O
Agrobacterium O
tumefaciens O
T O
- O
DNA O
gene O
T B
- I
CYT I
correlates O
with O
cyt B
- I
1 I
directed O
gene O
expression O
in O
multiple O
tobacco O
tissue O
types O
. O

In O
the O
case O
of O
the O
pT181 O
plasmid O
, O
inactivation O
of O
the O
initiator B
RepC I
protein I
occurs O
by O
the O
attachment O
of O
an O
oligonucleotide O
to O
its O
active O
tyrosine O
residue O
. O

In O
this O
report O
, O
we O
describe O
a O
patient O
with O
renal O
cell O
carcinoma O
who O
experienced O
ventricular O
tachycardia O
while O
undergoing O
treatment O
with O
high O
- O
dose O
bolus O
IL B
- I
2 I
. O

Examination O
of O
the O
Coomassie O
- O
stained O
gels O
revealed O
that O
the O
capsid O
- O
like O
particles O
composed O
of O
the O
N11 B
- I
VP1 I
protein O
did O
not O
contain O
any O
host O
- O
derived O
histones B
. O

Conversion O
of O
an O
NF B
- I
kappaB I
into O
a O
GABP B
binding O
site O
is O
likely O
to O
have O
occurred O
also O
during O
the O
worldwide O
spread O
of O
HIV O
- O
1 O
, O
as O
we O
noticed O
the O
same O
LTR O
modification O
in O
subtype O
E O
isolates O
from O
Thailand O
. O

We O
then O
isolated O
the O
full O
- O
length O
coding O
region O
of O
the O
human B
BACH1 I
gene I
using O
expressed O
sequence O
tags O
, O
reverse O
transcription O
- O
polymerase O
chain O
reaction O
and O
rapid O
amplification O
of O
cDNA O
ends O
. O

Because O
c B
- I
myb I
encodes O
a O
transcriptional O
activator O
that O
functions O
via O
DNA O
binding O
, O
it O
is O
likely O
that O
c B
- I
myb I
exerts O
its O
biological O
activity O
by O
regulating O
the O
transcription O
of O
genes O
required O
for O
DNA O
synthesis O
and O
cell O
cycle O
progression O
. O

Because O
c B
- I
myb I
encodes O
a O
transcriptional O
activator O
that O
functions O
via O
DNA O
binding O
, O
it O
is O
likely O
that O
c B
- I
myb I
exerts O
its O
biological O
activity O
by O
regulating O
the O
transcription O
of O
genes O
required O
for O
DNA O
synthesis O
and O
cell O
cycle O
progression O
. O

Coexpression O
of O
c B
- I
Rel I
in O
combination O
with O
ATF B
- I
1 I
, O
CREB2 B
, O
or O
ATF B
- I
1 I
/ O
CREB2 B
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE B
- I
TRE I
reporter I
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

Coexpression O
of O
c B
- I
Rel I
in O
combination O
with O
ATF B
- I
1 I
, O
CREB2 B
, O
or O
ATF B
- I
1 I
/ O
CREB2 B
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE B
- I
TRE I
reporter I
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

Coexpression O
of O
c B
- I
Rel I
in O
combination O
with O
ATF B
- I
1 I
, O
CREB2 B
, O
or O
ATF B
- I
1 I
/ O
CREB2 B
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE B
- I
TRE I
reporter I
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

IGF B
- I
I I
levels O
were O
measured O
in O
the O
CSF O
of O
11 O
children O
with O
autism O
( O
4 O
females O
, O
7 O
males O
; O
mean O
age O
3 O
. O
8 O
years O
, O
SD O
1 O
. O
1 O
) O
using O
a O
sensitive O
radioimmunoassay O
method O
and O
compared O
with O
levels O
in O
11 O
control O
participants O
( O
6 O
females O
, O
5 O
males O
; O
mean O
age O
3 O
. O
8 O
years O
) O
. O

Our O
case O
, O
however O
, O
had O
no O
histologic O
evidence O
of O
malignancy O
, O
no O
serum B
alpha I
fetoprotein I
at O
7 O
months O
of O
age O
, O
and O
no O
recurrence O
at O
1 O
years O
. O

Cotransfection O
experiments O
revealed O
that O
both O
hGATA B
- I
4 I
and O
PMA O
/ O
A23187 O
stimulation O
are O
necessary O
for O
the O
IL B
- I
5 I
promoter I
activation O
. O

Here O
we O
show O
that O
expression O
of O
KRAB B
domain I
suppresses O
in O
vivo O
the O
activating O
function O
of O
various O
defined O
activating B
transcription I
factors I
, O
and O
we O
demonstrate O
that O
the O
KRAB B
domain I
specifically O
silences O
the O
activity O
of O
promoters O
whose O
initiation O
is O
dependent O
on O
the O
presence O
of O
a O
TATA O
box O
. O

These O
results O
support O
an O
in O
vivo O
interaction O
between O
Nck B
and O
CKI B
- I
gamma2 I
and O
suggest O
that O
CKI B
- I
gamma2 I
could O
be O
involved O
in O
signaling O
pathways O
downstream O
of O
RTKs B
. O

These O
results O
support O
an O
in O
vivo O
interaction O
between O
Nck B
and O
CKI B
- I
gamma2 I
and O
suggest O
that O
CKI B
- I
gamma2 I
could O
be O
involved O
in O
signaling O
pathways O
downstream O
of O
RTKs B
. O

It O
also O
showed O
which O
amino O
acid O
residues O
would O
contact O
an O
extended O
TATA O
box O
with O
a O
B B
recognition I
element I
, O
and O
evolutionary O
conservation O
of O
the O
TBP B
- O
TFB B
- O
DNA O
complex O
orientation O
between O
two O
archaeal O
organisms O
with O
widely O
different O
optimal O
temperature O
for O
growth O
( O
37 O
and O
100 O
degrees O
C O
) O
. O

Comparison O
of O
this O
gene O
with O
the O
available O
databases O
reveals O
very O
significant O
homology O
to O
the O
ETS B
factor I
PE B
- I
1 I
and O
probable O
near O
- O
identity O
with O
the O
recently O
cloned O
factor O
ERF B
. O

Such O
tetranucleotides O
are O
common O
in O
promoter O
regions O
, O
particularly O
in O
activating B
transcription I
factor I
/ O
cyclic B
AMP I
response I
element I
- I
binding I
protein I
( O
ATF B
/ O
CREB B
) O
and O
E O
- O
box O
motifs O
, O
suggesting O
that O
PIF B
may O
modulate O
the O
transcription O
of O
many O
genes O
. O

The O
dominant O
inhibitory O
biological O
activity O
of O
the O
N O
terminus O
correlated O
with O
its O
ability O
to O
impair O
EGF B
- O
dependent O
activation O
of O
GTP B
- I
Ras I
and O
of O
MAP B
kinase I
, O
as O
well O
with O
the O
ability O
of O
endogenous O
Sos B
to O
form O
a O
stable O
complex O
with O
activated O
EGF B
receptors I
. O

Analysis O
of O
exon O
2 O
of O
the O
factor B
IX I
gene I
revealed O
a O
C O
- O
- O
> O
T O
mutation O
in O
codon O
10 O
of O
the O
propeptide O
region O
, O
resulting O
in O
the O
substitution O
of O
alanine O
by O
valine O
. O

Three O
putative O
ORFs O
have O
significant O
homology O
with O
known O
proteins O
: O
L0968 B
is O
a O
new O
member O
of O
the O
very O
large O
' B
seripauperins I
' I
family O
, O
comprising O
at O
least O
20 O
yeast O
members O
; O
L1313 B
is O
a O
new O
ABC B
transporter I
highly O
homologous O
to O
the O
yeast O
cadmium O
resistance O
protein O
Ycf1p B
and O
to O
the O
human B
multidrug I
resistance I
protein I
hMRP1 B
; O
the O
C O
- O
terminal O
part O
of O
L1325 B
present O
in O
our O
sequence O
is O
very O
homologous O
to O
the O
fruit O
fly O
abdominal O
segment O
formation O
protein O
Pumilio B
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 B
- I
binding I
protein I
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 B
- I
binding I
protein I
. O

This O
B O
- O
box O
is O
not O
present O
in O
ETS1 B
, O
ETS2 B
, O
PEA3 B
or O
PU B
. I
1 I
and O
these O
proteins O
were O
unable O
to O
form O
ternary O
complexes O
with O
SRF B
and O
Egrl B
- O
SREs O
or O
c B
- I
fos I
SRE O
. O

This O
B O
- O
box O
is O
not O
present O
in O
ETS1 B
, O
ETS2 B
, O
PEA3 B
or O
PU B
. I
1 I
and O
these O
proteins O
were O
unable O
to O
form O
ternary O
complexes O
with O
SRF B
and O
Egrl B
- O
SREs O
or O
c B
- I
fos I
SRE O
. O

Viral B
protein I
U I
( O
Vpu B
) O
is O
a O
protein O
encoded O
by O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
that O
promotes O
the O
degradation O
of O
the O
virus O
receptor O
, O
CD4 B
, O
and O
enhances O
the O
release O
of O
virus O
particles O
from O
cells O
. O

CSEn B
stimulated O
transcription O
of O
a O
variety O
of O
promoters O
, O
including O
the O
hCS B
, O
human B
growth I
hormone I
, O
thymidine B
kinase I
, O
and O
Rous B
sarcoma I
virus I
promoters I
, O
in O
human O
choriocarcinoma O
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
but O
not O
HeLa O
cells O
or O
rat O
somatolactotrophes O
( O
GC O
) O
. O

Pretreatment O
of O
human O
skin O
with O
tRA O
inhibited O
UV O
induction O
of O
c B
- I
Jun I
protein I
and O
, O
consequently O
, O
AP B
- I
1 I
. O

During O
seed O
maturation O
, O
the O
transcriptional O
activity O
of O
napin B
genes I
is O
regulated O
by O
developmental O
signals O
involving O
the O
transcriptional B
activator I
ABI3 I
and O
abscisic O
acid O
( O
ABA O
) O
. O

To O
study O
the O
mechanisms O
and O
the O
signaling O
pathways O
involved O
, O
IGF B
- I
1R I
promoter I
reporter I
constructs I
were O
transiently O
transfected O
in O
CHO O
- O
AT1 O
cells O
that O
overexpress O
angiotensin B
AT1 I
receptors I
. O

NGF B
also O
induced O
a O
synthetic O
promoter O
with O
repeated O
Sp1 B
sites I
linked O
to O
a O
core O
promoter O
, O
and O
a O
plasmid O
regulated O
by O
a O
chimeric O
transactivator O
in O
which O
the O
Gal4 B
DNA I
binding I
domain I
is O
fused O
to O
the O
Sp1 B
transactivation I
domain I
, O
indicating O
that O
this O
transactivation O
domain O
is O
regulated O
by O
NGF B
. O

In O
cotransfection O
assays O
, O
a O
small O
fragment O
of O
Sin B
retaining O
the O
Src B
- O
SH3 B
- O
binding O
site O
and O
one O
tyrosine O
- O
containing O
motif O
induced O
c B
- I
Src I
activation O
as O
measured O
by O
a O
transcriptional O
reporter O
. O

The O
structure O
of O
the O
murine B
Dtk I
gene I
has O
been O
determined O
. O

In O
previous O
studies O
, O
we O
showed O
that O
the O
nuclear O
import O
of O
SREBP B
- I
2 I
occurs O
via O
the O
direct O
interaction O
of O
importin B
beta I
with O
the O
HLH O
- O
Zip O
domain O
. O

These O
studies O
suggest O
that O
tandem O
alpha O
- O
helices O
located O
near O
the O
C O
- O
terminus O
of O
PC B
- I
TP I
facilitate O
membrane O
binding O
and O
extraction O
of O
phosphatidylcholines O
. O

Interestingly O
, O
these O
" O
activation O
- O
defective O
" O
mutants O
segregated O
into O
two O
classes O
: O
1 O
) O
those O
that O
were O
unable O
to O
form O
dimers O
but O
that O
could O
still O
form O
higher O
order O
oligomers O
and O
transform O
cells O
, O
and O
2 O
) O
those O
that O
were O
defective O
for O
PDGF B
- I
R I
binding O
and O
were O
transformation O
- O
incompetent O
. O

When O
transfected O
into O
HepG2 O
cells O
, O
which O
lack O
C B
/ I
EBP I
alpha I
, O
the O
mouse B
ob I
promoter I
was O
only O
weakly O
active O
. O

A O
heterologous O
promoter O
construct O
containing O
three O
repeats O
of O
a O
consensus O
Sp1 B
site I
, O
cloned O
upstream O
of O
a O
single O
copy O
of O
the O
ZII B
( O
CREB B
/ O
AP1 B
) O
element O
from O
the O
BZLF1 B
promoter I
linked O
to O
the O
beta B
- I
globin I
TATA O
box O
, O
exhibited O
phorbol O
ester O
inducibility O
. O

We O
also O
show O
that O
psbH B
and O
psbT B
are O
transcribed O
from O
the O
upstream O
psbB B
gene I
promoter I
, O
and O
that O
the O
psbH B
mRNA I
has O
its O
own O
target O
sequence O
for O
Mbb1 B
function O
. O

Samples O
( O
1 O
g O
) O
were O
extracted O
with O
0 O
. O
5 O
% O
potassium O
chloride O
( O
KCl O
) O
in O
70 O
% O
methanol O
( O
5 O
ml O
) O
and O
diluted O
subsequently O
to O
give O
two O
- O
fold O
to O
ten O
- O
fold O
step O
- O
wise O
dilutions O
in O
phosphate O
- O
buffered O
saline O
containing O
0 O
. O
05 O
% O
Tween O
20 O
and O
0 O
. O
2 O
% O
bovine B
serum I
albumin I
( O
PBS O
- O
T O
BSA B
) O
. O

Following O
immunization O
of O
transgenic O
mice O
, O
hybrid O
molecules O
were O
isolated O
from O
B O
cell O
DNA O
which O
contained O
the O
transgene O
recombined O
with O
the O
endogenous B
IgH I
locus I
. O

Transforming B
growth I
factor I
beta I
activates O
the O
promoter O
of O
cyclin B
- I
dependent I
kinase I
inhibitor O
p15INK4B B
through O
an O
Sp1 B
consensus I
site I
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

The O
mouse B
alpha I
A I
- I
CRYBP1 I
gene I
specifies O
a O
2 O
, O
688 O
- O
amino O
acid O
protein O
with O
72 O
% O
amino O
acid O
identity O
to O
its O
human O
homologue O
, O
PRDII B
- I
BF1 I
. O

Mad3 B
and O
Mad4 B
: O
novel O
Max B
- O
interacting O
transcriptional O
repressors O
that O
suppress O
c B
- I
myc I
dependent O
transformation O
and O
are O
expressed O
during O
neural O
and O
epidermal O
differentiation O
. O

The O
pcaR B
regulatory I
locus I
has O
been O
found O
to O
be O
required O
for O
both O
induction O
of O
all O
of O
the O
genes O
within O
the O
pca B
regulon I
( O
pcaBDC B
, O
pcaIJ B
, O
and O
pcaF B
) O
and O
the O
chemotactic O
response O
of O
the O
bacteria O
to O
aromatic O
compounds O
. O

Furthermore O
, O
we O
have O
identified O
the O
major O
open O
reading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essential O
for O
activation O
, O
and O
we O
have O
shown O
that O
the O
NF B
kappa I
B I
, O
SP1 B
, O
and O
TATA O
box O
motifs O
in O
the O
human B
immunodeficiency I
virus I
LTR I
are O
all O
required O
for O
full O
induction O
of O
the O
promoter O
by O
the O
HHV B
- I
6 I
- I
encoded I
transactivator I
. O

PKCI B
- I
1 I
is O
a O
member O
of O
the O
HIT B
family I
of O
proteins O
, O
shown O
by O
sequence O
identity O
to O
be O
conserved O
in O
a O
broad O
range O
of O
organisms O
including O
mycoplasma O
, O
plants O
, O
and O
humans O
. O

Dual O
signal O
peptides O
mediate O
the O
signal B
recognition I
particle I
/ O
Sec B
- O
independent O
insertion O
of O
a O
thylakoid O
membrane O
polyprotein O
, O
PsbY B
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

TFIIIB B
assembles O
autonomously O
on O
the O
upstream O
promoter O
of O
the O
yeast B
U6 I
snRNA I
( O
SNR6 B
) O
gene O
in O
vitro O
, O
through O
the O
interaction O
of O
its O
TBP B
subunit I
with O
a O
consensus O
TATA O
box O
located O
at O
base O
pair O
- O
30 O
. O

Effect O
of O
TNF B
, O
IL B
- I
1 I
, O
and O
IL B
- I
6 I
on O
the O
proliferation O
of O
human O
Tenon O
' O
s O
capsule O
fibroblasts O
in O
tissue O
culture O
. O

Effect O
of O
TNF B
, O
IL B
- I
1 I
, O
and O
IL B
- I
6 I
on O
the O
proliferation O
of O
human O
Tenon O
' O
s O
capsule O
fibroblasts O
in O
tissue O
culture O
. O

Genetic O
and O
physiological O
experiments O
suggest O
a O
close O
relationship O
between O
cdc27 B
+ I
and O
the O
cdc2 B
+ I
gene I
, O
a O
key O
regulator O
of O
mitosis O
in O
yeast O
and O
also O
in O
higher O
eukaryotic O
cells O
. O

Recently O
we O
have O
performed O
a O
detailed O
analysis O
of O
specific O
neuronal O
populations O
affected O
by O
the O
mutation O
which O
shed O
new O
light O
on O
the O
role O
of O
Krox B
- I
20 I
in O
the O
segmentation O
and O
on O
the O
physiological O
consequences O
of O
its O
inactivation O
. O

Using O
probes O
containing O
C B
/ I
EBP I
- I
binding I
sites I
from O
the O
iNOS B
gene I
revealed O
further O
binding O
of O
different O
complexes O
, O
all O
of O
which O
were O
strongly O
inducible O
by O
cAMP O
and O
to O
a O
lower O
extent O
also O
by O
IL B
- I
1beta I
. O

Desensitization O
of O
the O
growth B
hormone I
- O
induced O
Janus B
kinase I
2 I
( O
Jak B
2 I
) O
/ O
signal B
transducer I
and I
activator I
of I
transcription I
5 I
( O
Stat5 B
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase B
C I
. O

Two O
adjacent O
, O
highly O
homologous B
endoglucanase I
genes I
, O
celD B
and O
celE B
from O
Fibrobacter O
succinogenes O
S85 O
, O
which O
were O
separated O
by O
an O
AT O
- O
rich O
223 O
- O
nucleotide O
intergenic O
region O
were O
characterized O
. O

We O
generated O
" O
signature O
" O
oligonucleotides O
from O
these O
CDR3s B
and O
probed O
PCR O
amplified O
V B
kappa I
products I
from O
the O
synovium O
and O
PBLs O
of O
the O
same O
patient O
, O
and O
from O
PBLs O
and O
spleen O
of O
individuals O
without O
rheumatic O
disease O
. O

Induction O
of O
interferon B
- I
alpha I
( O
IFNalpha B
) O
gene O
expression O
in O
virus O
- O
infected O
cells O
requires O
phosphorylation O
- O
induced O
activation O
of O
the O
transcription O
factors O
IRF3 B
and O
IRF7 B
. O

In O
contrast O
, O
vRel B
lacks O
a O
strong O
C O
- O
terminal O
gene O
activation O
function O
, O
since O
a O
LexA B
fusion I
protein I
containing O
C B
- I
terminal I
vRel I
sequences I
alone O
only O
weakly O
activated O
transcription O
. O

The O
crystal O
structure O
of O
the O
yeast O
Phe B
- I
tRNAPhe I
ternary I
complex I
with O
Thermus O
aquaticus O
EF B
- I
Tu I
- O
GDPNP O
( O
Phe B
- I
TC I
) O
has O
previously O
been O
determined O
as O
one O
representative O
of O
this O
general O
yet O
highly O
discriminating O
complex O
formation O
. O

The O
crystal O
structure O
of O
the O
yeast O
Phe B
- I
tRNAPhe I
ternary I
complex I
with O
Thermus O
aquaticus O
EF B
- I
Tu I
- O
GDPNP O
( O
Phe B
- I
TC I
) O
has O
previously O
been O
determined O
as O
one O
representative O
of O
this O
general O
yet O
highly O
discriminating O
complex O
formation O
. O

Quantitative O
measurement O
of O
antigamma B
globulin I
factors I
( O
rheumatoid B
factors I
) O
using O
laser O
- O
nephelometry O
in O
comparison O
with O
the O
latex O
agglutination O
test O
and O
the O
Waaler O
- O
Rose O
test O

Collectively O
, O
a O
unique O
mechanism O
involving O
NF B
- I
ATp I
appears O
to O
regulate O
the O
cell O
type O
- O
specific O
and O
activation O
- O
dependent O
expression O
of O
the O
SCM B
- I
1 I
genes I
. O

The O
sensitivity O
of O
central B
dopamine I
receptors I
was O
assessed O
with O
the O
growth B
hormone I
response O
to O
apomorphine O
application O
. O

A O
DNA O
fragment O
that O
complements O
the O
uvs B
- I
2 I
mutation O
was O
subcloned O
by O
monitoring O
its O
ability O
to O
transform O
the O
uvs B
- I
2 I
mutant I
to O
MMS O
resistance O
. O

Insulin B
- O
stimulated O
autophosphorylation O
at O
specific O
sites O
in O
the O
tyrosine B
kinase I
domain I
of O
the O
receptor O
' O
s O
beta O
- O
subunit O
is O
correlated O
kinetically O
with O
activation O
of O
kinase O
- O
catalyzed O
phosphorylation O
of O
a O
model O
substrate O
( O
reduced O
and O
carboxyamidomethylated O
lysozyme B
; O
RCAM B
- I
lysozyme I
) O
. O

Insulin B
- O
stimulated O
autophosphorylation O
at O
specific O
sites O
in O
the O
tyrosine B
kinase I
domain I
of O
the O
receptor O
' O
s O
beta O
- O
subunit O
is O
correlated O
kinetically O
with O
activation O
of O
kinase O
- O
catalyzed O
phosphorylation O
of O
a O
model O
substrate O
( O
reduced O
and O
carboxyamidomethylated O
lysozyme B
; O
RCAM B
- I
lysozyme I
) O
. O

Specifically O
, O
we O
engineered O
two O
chimeras O
in O
which O
the O
N O
- O
terminal O
lobe O
of O
the O
SH1 B
domain I
of O
c B
- I
Abl I
was O
swapped O
with O
that O
of O
v B
- I
Src I
. O

Specifically O
, O
we O
engineered O
two O
chimeras O
in O
which O
the O
N O
- O
terminal O
lobe O
of O
the O
SH1 B
domain I
of O
c B
- I
Abl I
was O
swapped O
with O
that O
of O
v B
- I
Src I
. O

The O
cDNA O
contains O
a O
reading O
frame O
for O
a O
145 O
- O
amino O
- O
acid O
protein O
and O
it O
lacks O
the O
UGA O
codons O
, O
which O
have O
been O
found O
in O
the O
reading O
frame O
of O
the O
mouse B
MCS I
cDNA I
and O
have O
been O
presumed O
to O
encode O
the O
selenocysteine O
in O
the O
amino O
terminal O
of O
the O
deduced O
mouse O
amino O
acid O
sequence O
. O

Highly O
conserved O
regions O
called O
src B
homology I
2 I
and O
3 O
( O
SH2 B
and O
SH3 B
) O
, O
comprising O
amino O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein B
- I
tyrosine I
kinase I
activity O
present O
in O
the O
carboxy O
- O
terminal O
halves O
of O
the O
src B
proteins I
. O

Interestingly O
, O
the O
NES B
mutant I
proteins I
appeared O
to O
have O
altered O
interactions O
with O
the O
splicing O
complex O
, O
binding O
more O
tightly O
to O
SC35 B
in O
co O
- O
immunoprecipitation O
assays O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
show O
that O
sae1 B
- I
1 I
and O
sae3 B
- I
1 I
mutations I
each O
confer O
a O
distinct O
defect O
in O
meiotic O
recombination O
. O

sae1 B
- I
1 I
produces O
recombinants O
but O
very O
slowly O
and O
ultimately O
to O
less O
than O
half O
the O
wild O
- O
type O
level O
; O
sae3 B
- I
1 I
makes O
persistent O
hyper O
- O
resected O
meiotic O
double O
- O
strand O
breaks O
and O
has O
a O
severe O
defect O
in O
formation O
of O
recombinants O
. O

sae1 B
- I
1 I
produces O
recombinants O
but O
very O
slowly O
and O
ultimately O
to O
less O
than O
half O
the O
wild O
- O
type O
level O
; O
sae3 B
- I
1 I
makes O
persistent O
hyper O
- O
resected O
meiotic O
double O
- O
strand O
breaks O
and O
has O
a O
severe O
defect O
in O
formation O
of O
recombinants O
. O

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

Transcriptional O
analysis O
of O
this O
gene O
cluster O
was O
performed O
by O
detecting O
the O
presence O
of O
mRNAs O
spanning O
adjacent O
genes O
as O
well O
as O
by O
using O
a O
promoterless O
lacZ B
reporter I
gene I
fused O
to O
each O
of O
the O
seven O
genes O
contained O
in O
the O
tol B
- O
oprL B
locus O
. O

As O
a O
member O
of O
the O
uncoupling B
protein I
family I
, O
UCP2 B
is O
ubiquitously O
expressed O
in O
rodents O
and O
humans O
, O
implicating O
a O
major O
role O
in O
thermogenesis O
. O

Parental O
and O
vector O
- O
transfected O
MCF7 O
cells O
, O
which O
were O
sensitive O
to O
the O
growth O
- O
inhibitory O
effects O
of O
atRA O
, O
exhibited O
atRA O
- O
dependent O
retinoic B
acid I
receptor I
( O
RAR B
) O
transactivation O
and O
transrepression O
of O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
AP B
- I
1 I
activity O
. O

Parental O
and O
vector O
- O
transfected O
MCF7 O
cells O
, O
which O
were O
sensitive O
to O
the O
growth O
- O
inhibitory O
effects O
of O
atRA O
, O
exhibited O
atRA O
- O
dependent O
retinoic B
acid I
receptor I
( O
RAR B
) O
transactivation O
and O
transrepression O
of O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
AP B
- I
1 I
activity O
. O

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Site O
- O
directed O
mutagenesis O
shows O
that O
sites O
throughout O
the O
IRE B
alter O
negative O
control O
and O
IRE B
- I
BP I
binding O
reflecting O
the O
fact O
that O
the O
footprint O
of O
the O
IRE B
- I
BP I
is O
over O
the O
entire O
IRE B
. O

Site O
- O
directed O
mutagenesis O
shows O
that O
sites O
throughout O
the O
IRE B
alter O
negative O
control O
and O
IRE B
- I
BP I
binding O
reflecting O
the O
fact O
that O
the O
footprint O
of O
the O
IRE B
- I
BP I
is O
over O
the O
entire O
IRE B
. O

Nonlethal O
sec71 B
- I
1 I
and O
sec72 B
- I
1 I
mutations I
eliminate O
proteins O
associated O
with O
the O
Sec63p B
- O
BiP B
complex O
from O
S O
. O
cerevisiae O
. O

Sequence O
and O
deletion O
analysis O
of O
the O
recombination B
enhancement I
gene I
( O
ref B
) O
of O
bacteriophage O
P1 O
: O
evidence O
for O
promoter O
- O
operator O
and O
attenuator O
- O
antiterminator O
control O
. O

A O
high O
titer O
of O
anti B
- I
HBc I
, O
thus O
suggested O
to O
be O
an O
indicator O
of O
persistent O
hepatitis O
B O
virus O
infection O
, O
was O
found O
rarely O
in O
seronegative O
patients O
with O
chronic O
hepatitis O
, O
non O
- O
alcoholic O
cirrhosis O
, O
or O
alcoholic O
liver O
diseases O
. O

To O
increase O
the O
number O
of O
circulating O
polymorphonuclear O
neutrophils O
, O
the O
patient O
was O
treated O
with O
recombinant O
granulocyte B
- I
macrophage I
colony I
- I
stimulating I
factor I
( O
GM B
- I
CSF I
) O
at O
a O
dose O
of O
2 O
micrograms O
protein O
/ O
kg O
bodyweight O
s O
. O
c O
. O
/ O
12 O
h O
. O

Transcripts O
appear O
to O
be O
initiated O
from O
an O
upstream O
promoter O
, O
P1 O
, O
located O
in O
front O
of O
the O
tRNA B
( I
met1 I
) I
gene I
and O
from O
three O
internal O
promoters O
: O
P2 O
is O
located O
immediately O
in O
front O
of O
the O
tRNA B
( I
met2 I
) I
gene I
; O
PL10 O
is O
near O
the O
beginning O
of O
the O
L1 B
- O
L10 B
intergenic O
space O
, O
and O
PL12 O
is O
at O
the O
end O
of O
the O
L10 B
gene I
sequence I
. O

Similarly O
, O
TAM B
- I
67 I
reverted O
the O
morphology O
of O
the O
AdoMetDC B
- I
antisense I
expressors I
. O

Cotransfection O
of O
expression O
plasmids O
encoding O
the O
protein B
kinase I
A I
inhibitor O
, O
or O
an O
inactive O
protein B
kinase I
A I
( O
PKA B
) O
catalytic O
beta O
subunit O
, O
inhibited O
both O
forskolin O
and O
PACAP B
activation O
of O
chromogranin B
A I
transcription O
, O
revealing O
that O
PACAP B
- O
induced O
trans O
- O
activation O
is O
highly O
dependent O
on O
PKA B
. O

Cotransfection O
of O
expression O
plasmids O
encoding O
the O
protein B
kinase I
A I
inhibitor O
, O
or O
an O
inactive O
protein B
kinase I
A I
( O
PKA B
) O
catalytic O
beta O
subunit O
, O
inhibited O
both O
forskolin O
and O
PACAP B
activation O
of O
chromogranin B
A I
transcription O
, O
revealing O
that O
PACAP B
- O
induced O
trans O
- O
activation O
is O
highly O
dependent O
on O
PKA B
. O

Furthermore O
, O
CBP B
/ O
p300 B
stimulated O
both O
TGF B
- I
beta I
- O
and O
Smad B
- O
induced O
transcription O
in O
a O
Smad4 B
/ O
DPC4 B
- O
dependent O
fashion O
. O

Sequences O
within O
and O
flanking O
hypersensitive O
sites O
3 O
and O
2 O
of O
the O
beta B
- I
globin I
locus O
control O
region O
required O
for O
synergistic O
versus O
additive O
interaction O
with O
the O
epsilon B
- I
globin I
gene I
promoter I
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Internal O
controls O
over O
the O
volume O
of O
milk O
suckled O
do O
not O
appear O
until O
infant O
rats O
are O
about O
2 O
weeks O
of O
age O
at O
which O
time O
gastric O
distension O
, O
milk O
, O
systemic O
dehydration O
, O
and O
intestinal B
hormone I
cholecystokinin I
suppress O
milk O
intake O
derived O
through O
suckling O
. O

Concerning O
the O
practical O
approach O
in O
a O
clinical O
setting O
, O
it O
has O
to O
be O
pointed O
out O
that O
with O
these O
diseases O
a O
hepatitis O
C O
infection O
has O
to O
be O
considered O
and O
testing O
for O
hepatitis B
C I
antibodies I
and O
, O
if O
positive O
, O
hepatitis B
C I
- I
RNA I
is O
indicated O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

A O
gene O
( O
FMR B
- I
1 I
) O
was O
identified O
within O
a O
four O
cosmid O
contig O
of O
YAC O
DNA O
that O
expresses O
a O
4 O
. O
8 O
kb O
message O
in O
human O
brain O
. O

Detailed O
comparison O
of O
the O
sequences O
of O
cp35 B
and O
human B
calpactin I
II I
shows O
that O
the O
only O
substantial O
sequence O
dissimilarity O
is O
a O
domain O
encoding O
amino O
acids O
between O
residues O
20 O
and O
40 O
which O
includes O
a O
tyrosine O
phosphorylation O
site O
in O
the O
human O
molecule O
, O
along O
with O
other O
residues O
of O
possible O
physiological O
significance O
. O

Alternative O
immune B
globulin I
preparation O
when O
standard O
immune B
serum I
globulin I
is O
not O
available O
. O

A O
transient O
induction O
of O
both O
c B
- I
fos I
and O
c B
- I
jun I
mRNAs I
by O
TPA O
was O
observed O
in O
both O
cell O
populations O
, O
together O
with O
an O
associated O
suppression O
of O
BSP B
mRNA I
in O
the O
fetal O
rat O
calvarial O
cells O
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf B
- I
1 I
in O
the O
regulation O
of O
IgH B
gene I
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP B
- I
1 I
proteins I
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM B
receptor I
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

The O
maternal B
par I
genes I
and O
the O
segregation O
of O
cell O
fate O
specification O
activities O
in O
early O
Caenorhabditis O
elegans O
embryos O
. O

The O
POU B
- O
specific O
domain O
of O
Pit B
- I
1 I
is O
essential O
for O
sequence O
- O
specific O
, O
high O
affinity O
DNA O
binding O
and O
DNA O
- O
dependent O
Pit B
- I
1 I
- O
Pit B
- I
1 I
interactions O
. O

The O
POU B
- O
specific O
domain O
of O
Pit B
- I
1 I
is O
essential O
for O
sequence O
- O
specific O
, O
high O
affinity O
DNA O
binding O
and O
DNA O
- O
dependent O
Pit B
- I
1 I
- O
Pit B
- I
1 I
interactions O
. O

The O
POU B
- O
specific O
domain O
of O
Pit B
- I
1 I
is O
essential O
for O
sequence O
- O
specific O
, O
high O
affinity O
DNA O
binding O
and O
DNA O
- O
dependent O
Pit B
- I
1 I
- O
Pit B
- I
1 I
interactions O
. O

These O
results O
suggest O
an O
essential O
role O
of O
the O
binding O
of O
HNF B
- I
4 I
and O
/ O
or O
HNF B
- I
4 I
- I
related I
nuclear I
factors I
to O
the O
6 O
beta O
A O
- O
A O
site O
on O
the O
basal O
transcriptional O
activation O
of O
the O
CYP3A2 B
gene I
in O
liver O
cells O
. O

Using O
the O
yeast O
two O
- O
hybrid O
system O
, O
we O
have O
isolated O
an O
835 O
amino O
acid O
RING O
finger O
( O
C3HC4 O
zinc O
finger O
) O
protein O
, O
TIF1 B
beta I
( O
also O
named O
KAP B
- I
1 I
) O
, O
that O
specifically O
interacts O
with O
the O
KRAB B
domain I
of O
the O
human O
zinc O
finger O
factor O
KOX1 B
/ O
ZNF10 B
. O

Unestablished O
quail O
myoblasts O
were O
infected O
with O
a O
retroviral O
vector O
encoding O
the O
oncogenic O
form O
of O
H B
- I
Ras I
in O
order O
to O
investigate O
the O
mechanism O
by O
which O
this O
oncoprotein O
interferes O
with O
terminal O
differentiation O
. O

Moreover O
, O
we O
show O
that O
GATA B
- I
1 I
and O
Sp1 B
synergize O
from O
a O
distance O
in O
constructs O
designed O
to O
mimic O
the O
architecture O
of O
globin B
locus I
control I
regions I
and O
downstream O
globin B
promoters I
. O

In O
situ O
hybridization O
of O
whole O
- O
mount O
mouse O
embryos O
with O
Mex5 B
antisense I
RNA I
provide O
no O
evidence O
for O
the O
exclusion O
of O
Mex5 B
during O
embryonic O
development O
. O

The O
Ick B
protein B
tyrosine I
kinase I
is O
not O
involved O
in O
antibody O
- O
mediated O
CD4 B
( O
CDR3 B
- I
loop I
) O
signal O
transduction O
that O
inhibits O
HIV O
- O
1 O
transcription O
. O

The O
Ick B
protein B
tyrosine I
kinase I
is O
not O
involved O
in O
antibody O
- O
mediated O
CD4 B
( O
CDR3 B
- I
loop I
) O
signal O
transduction O
that O
inhibits O
HIV O
- O
1 O
transcription O
. O

Deletion O
analysis O
of O
the O
7 B
. I
3 I
- I
kb I
GATA I
- I
2 I
promoter I
region I
revealed O
that O
a O
1 O
. O
1 O
- O
kb O
DNA O
sequence O
is O
critical O
for O
expression O
of O
GATA B
- I
2 I
in O
neurons O
. O

Fulminant O
hepatic O
failure O
in O
these O
cases O
could O
be O
characterized O
by O
: O
( O
1 O
) O
rapid O
decrease O
in O
serum B
alanine I
transaminase I
( O
ALT B
) O
level O
after O
discontinuation O
of O
ecarazine O
, O
( O
2 O
) O
prolonged O
jaundice O
despite O
discontinuation O
of O
ecarazine O
, O
( O
3 O
) O
high O
incidence O
of O
anti B
- I
nuclear I
antibody I
( O
ANA B
) O
( O
57 O
% O
) O
, O
and O
( O
4 O
) O
histological O
findings O
of O
extensive O
hepatocellular O
necrosis O
ranging O
from O
bridging O
necrosis O
to O
massive O
necrosis O
. O

This O
substrate O
was O
cleaved O
efficiently O
in O
trans O
by O
protease B
3C I
derived O
from O
another O
recombinant O
vaccinia O
virus O
expressing O
a O
3C B
precursor I
protein I
. O

In O
particular O
, O
lacZ B
transcripts I
synthesised O
this O
way O
are O
highly O
unstable O
and O
yield O
little O
beta B
- I
galactosidase I
. O

Six O
cDNAs O
represent O
human O
homologs O
of O
genes O
known O
in O
other O
species O
, O
namely O
, O
mouse B
HSPE71 I
, O
Rat B
RhoGAP I
protein I
, O
S B
cerevisiae I
leucyl I
tRNA I
synthetase I
and O
S B
cerevisiae I
chromosome I
II I
ORF I
YBLO44W I
. O

To O
determine O
the O
role O
of O
elevated O
FAK B
expression O
in O
facilitating O
epidermal B
growth I
factor I
( O
EGF B
) O
- O
stimulated O
human O
adenocarcinoma O
( O
A549 O
) O
cell O
motility O
, O
antisense O
oligonucleotides O
were O
used O
to O
reduce O
FAK B
protein I
expression O
> O
75 O
% O
. O

The O
BRSV B
L I
gene I
is O
6573 O
nt O
in O
length O
and O
the O
derived O
polypeptide O
has O
2162 O
aa O
. O

By O
contrast O
, O
CIS B
failed O
to O
affect O
the O
IL B
- I
9 I
response O
. O

We O
have O
analyzed O
the O
function O
of O
these O
putative O
SL O
structures O
in O
RNA O
translation O
by O
constructing O
chimeric B
chloramphenicol I
acetyltransferase I
( B
CAT I
) I
RNAs I
, O
flanked O
either O
by O
both O
5 O
' O
- O
and O
3 O
' O
- O
terminal O
sequence O
domains O
from O
the O
RV O
genome O
or O
several O
deletion O
derivatives O
of O
the O
same O
sequences O
. O

Despite O
the O
fact O
that O
biochemical O
estimates O
of O
bone O
turnover O
indicate O
that O
( O
short O
- O
term O
) O
administration O
of O
rhGH B
and O
IGF B
- I
I I
stimulates O
bone O
metabolism O
in O
non O
- O
osteoporotic O
older O
people O
, O
no O
significant O
changes O
have O
been O
observed O
in O
bone O
mineral O
density O
at O
the O
proximal O
femur O
. O

Blood O
pressure O
was O
controlled O
long O
term O
( O
with O
/ O
without O
diuretics O
/ O
beta B
- I
adrenoreceptor I
blocking O
drugs O
) O
in O
sixteen O
out O
of O
nineteen O
patients O
with O
mild O
- O
moderate O
hypertension O
. O

However O
, O
FosB B
- I
L I
and O
FosB B
- I
S I
do O
not O
differ O
in O
all O
trans O
- O
regulatory O
properties O
: O
Trans O
- O
activation O
of O
a O
5x O
TRE B
- I
CAT I
reporter O
construct O
in O
HeLa O
and O
NIH O
- O
3T3 O
cells O
was O
found O
with O
both O
FosB B
forms O
. O

However O
, O
FosB B
- I
L I
and O
FosB B
- I
S I
do O
not O
differ O
in O
all O
trans O
- O
regulatory O
properties O
: O
Trans O
- O
activation O
of O
a O
5x O
TRE B
- I
CAT I
reporter O
construct O
in O
HeLa O
and O
NIH O
- O
3T3 O
cells O
was O
found O
with O
both O
FosB B
forms O
. O

However O
, O
FosB B
- I
L I
and O
FosB B
- I
S I
do O
not O
differ O
in O
all O
trans O
- O
regulatory O
properties O
: O
Trans O
- O
activation O
of O
a O
5x O
TRE B
- I
CAT I
reporter O
construct O
in O
HeLa O
and O
NIH O
- O
3T3 O
cells O
was O
found O
with O
both O
FosB B
forms O
. O

Disruption O
of O
INP53 B
, O
but O
not O
the O
related O
INP51 B
and O
INP52 B
genes I
, O
resulted O
in O
alpha B
- I
factor I
maturation O
defects O
and O
exacerbated O
alpha B
- I
factor I
maturation O
defects O
when O
combined O
with O
chc1 B
- I
521 I
. O

Disruption O
of O
INP53 B
, O
but O
not O
the O
related O
INP51 B
and O
INP52 B
genes I
, O
resulted O
in O
alpha B
- I
factor I
maturation O
defects O
and O
exacerbated O
alpha B
- I
factor I
maturation O
defects O
when O
combined O
with O
chc1 B
- I
521 I
. O

Disruption O
of O
INP53 B
, O
but O
not O
the O
related O
INP51 B
and O
INP52 B
genes I
, O
resulted O
in O
alpha B
- I
factor I
maturation O
defects O
and O
exacerbated O
alpha B
- I
factor I
maturation O
defects O
when O
combined O
with O
chc1 B
- I
521 I
. O

By O
subtractive O
and O
differential O
screening O
, O
we O
have O
cloned O
12 O
of O
these O
sequences O
, O
2 O
of O
which O
were O
c B
- I
fos I
and O
krox B
- I
24 I
. O

By O
subtractive O
and O
differential O
screening O
, O
we O
have O
cloned O
12 O
of O
these O
sequences O
, O
2 O
of O
which O
were O
c B
- I
fos I
and O
krox B
- I
24 I
. O

Furthermore O
, O
rubella B
IgM I
antibody I
was O
never O
detected O
after O
immunization O
in O
women O
who O
were O
HAI O
- O
negative O
and O
LA O
- O
positive O
during O
pregnancy O
. O

Plasma B
beta I
- I
thromboglobulin I
( O
beta B
- I
TG I
) O
, O
a O
platelet O
- O
specific O
protein O
, O
is O
a O
marker O
of O
intravascular O
platelet O
degranulation O
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

DP B
- I
1 I
and O
DP B
- I
2 I
encode O
maternally O
stored O
transcripts O
that O
are O
expressed O
during O
early O
development O
. O

DP B
- I
1 I
and O
DP B
- I
2 I
encode O
maternally O
stored O
transcripts O
that O
are O
expressed O
during O
early O
development O
. O

Furthermore O
, O
deletion O
of O
two O
potential O
Ste11 B
recognition I
sites I
in O
the O
fus1 B
promoter I
region O
abolished O
transcription O
, O
and O
expression O
could O
be O
restored O
when O
we O
inserted O
a O
different O
Ste11 B
site I
from O
the O
mat1 B
- I
P I
promoter I
. O

However O
, O
an O
analogous O
myristoylated O
peptide O
derived O
from O
c B
- I
Yes I
also O
has O
no O
inhibitory O
activity O
. O

Recently O
, O
we O
reported O
that O
SMRT B
also O
directly O
associates O
with O
LAZ3 B
( O
BCL B
- I
6 I
) O
, O
a O
POZ O
/ O
Zn O
finger O
transcriptional O
repressor O
involvedin O
the O
pathogenesis O
of O
non O
- O
Hodgkin O
lymphomas O
. O

Characterization O
of O
a O
cDNA B
encoding I
CNN I
predicts O
a O
novel O
structural O
protein O
with O
three O
leucine O
zipper O
motifs O
and O
several O
coiled O
- O
coil O
domains O
exhibiting O
limited O
homology O
to O
the O
rod O
portion O
of O
myosin B
. O

Previous O
work O
established O
that O
the O
TAL1 B
proteins I
are O
phosphorylated O
exclusively O
on O
serine O
and O
identified O
Ser122 O
as O
a O
substrate O
for O
the O
mitogen B
- I
activated I
protein I
kinase I
ERK B
- I
1 I
. O

The O
induction O
of O
the O
composite O
H B
- I
PK I
/ O
Tag B
and O
SV B
- I
PK I
/ O
Tag B
transgenes O
by O
a O
carbohydrate O
- O
rich O
diet O
in O
the O
liver O
was O
similar O
to O
that O
of O
the O
endogenous B
L I
- I
PK I
gene I
. O

The O
induction O
of O
the O
composite O
H B
- I
PK I
/ O
Tag B
and O
SV B
- I
PK I
/ O
Tag B
transgenes O
by O
a O
carbohydrate O
- O
rich O
diet O
in O
the O
liver O
was O
similar O
to O
that O
of O
the O
endogenous B
L I
- I
PK I
gene I
. O

In O
- O
111 O
- O
BLMC O
uptake O
was O
directly O
proportional O
to O
Ki B
- I
67 I
/ O
MIB B
- I
1 I
activity O
and O
number O
of O
mitoses O
in O
tumor O
tissue O
. O

In O
- O
111 O
- O
BLMC O
uptake O
was O
directly O
proportional O
to O
Ki B
- I
67 I
/ O
MIB B
- I
1 I
activity O
and O
number O
of O
mitoses O
in O
tumor O
tissue O
. O

Binding O
of O
transformed O
Ah B
receptor I
complex I
to O
a O
dioxin O
responsive O
transcriptional O
enhancer O
: O
evidence O
for O
two O
distinct O
heteromeric O
DNA O
- O
binding O
forms O
. O

Interestingly O
, O
VDR B
was O
able O
to O
bind O
to O
VDREs O
with O
high O
affinity O
and O
to O
fully O
activate O
transcription O
in O
intact O
yeast O
cells O
in O
the O
presence O
of O
the O
retinoid B
X I
receptor I
( O
RXR B
) O
. O

Here O
we O
describe O
the O
cloning O
and O
initial O
characterization O
of O
IPP B
, O
a O
novel O
human O
gene O
that O
predicts O
a O
kelch B
family I
protein I
homologous O
to O
the O
mouse B
Ipp I
gene I
, O
a O
previously O
described O
kelch B
family I
member I
. O

Here O
we O
describe O
the O
cloning O
and O
initial O
characterization O
of O
IPP B
, O
a O
novel O
human O
gene O
that O
predicts O
a O
kelch B
family I
protein I
homologous O
to O
the O
mouse B
Ipp I
gene I
, O
a O
previously O
described O
kelch B
family I
member I
. O

Here O
we O
describe O
the O
cloning O
and O
initial O
characterization O
of O
IPP B
, O
a O
novel O
human O
gene O
that O
predicts O
a O
kelch B
family I
protein I
homologous O
to O
the O
mouse B
Ipp I
gene I
, O
a O
previously O
described O
kelch B
family I
member I
. O

The O
encoded O
260 B
- I
amino I
- I
acid I
( I
aa I
) I
( I
H1 I
- I
I I
) I
and O
240 B
- I
aa I
( I
H1 I
- I
II I
) I
polypeptides I
possess O
the O
typical O
tripartite O
organization O
of O
animal B
H1 I
histones I
, O
with O
variable O
N O
- O
and O
C O
- O
terminal O
domains O
flanking O
a O
conserved O
' O
globular O
' O
DNA O
- O
binding O
domain O
. O

No O
significant O
difference O
was O
seen O
found O
between O
the O
two O
groups O
in O
the O
degree O
of O
postoperative O
deterioration O
in O
cardiopulmonary O
function O
or O
in O
interleukin B
- I
6 I
levels O
. O

Furthermore O
, O
addition O
of O
the O
recombinant B
NF I
- I
YA I
subunit I
restores O
NF B
- I
Y I
binding O
. O

Our O
results O
suggest O
that O
Sp1 B
binding I
site I
can O
function O
as O
a O
distinct O
TGF B
- I
beta I
responsive I
element I
for O
TGF B
- I
beta I
mediated O
promoter O
expression O
and O
Sp1 B
per O
se O
can O
mediate O
this O
response O
. O

Our O
results O
suggest O
that O
Sp1 B
binding I
site I
can O
function O
as O
a O
distinct O
TGF B
- I
beta I
responsive I
element I
for O
TGF B
- I
beta I
mediated O
promoter O
expression O
and O
Sp1 B
per O
se O
can O
mediate O
this O
response O
. O

In O
addition O
, O
we O
found O
that O
the O
transactivation O
mediated O
by O
the O
p68c B
- I
ets I
- I
1 I
pr I
p55erg B
through O
the O
Polyomavirus B
enhancer I
sequence I
is O
specifically O
inhibited O
by O
the O
p46kDaPax B
- I
QNR I
in O
transient O
transfection O
assay O
. O

In O
addition O
, O
we O
found O
that O
the O
transactivation O
mediated O
by O
the O
p68c B
- I
ets I
- I
1 I
pr I
p55erg B
through O
the O
Polyomavirus B
enhancer I
sequence I
is O
specifically O
inhibited O
by O
the O
p46kDaPax B
- I
QNR I
in O
transient O
transfection O
assay O
. O

mCgA B
- O
92 O
to O
- O
64 O
bp O
, O
comprising O
the O
Sp1 B
/ O
Egr B
- I
1 I
site O
and O
the O
CRE O
motif O
, O
conferred O
gastrin B
responsiveness O
to O
a O
heterologous B
thymidine I
kinase I
promoter I
system O
, O
and O
therefore O
functions O
as O
a O
" O
true O
" O
enhancer O
element O
. O

A O
phase O
II O
study O
of O
interferon B
- I
alpha I
, O
interleukin B
- I
2 I
and O
5 O
- O
fluorouracil O
in O
advanced O
renal O
carcinoma O
: O
clinical O
data O
and O
laboratory O
evidence O
of O
protease O
activation O
. O

A O
phase O
II O
study O
of O
interferon B
- I
alpha I
, O
interleukin B
- I
2 I
and O
5 O
- O
fluorouracil O
in O
advanced O
renal O
carcinoma O
: O
clinical O
data O
and O
laboratory O
evidence O
of O
protease O
activation O
. O

Rat B
p8 I
mRNA I
was O
discovered O
because O
of O
its O
strong O
activation O
in O
pancreas O
during O
the O
acute O
phase O
of O
pancreatitis O
. O

Subclones O
of O
R15 O
which O
reverted O
to O
kappa B
light I
chain I
production O
contained O
genomic O
deletions O
of O
R15ns O
and O
/ O
or O
the O
surrounding O
intron O
. O

The O
authors O
recommend O
in O
cases O
with O
an O
elevated O
transaminase O
serum O
activity O
more O
frequent O
check O
- O
up O
examinations O
to O
avoid O
missing O
of O
a O
relapse O
, O
and O
to O
examine O
repeatedly O
IgM B
anti B
- I
HAV I
as O
in O
protracted O
forms O
of O
hepatitis O
IgM B
anti B
- I
HAV I
may O
persist O
even O
when O
the O
transaminase O
activity O
is O
normal O
. O

The O
authors O
recommend O
in O
cases O
with O
an O
elevated O
transaminase O
serum O
activity O
more O
frequent O
check O
- O
up O
examinations O
to O
avoid O
missing O
of O
a O
relapse O
, O
and O
to O
examine O
repeatedly O
IgM B
anti B
- I
HAV I
as O
in O
protracted O
forms O
of O
hepatitis O
IgM B
anti B
- I
HAV I
may O
persist O
even O
when O
the O
transaminase O
activity O
is O
normal O
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

Developmental O
regulation O
of O
expression O
of O
the O
malate B
synthase I
gene I
in O
transgenic O
plants O
. O

Cytochrome B
bd I
biosynthesis O
in O
Escherichia O
coli O
: O
the O
sequences O
of O
the O
cydC B
and O
cydD B
genes I
suggest O
that O
they O
encode O
the O
components O
of O
an O
ABC B
membrane I
transporter I
. O

In O
contrast O
, O
inhibition O
of O
MAPK B
activity O
by O
MAPK B
kinase I
inhibitor O
( O
PD O
98059 O
) O
or O
by O
overexpression O
of O
kinase O
- O
deficient O
MAPKs B
activated O
basal O
and O
GnRH B
- I
A I
- O
stimulated O
GnRHR B
- O
Luc B
activity O
. O

In O
addition O
, O
both O
inhibitors O
blocked O
phosphatidylcholine O
hydrolysis O
and O
protein B
kinase I
C I
translocation O
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

In O
addition O
, O
Fc B
epsilon I
R1 I
cross O
- O
linking O
activates O
PI B
3 I
- I
kinase I
. O

Ribosome O
association O
of O
GCN2 B
protein I
kinase I
, O
a O
translational O
activator O
of O
the O
GCN4 B
gene I
of O
Saccharomyces O
cerevisiae O
. O

Treatment O
with O
H7 O
did O
not O
affect O
IL B
- I
4R I
- O
mediated O
immediate O
signaling O
events O
such O
as O
tyrosine O
phosphorylation O
of O
Jak1 B
, O
Jak3 B
, O
insulin B
receptor I
substrate I
( I
IRS I
) I
- I
1 I
and O
IRS B
- I
2 I
, O
or O
tyrosine O
phosphorylation O
and O
DNA O
binding O
of O
Stat6 B
. O

Treatment O
with O
H7 O
did O
not O
affect O
IL B
- I
4R I
- O
mediated O
immediate O
signaling O
events O
such O
as O
tyrosine O
phosphorylation O
of O
Jak1 B
, O
Jak3 B
, O
insulin B
receptor I
substrate I
( I
IRS I
) I
- I
1 I
and O
IRS B
- I
2 I
, O
or O
tyrosine O
phosphorylation O
and O
DNA O
binding O
of O
Stat6 B
. O

Transfection O
assays O
using O
the O
first O
600 O
bp O
of O
the O
upstream O
nucleotide O
sequences O
indicated O
that O
a O
region O
from O
- O
75 O
to O
- O
120 O
was O
necessary O
for O
the O
ALDH2 B
gene I
expression O
, O
and O
especially O
NF B
- I
Y I
/ O
CP1 B
binding O
site O
from O
- O
92 O
to O
- O
96 O
( O
CCAAT O
box O
) O
is O
important O
in O
the O
expression O
of O
the O
gene O
. O

This O
distinct O
biochemical O
difference O
between O
STAT5A B
and O
STAT5B B
was O
confirmed O
with O
purified O
activated O
STAT5 B
recombinant I
proteins I
. O

The O
exon O
sequences O
determined O
from O
genomic O
DNA O
sequencing O
showed O
some O
differences O
when O
compared O
to O
the O
published O
rat B
GLUT2 I
cDNA I
. O

Intramolecular O
interaction O
is O
believed O
to O
result O
in O
the O
formation O
of O
MxA B
monomers I
, O
whereas O
intermolecular O
interaction O
may O
induce O
the O
formation O
of O
large B
MxA I
oligomers I
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF B
- I
beta I
on O
COL1A2 B
promoter I
activity O
and O
allows O
antagonistic O
activity O
of O
TNF B
- I
alpha I
on O
the O
TGF B
- I
beta I
effect O
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF B
- I
beta I
on O
COL1A2 B
promoter I
activity O
and O
allows O
antagonistic O
activity O
of O
TNF B
- I
alpha I
on O
the O
TGF B
- I
beta I
effect O
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF B
- I
beta I
on O
COL1A2 B
promoter I
activity O
and O
allows O
antagonistic O
activity O
of O
TNF B
- I
alpha I
on O
the O
TGF B
- I
beta I
effect O
. O

These O
Tlr B
family I
members I
, O
unlike O
others O
reported O
to O
date O
, O
were O
identified O
within O
a O
genomic O
database O
. O

To O
explore O
the O
mechanism O
of O
insulin B
receptor I
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human B
EGF I
receptor I
and O
the O
cytosolic O
domain O
of O
the O
human B
insulin I
receptor I
beta I
- I
subunit I
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human B
insulin I
receptor I
. O

To O
explore O
the O
mechanism O
of O
insulin B
receptor I
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human B
EGF I
receptor I
and O
the O
cytosolic O
domain O
of O
the O
human B
insulin I
receptor I
beta I
- I
subunit I
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human B
insulin I
receptor I
. O

Based O
on O
the O
requirement O
for O
CREM B
/ O
ICER B
and O
Rad6B B
proteins I
in O
spermatogenesis O
, O
we O
determined O
expression O
of O
Cdc34 B
, O
Rad6B B
, O
CREM B
/ O
ICER B
isoforms O
, O
and O
the O
Skp1 B
- O
Cullin B
- O
F O
- O
box O
ubiquitin B
protein O
ligase O
subunits O
Cul B
- I
1 I
and O
Cul B
- I
2 I
, O
which O
are O
associated O
with O
Cdc34 B
activity O
during O
murine O
testicular O
development O
. O

Based O
on O
the O
requirement O
for O
CREM B
/ O
ICER B
and O
Rad6B B
proteins I
in O
spermatogenesis O
, O
we O
determined O
expression O
of O
Cdc34 B
, O
Rad6B B
, O
CREM B
/ O
ICER B
isoforms O
, O
and O
the O
Skp1 B
- O
Cullin B
- O
F O
- O
box O
ubiquitin B
protein O
ligase O
subunits O
Cul B
- I
1 I
and O
Cul B
- I
2 I
, O
which O
are O
associated O
with O
Cdc34 B
activity O
during O
murine O
testicular O
development O
. O

Transcription B
factor I
IIIC I
( O
TFIIIC B
) O
is O
required O
for O
the O
assembly O
of O
a O
preinitiation O
complex O
on O
5S B
RNA I
, O
tRNA O
, O
and O
adenovirus B
VA I
RNA O
genes O
and O
contains O
two O
separable O
components O
, O
TFIIIC1 B
and O
TFIIIC2 B
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS B
- I
1 I
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS B
- I
1 I
. O

These O
two O
enhancer O
elements O
also O
enhanced O
transcription O
when O
fused O
separately O
to O
the O
basal O
promoter O
region O
of O
the O
chicken B
vimentin I
gene I
. O

Protein O
sequencing O
, O
electrophoretic O
mobility O
shift O
assay O
, O
and O
immunoblot O
analyses O
identify O
p54 B
and O
p47 B
/ I
48 I
as O
members O
of O
the O
hepatocyte B
nuclear I
factor I
3 I
( O
HNF3 B
[ O
forkhead B
] O
) O
family O
of O
transcription O
factors O
. O

p54 B
belongs O
to O
the O
subfamily O
of O
HNF3 B
beta I
proteins I
, O
while O
p47 B
/ I
48 I
binding O
activity O
includes O
HNF3 B
gamma I
. O

p54 B
belongs O
to O
the O
subfamily O
of O
HNF3 B
beta I
proteins I
, O
while O
p47 B
/ I
48 I
binding O
activity O
includes O
HNF3 B
gamma I
. O

Promoter O
activity O
was O
assayed O
by O
transient O
transfection O
of O
luciferase B
reporter I
constructs I
containing O
nested O
deletions O
of O
the O
upstream O
sequence O
in O
the O
human O
RPE O
cell O
lines O
ARPE19 O
and O
D407 O
, O
as O
well O
as O
in O
the O
SK O
- O
Mel O
- O
28 O
and O
HeLa O
cell O
lines O
. O

In O
addition O
, O
mrp17 B
- I
1 I
, O
in O
combination O
with O
some O
mutations O
affecting O
another O
mitochondrial O
ribosomal O
protein O
, O
caused O
a O
synthetic O
defective O
phenotype O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

SF1 B
/ O
mBBP B
utilizes O
a O
" B
maxi I
- I
K I
homology I
" I
( O
maxi B
- I
KH I
) O
domain O
for O
recognition O
of O
the O
single O
- O
stranded O
BPS O
and O
requires O
a O
cooperative O
interaction O
with O
splicing O
factor O
U2AF65 B
bound O
to O
an O
adjacent O
polypyrimidine O
tract O
( O
PPT O
) O
for O
high O
- O
affinity O
binding O
. O

An O
X O
- O
linked O
zinc B
finger I
gene I
mapping O
to O
Xq21 O
. O
1 O
- O
q21 O
. O
3 O
closely O
related O
to O
ZFX B
and O
ZFY B
: O
possible O
origins O
from O
a O
common O
ancestral O
gene O
. O

The O
1 O
. O
3 O
- O
kb O
DNA O
, O
when O
placed O
upstream O
of O
the O
chloramphenicol B
acetyltransferase I
gene I
, O
was O
shown O
to O
be O
functionally O
active O
. O

The O
5 B
- I
HT3 I
antagonist O
ondansetron O
reduced O
alcohol O
intake O
in O
both O
the O
medium O
and O
high O
alcohol O
preferring O
rats O
at O
doses O
between O
0 O
. O
01 O
and O
0 O
. O
16 O
mg O
/ O
kg O
. O

Analysis O
of O
pseudo B
VH I
gene I
segment I
recombination I
products I
reveals O
no O
bias O
in O
D B
gene I
segment I
reading O
frame O
utilization O
. O

Brome B
mosaic I
virus I
polymerase I
- O
like O
protein B
2a I
is O
directed O
to O
the O
endoplasmic O
reticulum O
by O
helicase B
- O
like O
viral B
protein I
1a I
. O

In O
NIH O
3T3 O
fibroblasts O
the O
high O
affinity O
IL B
- I
2R I
bearing O
a O
deletion O
of O
a O
region O
rich O
in O
acidic O
amino O
acids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL B
- I
2R I
beta I
- I
chain I
failed O
to O
induce O
the O
tyrosine O
phosphorylation O
of O
MAP B
kinase I
as O
well O
as O
the O
expression O
of O
the O
all O
three O
nuclear O
proto O
- O
oncogenes O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

Of O
3841 O
serum O
samples O
from O
sows O
received O
from O
the O
Tennessee O
State O
Diagnostic O
Laboratory O
in O
1991 O
- O
1992 O
, O
1130 O
were O
positive O
for O
Toxoplasma B
gondii I
antibody I
. O

The O
BCL B
- I
6 I
POZ O
domain O
and O
other O
POZ O
domains O
interact O
with O
the O
co O
- O
repressors O
N B
- I
CoR I
and O
SMRT B
. O

The O
BCL B
- I
6 I
POZ O
domain O
and O
other O
POZ O
domains O
interact O
with O
the O
co O
- O
repressors O
N B
- I
CoR I
and O
SMRT B
. O

Cytokine O
inducibility O
of O
VCAM1 B
in O
endothelial O
cells O
utilizes O
the O
interaction O
of O
heterodimeric O
p50 B
/ O
p65 B
proteins O
with O
IRF B
- I
1 I
. O

To O
gain O
additional O
insights O
into O
this O
novel O
apoptotic O
checkpoint O
, O
we O
have O
now O
characterized O
the O
mouse B
survivin I
locus I
. O

To O
facilitate O
the O
characterization O
of O
NF B
- I
E2 I
functions O
in O
human O
cells O
, O
we O
isolated O
cDNAs O
encoding O
two O
members O
of O
the O
small B
Maf I
family I
, O
MafK B
and O
MafG B
. O

To O
facilitate O
the O
characterization O
of O
NF B
- I
E2 I
functions O
in O
human O
cells O
, O
we O
isolated O
cDNAs O
encoding O
two O
members O
of O
the O
small B
Maf I
family I
, O
MafK B
and O
MafG B
. O

In O
contrast O
to O
the O
effect O
on O
DNA O
replication O
, O
the O
L13V O
substitution O
in O
large B
T I
antigen I
did O
not O
prevent O
complex O
formation O
with O
Hsc70 B
and O
the O
Rb B
protein I
. O

Three O
RasV12 B
mutants I
( O
S35 B
, O
G37 B
, O
and O
C40 B
) O
which O
differ O
by O
their O
ability O
to O
bind O
to O
Ras B
effectors I
( O
Raf B
, O
Ral B
- I
GEFs I
, O
and O
the O
p110 B
subunit I
of I
PI I
3 I
- I
kinase I
, O
respectively O
) O
were O
able O
to O
induce O
sustained O
NR O
cell O
proliferation O
, O
although O
none O
of O
these O
mutants O
was O
reported O
to O
transform O
NIH O
3T3 O
cells O
. O

Here O
, O
we O
characterize O
TCR B
/ O
CD48 B
and O
TCR B
/ O
CD28 B
costimulation O
in O
T O
cells O
expressing O
Lck B
Src B
homology I
3 I
( O
SH3 B
) O
mutants O
. O

Using O
the O
interaction O
- O
trap O
assay O
to O
identify O
candidate O
proteins O
that O
bind O
the O
cytoplasmic O
region O
of O
the O
LAR B
transmembrane I
protein I
tyrosine I
phosphatase I
( O
PT B
- I
Pase I
) O
, O
we O
isolated O
a O
cDNA O
encoding O
a O
2861 O
- O
amino O
acid O
protein O
termed O
Trio B
that O
contains O
three O
enzyme O
domains O
: O
two O
functional O
GEF B
domains I
and O
a O
protein B
serine I
/ I
threonine I
kinase I
( O
PSK B
) O
domain O
. O

The O
related O
adhesion B
focal I
tyrosine I
kinase I
is O
tyrosine O
- O
phosphorylated O
after O
beta1 B
- I
integrin I
stimulation O
in O
B O
cells O
and O
binds O
to O
p130cas B
. O

The O
PHO5 B
gene I
is O
activated O
by O
the O
Pho4p B
transcription I
factor I
, O
which O
itself O
is O
negatively O
regulated O
through O
phosphorylation O
by O
the O
products O
of O
PHO80 B
and O
PHO85 B
. O

We O
suggest O
that O
the O
responses O
to O
types B
I I
and I
II I
collagen I
were O
caused O
by O
a O
cross O
- O
reaction O
with O
type B
III I
collagen I
peptides O
. O

The O
5 O
' O
half O
of O
the O
EWS B
gene I
has O
recently O
been O
described O
to O
be O
fused O
to O
the O
3 O
' O
regions O
of O
genes O
encoding O
the O
DNA O
- O
binding O
domain O
of O
several O
transcriptional O
regulators O
, O
including O
ATF1 B
, O
FLI B
- I
1 I
, O
and O
ERG B
, O
in O
several O
human O
tumors O
. O

Thus O
, O
transgene O
expression O
directed O
by O
both O
the O
human O
and O
mouse B
Rb I
promoters I
is O
restricted O
to O
a O
subset O
of O
tissues O
in O
which O
Rb B
is O
normally O
expressed O
during O
embryogenesis O
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

In O
contrast O
, O
the O
holo B
- I
dTFIIA I
( O
L O
/ O
S O
) O
binds O
TBP B
with O
high O
affinity O
. O

Overexpression O
of O
wild O
type O
and O
SeCys O
/ O
Cys O
mutant O
of O
human B
thioredoxin I
reductase I
in O
E O
. O
coli O
: O
the O
role O
of O
selenocysteine O
in O
the O
catalytic O
activity O
. O

Maximum O
overexpression O
of O
holoenzyme O
activity O
was O
achieved O
by O
the O
inclusion O
in O
such O
plasmids O
of O
Salmonella O
typhimurium O
cysG O
, O
which O
encodes O
a O
uroporphyrinogen B
III I
methyltransferase I
required O
for O
the O
synthesis O
of O
siroheme O
, O
a O
cofactor O
for O
the O
hemoprotein O
. O

In O
addition O
to O
TAK1 B
, O
TGF B
- I
beta I
also O
stimulated O
JNK B
activity O
. O

Uncoupling O
gene O
activity O
from O
chromatin O
structure O
: O
promoter O
mutations O
can O
inactivate O
transcription O
of O
the O
yeast B
HSP82 I
gene I
without O
eliminating O
nucleosome O
- O
free O
regions O
. O

Spodoptera O
frugiperda O
( O
Sf9 O
) O
cells O
have O
proved O
a O
suitable O
cell O
system O
in O
which O
to O
study O
this O
association O
and O
to O
produce O
recombinant B
CR3 I
, O
and O
we O
show O
here O
that O
another O
lepidopteran O
cell O
line O
, O
Trichoplusia O
niTN O
- O
5B1 O
- O
4 O
( O
High O
- O
Five O
) O
cells O
, O
allows O
the O
recovery O
of O
large O
amounts O
of O
functional B
recombinant I
CR3 I
. O

INTERVENTIONS O
: O
Postoperative O
follow O
- O
up O
consisted O
of O
serial O
determination O
of O
different O
biochemical O
markers O
( O
CK B
, O
CK B
- I
MB I
, O
cTnI B
) O
, O
ECGs O
, O
and O
echocardiography O
. O

The O
point O
mutation O
Asp O
- O
316 O
- O
- O
> O
Asn O
in O
the O
C O
- O
terminus O
of O
p38 B
, O
analogous O
to O
the O
ERK2 B
( O
extracellular B
- I
signal I
- I
regulated I
kinase I
2 I
) O
sevenmaker B
mutation O
, O
dramatically O
decreases O
its O
binding O
to O
MKP B
- I
1 I
and O
substantially O
compromises O
its O
stimulatory O
effect O
on O
the O
catalytic O
activity O
of O
this O
phosphatase O
. O

Immunoblotting O
with O
antiphosphotyrosine O
antibody O
showed O
that O
many O
yeast O
proteins O
, O
including O
the O
p34CDC28 B
kinase I
, O
became O
phosphorylated O
at O
tyrosine O
in O
cells O
expressing O
v B
- I
src I
. O

Thus O
the O
Hi O
- O
RARE O
represents O
a O
new O
type O
of O
RA O
response O
element O
with O
a O
role O
in O
the O
modulation O
of O
the O
expression O
of O
MHC B
class I
1 I
family O
genes O
. O

Both O
v B
- I
Myb I
and O
c B
- I
Myb I
bind O
specifically O
to O
delta B
E3 I
. O

Both O
v B
- I
Myb I
and O
c B
- I
Myb I
bind O
specifically O
to O
delta B
E3 I
. O

Serum O
levels O
of O
total O
and O
specific B
immunoglobulin I
E I
( O
IgE B
) O
have O
been O
determined O
by O
radioimmunoassays O
in O
sixty O
- O
nine O
allergic O
subjects O
. O

We O
also O
show O
that O
the O
products O
of O
both O
the O
GIY B
- I
YIG I
ORF O
and O
the O
non O
- O
canonical O
LAGLI B
- I
DADG I
- I
GIY I
- I
YIG I
ORF O
, O
which O
is O
generated O
by O
its O
integration O
, O
have O
endonuclease O
activities O
which O
recognize O
and O
cut O
the O
insertion O
site O
of O
the O
optional O
sequence O
. O

The O
proliferative O
potential O
of O
the O
pilocytic O
astrocytoma O
: O
the O
relation O
between O
MIB B
- I
1 I
labeling O
and O
clinical O
and O
neuro O
- O
radiological O
follow O
- O
up O
. O

Papillomavirus O
type O
16 O
oncogenes O
downregulate O
expression O
of O
interferon B
- O
responsive O
genes O
and O
upregulate O
proliferation O
- O
associated O
and O
NF B
- I
kappaB I
- O
responsive O
genes O
in O
cervical O
keratinocytes O
. O

The O
human B
CA11 I
gene I
appears O
to O
be O
located O
between O
the O
secretor B
type I
alpha I
( I
1 I
, I
2 I
) I
- I
fucosyltransferase I
gene I
cluster I
( O
FUT1 B
- O
FUT2 B
- O
FUT2P B
) O
and O
the O
D B
- I
site I
binding I
protein I
gene I
( O
DBP B
) O
on O
chromosome O
19q13 O
. O
3 O
. O

Second O
, O
overexpression O
of O
RIM11 B
can O
suppress O
an O
ime1 B
missense O
mutation O
( O
ime1 B
- I
L321F I
) O
but O
not O
an O
ime1 B
deletion O
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 B
domains I
and O
an O
inter B
- I
SH2 I
domain I
of O
p85alpha B
, O
but O
the O
SH3 B
and O
bcr B
homology I
domains I
of O
p85alpha B
were O
replaced O
by O
a O
unique O
6 O
- O
amino O
acid O
sequence O
. O

However O
, O
microinjection O
of O
reconstituted O
mRNPs O
into O
Xenopus O
oocytes O
demonstrates O
that O
although O
translational O
repression O
occurs O
in O
the O
absence O
of O
consensus O
RNA O
binding O
sequences O
for O
FRGY2 B
, O
the O
presence O
of O
FRGY2 B
recognition I
elements I
within O
mRNA O
potentiates O
translational O
repression O
. O

IL B
- I
6 I
was O
detected O
in O
the O
urine O
of O
52 O
% O
of O
children O
with O
pyelonephritis O
compared O
with O
15 O
% O
of O
other O
children O
( O
P O
< O
0 O
. O
001 O
) O
. O

G B
- I
CSF I
( O
10 O
microg O
/ O
kg O
) O
was O
started O
on O
day O
+ O
1 O
and O
all O
patients O
engrafted O
within O
a O
median O
day O
number O
of O
12 O
( O
range O
, O
10 O
- O
22 O
) O
until O
leukocytes O
> O
1 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
and O
a O
median O
day O
number O
of O
56 O
( O
range O
, O
10 O
- O
180 O
) O
until O
platelets O
> O
20 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
( O
ie O
platelet O
transfusion O
independence O
) O
. O

NF B
- I
kappaB I
only O
partially O
mediates O
Epstein B
- I
Barr I
virus I
latent I
membrane I
protein I
1 I
activation O
of O
B O
cells O
. O

To O
assay O
for O
sequences O
that O
could O
potentially O
regulate O
Xenopus B
proenkephalin I
expression O
, O
we O
transfected O
constructs O
that O
contained O
upstream O
genomic O
sequences O
linked O
to O
the O
CAT B
reporter I
gene I
into O
various O
eukaryotic O
cell O
lines O
. O

This O
suggests O
that O
the O
ratio O
of O
IL B
- I
6 I
to O
IL B
- I
10 I
may O
be O
used O
to O
predict O
the O
injury O
severity O
after O
trauma O
. O

This O
suggests O
that O
the O
ratio O
of O
IL B
- I
6 I
to O
IL B
- I
10 I
may O
be O
used O
to O
predict O
the O
injury O
severity O
after O
trauma O
. O

Gastrin B
stimulates O
transcription O
of O
the O
human B
histidine I
decarboxylase I
( O
HDC B
) O
gene O
through O
binding O
to O
the O
G B
- I
protein I
- O
coupled O
cholecystokinin B
- I
B I
/ O
gastrin B
receptor I
. O

Gastrin B
stimulates O
transcription O
of O
the O
human B
histidine I
decarboxylase I
( O
HDC B
) O
gene O
through O
binding O
to O
the O
G B
- I
protein I
- O
coupled O
cholecystokinin B
- I
B I
/ O
gastrin B
receptor I
. O

Gastrin B
stimulates O
transcription O
of O
the O
human B
histidine I
decarboxylase I
( O
HDC B
) O
gene O
through O
binding O
to O
the O
G B
- I
protein I
- O
coupled O
cholecystokinin B
- I
B I
/ O
gastrin B
receptor I
. O

Hepatocyte B
growth I
factor I
( O
HGF B
) O
is O
an O
inducible O
cytokine O
that O
is O
essential O
for O
the O
normal O
growth O
and O
development O
of O
various O
tissues O
, O
such O
as O
the O
liver O
. O

Structure O
and O
chromosomal O
localization O
of O
the O
human O
gene O
of O
the O
phosphotyrosyl B
phosphatase I
activator I
( O
PTPA B
) O
of O
protein B
phosphatase I
2A I
. O

Structure O
and O
chromosomal O
localization O
of O
the O
human O
gene O
of O
the O
phosphotyrosyl B
phosphatase I
activator I
( O
PTPA B
) O
of O
protein B
phosphatase I
2A I
. O

We O
therefore O
investigated O
whether O
the O
promoter O
activity O
of O
the O
mouse B
TRH I
gene I
is O
directly O
regulated O
by O
RA O
using O
a O
transient O
transfection O
assay O
into O
CV O
- O
1 O
cells O
. O

The O
enzyme B
ACC I
oxidase I
catalyses O
the O
last O
step O
of O
ethylene O
biosynthesis O
in O
plants O
, O
converting O
1 O
- O
aminocyclopropane O
- O
1 O
- O
carboxylic O
acid O
( O
ACC O
) O
to O
ethylene O
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate B
reductase I
( O
DHFR B
) O
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate B
reductase I
( O
DHFR B
) O
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate B
reductase I
( O
DHFR B
) O
. O

Members O
of O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
/ O
activating B
transcription I
factor I
transcription O
family O
as O
well O
as O
members O
of O
the O
Jun B
/ O
Fos B
family O
have O
been O
shown O
to O
bind O
to O
this O
sequence O
. O

Csk B
( O
C B
- I
terminal I
Src I
kinase I
) O
is O
a O
protein B
tyrosine I
kinase I
that O
phosphorylates O
Src B
family I
member I
C I
- I
terminal I
tails I
, O
resulting O
in O
downregulation O
of O
Src B
family O
members O
. O

Mutations O
of O
the O
human B
PTEN I
gene I
. O

Guanylyl B
cyclase I
C I
, O
the O
apparent O
guanylin B
receptor I
, O
was O
found O
in O
abundant O
amounts O
in O
the O
intestine O
by O
Northern O
analysis O
, O
and O
by O
the O
polymerase O
chain O
reaction O
or O
cDNA O
cloning O
it O
was O
also O
found O
in O
adrenal O
gland O
, O
airway O
epithelial O
cells O
, O
brain O
, O
and O
olfactory O
and O
tracheal O
mucosa O
. O

The O
Polycomb B
group I
proteins I
are O
involved O
in O
maintenance O
of O
the O
silenced O
state O
of O
several O
developmentally O
regulated O
genes O
. O

It O
is O
noteworthy O
that O
under O
more O
physiological O
conditions O
mimicking O
the O
cellular O
GDP O
/ O
GTP O
ratio O
, O
Raf B
enhances O
the O
GEF B
- O
stimulated O
GDP O
/ O
GTP O
exchange O
on O
Ha B
- I
Ras I
, O
in O
agreement O
with O
the O
sequestration O
of O
Ras B
. I
GTP I
by O
Raf B
. O

It O
is O
noteworthy O
that O
under O
more O
physiological O
conditions O
mimicking O
the O
cellular O
GDP O
/ O
GTP O
ratio O
, O
Raf B
enhances O
the O
GEF B
- O
stimulated O
GDP O
/ O
GTP O
exchange O
on O
Ha B
- I
Ras I
, O
in O
agreement O
with O
the O
sequestration O
of O
Ras B
. I
GTP I
by O
Raf B
. O

When O
O O
- O
2A O
/ O
c B
- I
myc I
cells O
underwent O
terminal O
differentiation O
APprog B
complexes I
were O
lost O
and O
conventional O
AP B
- I
1 I
DNA O
- O
binding O
activity O
became O
evident O
, O
particularly O
in O
astrocytes O
. O

When O
O O
- O
2A O
/ O
c B
- I
myc I
cells O
underwent O
terminal O
differentiation O
APprog B
complexes I
were O
lost O
and O
conventional O
AP B
- I
1 I
DNA O
- O
binding O
activity O
became O
evident O
, O
particularly O
in O
astrocytes O
. O

TAF B
- I
1 I
activates O
transcription O
constitutively O
and O
was O
mapped O
to O
the O
first O
32 O
amino O
acids O
of O
the O
A O
- O
region O
. O

Site O
- O
directed O
mutagenesis O
of O
the O
conserved O
cysteine O
residue O
( O
tom1C3235A B
) O
in O
the O
hect B
- I
domain I
, O
supposed O
to O
be O
necessary O
for O
thioester O
- O
bond O
formation O
with O
ubiquitin B
, O
abolished O
the O
gene O
function O
. O

The O
two O
yeast B
pheromone I
receptors I
, O
the O
a B
and I
alpha I
- I
factor I
receptors I
, O
share O
many O
functional O
similarities O
: O
both O
G B
protein I
- I
coupled I
receptors I
couple O
to O
the O
same O
downstream O
signal O
transduction O
pathway O
, O
and O
both O
receptors O
undergo O
feedback O
regulation O
involving O
increased O
phosphorylation O
on O
their O
C O
- O
terminal O
domains O
in O
response O
to O
ligand O
challenge O
. O

This O
complex O
was O
eliminated O
by O
mutation O
of O
either O
half O
- O
site O
, O
and O
it O
was O
supershifted O
by O
antibodies O
against O
chicken B
ovalbumin I
upstream I
promoter I
- I
transcription I
factor I
( O
COUP B
- I
TF I
) O
. O

The O
fz B
- I
1 I
and O
fz B
- I
2 I
genes I
are O
widely O
expressed O
in O
rat O
tissues O
with O
the O
highest O
steady O
- O
state O
levels O
of O
mRNA O
in O
kidney O
, O
liver O
, O
heart O
, O
uterus O
, O
and O
ovary O
. O

A O
40 O
- O
fold O
stimulation O
of O
chloramphenicol B
acetyltransferase I
activity O
mediated O
by O
four O
tandem O
repeats O
of O
the O
SNE B
could O
be O
induced O
within O
2 O
h O
( O
and O
up O
to O
250 O
- O
fold O
within O
6 O
h O
) O
after O
addition O
of O
TPA O
in O
DNA O
- O
transfected O
U O
- O
937 O
cells O
, O
indicating O
that O
the O
stimulation O
appeared O
likely O
to O
be O
a O
true O
protein B
kinase I
C I
- O
mediated O
signal O
transduction O
event O
rather O
than O
a O
differentiation O
response O
. O

Deletion O
mutants O
of O
the O
human B
CHOP I
promoter I
identify O
a O
region O
comprising O
nucleotides O
- O
75 O
to O
- O
104 O
required O
for O
both O
constitutive O
and O
ER O
- O
stress O
- O
inducible O
expression O
. O

A O
mouse O
brain O
cDNA O
library O
in O
lambdagt11 O
was O
screened O
for O
this O
association O
, O
and O
two O
positive O
clones O
encoding O
tyrosine B
phosphatase I
SH B
- I
PTP2 I
were O
isolated O
. O

The O
1 O
. O
6 O
- O
kb O
cDNA O
( O
CBF B
- I
A I
) O
encoding O
285 O
amino O
acids O
( O
aa O
) O
was O
obtained O
, O
and O
a O
beta B
- I
galactosidase I
fusion I
protein I
, O
bacterially O
produced O
from O
the O
cDNA O
, O
bound O
to O
DNA O
fragments O
containing O
several O
CArG O
boxes O
. O

Mutant B
M I
proteins I
were O
tested O
for O
their O
ability O
to O
complement O
growth O
of O
the O
temperature O
- O
sensitive O
M B
protein I
mutant I
virus O
tsO23 O
at O
the O
nonpermissive O
temperature O
. O

Mutant B
M I
proteins I
were O
tested O
for O
their O
ability O
to O
complement O
growth O
of O
the O
temperature O
- O
sensitive O
M B
protein I
mutant I
virus O
tsO23 O
at O
the O
nonpermissive O
temperature O
. O

Two O
mutants O
, O
mapping O
at O
the O
HindIII B
site I
( O
between O
the O
consensus O
sequences O
) O
of O
the O
pSC101 B
tetA I
promoter I
, O
were O
studied O
: O
MA2 O
corresponds O
to O
a O
4 O
bp O
deletion O
between O
positions O
- O
12 O
and O
- O
15 O
; O
B30 O
bears O
a O
44 O
bp O
insertion O
C O
( O
TA O
) O
21 O
G O
at O
the O
HindIII B
site I
. O

The O
liver O
- O
specific O
sequence O
contains O
unique O
consensus O
sites O
for O
phosphorylation O
by O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
and O
by O
protein B
kinase I
C I
. O

The O
exact O
function O
of O
IP B
- I
30 I
is O
not O
yet O
known O
, O
but O
it O
may O
play O
a O
role O
in O
gamma B
- I
interferon I
mediated O
immune O
reactions O
. O

The O
exact O
function O
of O
IP B
- I
30 I
is O
not O
yet O
known O
, O
but O
it O
may O
play O
a O
role O
in O
gamma B
- I
interferon I
mediated O
immune O
reactions O
. O

These O
results O
establish O
that O
the O
DNA O
fragment O
we O
have O
isolated O
contains O
the O
human B
gp130 I
promoter I
and O
that O
interleukin B
- I
6 I
type I
cytokines I
may O
influence O
the O
activity O
of O
this O
promoter O
via O
activated O
STATs B
. O

The O
unexpected O
prevalence O
of O
c B
- I
myc I
and O
alpha B
- I
tubulin I
in O
the O
S O
- O
phase O
library O
is O
supported O
by O
Northern O
analysis O
of O
RNA O
from O
phase O
- O
synchronous O
cells O
. O

The O
unexpected O
prevalence O
of O
c B
- I
myc I
and O
alpha B
- I
tubulin I
in O
the O
S O
- O
phase O
library O
is O
supported O
by O
Northern O
analysis O
of O
RNA O
from O
phase O
- O
synchronous O
cells O
. O

Growth O
factors O
promote O
cell O
survival O
through O
phosphorylation O
of O
Bad B
, O
resulting O
in O
its O
dissociation O
from O
Bcl B
- I
2 I
and O
Bcl B
- I
x I
( I
L I
) I
and O
its O
association O
with O
14 B
- I
3 I
- I
3tau I
. O

We O
used O
an O
immobilized O
template O
- O
based O
assay O
to O
examine O
transcription O
termination O
by O
VA1 B
, O
7SL B
, O
and O
Alu B
class I
III I
templates O
and O
the O
role O
of O
transcript O
release O
in O
the O
pol B
III I
terminator O
- O
dependent O
inhibition O
of O
processing O
of O
B1 B
- O
Alu B
transcripts O
. O

Although O
IL B
- I
6 I
can O
activate O
ERK B
- I
1 I
in O
HepG2 O
cells O
, O
STAT3 B
transactivation O
and O
Ser O
( O
727 O
) O
phosphorylation O
were O
not O
reduced O
by O
using O
the O
MAP B
kinase I
/ O
ERK B
kinase I
( O
MEK B
) O
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negative O
Raf B
. O

Although O
IL B
- I
6 I
can O
activate O
ERK B
- I
1 I
in O
HepG2 O
cells O
, O
STAT3 B
transactivation O
and O
Ser O
( O
727 O
) O
phosphorylation O
were O
not O
reduced O
by O
using O
the O
MAP B
kinase I
/ O
ERK B
kinase I
( O
MEK B
) O
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negative O
Raf B
. O

Yet O
IL B
- I
2 I
and O
IFN B
- I
gamma I
production O
are O
independently O
regulated O
, O
as O
demonstrated O
by O
their O
differential O
expression O
in O
certain O
T O
cell O
subsets O
, O
suggesting O
that O
the O
regulatory O
elements O
in O
these O
two O
genes O
must O
differ O
. O

Yet O
IL B
- I
2 I
and O
IFN B
- I
gamma I
production O
are O
independently O
regulated O
, O
as O
demonstrated O
by O
their O
differential O
expression O
in O
certain O
T O
cell O
subsets O
, O
suggesting O
that O
the O
regulatory O
elements O
in O
these O
two O
genes O
must O
differ O
. O

Functional O
uncoupling O
of O
the O
Janus B
kinase I
3 I
- O
Stat5 B
pathway O
in O
malignant O
growth O
of O
human O
T O
cell O
leukemia O
virus O
type O
1 O
- O
transformed O
human O
T O
cells O
. O

The O
combination O
of O
ICP47 B
and O
US11 B
rendered O
fibroblasts O
negative O
for O
surface B
class I
I I
MHC I
and O
allowed O
a O
class B
I I
MHC I
- O
low O
population O
of O
T O
cells O
to O
be O
sorted O
by O
flow O
cytometry O
. O

Although O
IRS B
- I
1 I
, I
- I
2 I
, I
and I
- I
4 I
are O
similar O
in O
overall O
structure O
, O
IRS B
- I
3 I
is O
approximately O
50 O
% O
shorter O
and O
differs O
with O
respect O
to O
sites O
of O
tyrosine O
phosphorylation O
. O

This O
integration O
results O
in O
the O
production O
of O
MMTV B
/ I
mdr3 I
fusion I
transcripts I
that O
originate O
from O
the O
antisense O
5 B
' I
LTR I
of O
the O
provirus O
. O

Sequence O
comparisons O
reveal O
that O
the O
P B
. I
woesei I
GTP I
- I
binding I
protein I
is O
strikingly O
related O
in O
sequence O
to O
eubacterial B
FtsZ I
and O
is O
marginally O
more O
similar O
to O
eukaryotic B
tubulins I
than O
are O
bacterial B
FtsZ I
proteins I
. O

Vav B
and O
Dbl B
are O
members O
of O
a O
novel O
class O
of O
oncogene O
proteins O
that O
share O
significant O
sequence O
identity O
in O
a O
approximately O
250 O
- O
amino O
- O
acid O
domain O
, O
designated O
the O
Dbl B
homology I
domain I
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT B
- I
18 I
with O
a O
small O
RNA O
( O
P4 B
- I
P6 I
RNA I
) O
corresponding O
to O
the O
isolated O
P4 B
- I
P6 I
domain I
of O
the O
N B
. I
crassa I
mitochondrial I
large I
subunit I
ribosomal I
RNA I
intron I
. O

Blockade O
of O
T O
cell O
activation O
using O
a O
surface O
- O
linked O
single O
- O
chain O
antibody O
to O
CTLA B
- I
4 I
( O
CD152 B
) O
. O

The O
best O
- O
studied O
neurotrophin O
, O
nerve B
growth I
factor I
( O
NGF B
) O
, O
is O
a O
major O
survival O
factor O
in O
sympathetic O
and O
sensory O
neurons O
and O
promotes O
differentiation O
in O
a O
well O
- O
studied O
model O
system O
, O
PC12 O
cells O
. O

In O
contrast O
, O
MAPK B
activation O
stimulated O
by O
the O
Gq B
- O
coupled O
alpha O
1B O
AR O
or O
M1 B
muscarinic B
cholinergic I
receptor I
is O
unaffected O
by O
expression O
of O
beta B
ARKct I
or O
RasN17 B
expression O
or O
by O
PTK B
inhibitors O
, O
but O
is O
blocked O
by O
expression O
of O
N B
delta I
Raf I
or O
by O
PKC B
depletion O
. O

In O
contrast O
, O
MAPK B
activation O
stimulated O
by O
the O
Gq B
- O
coupled O
alpha O
1B O
AR O
or O
M1 B
muscarinic B
cholinergic I
receptor I
is O
unaffected O
by O
expression O
of O
beta B
ARKct I
or O
RasN17 B
expression O
or O
by O
PTK B
inhibitors O
, O
but O
is O
blocked O
by O
expression O
of O
N B
delta I
Raf I
or O
by O
PKC B
depletion O
. O

The O
steady O
- O
state O
levels O
of O
Cdk2 B
, O
Cdk4 B
and O
Cyclin B
A I
proteins I
were O
unaffected O
by O
HPR O
, O
while O
those O
of O
Cyclin B
D1 I
were O
significantly O
reduced O
in O
all O
three O
cell O
lines O
. O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

The O
induction O
by O
dexamethasone O
of O
rat B
liver I
CYP3A1 I
differs O
from O
classical O
glucocorticoid O
gene O
regulation O
in O
part O
because O
both O
glucocorticoids O
and O
antiglucocorticoids O
such O
as O
pregnenolone O
16 O
alpha O
- O
carbonitrile O
( O
PCN O
) O
induce O
CYP3A1 B
through O
transcriptional O
gene O
activation O
. O

Moreover O
, O
antibody O
binding O
to O
the O
same O
two O
determinants O
was O
also O
inhibited O
when O
ZAP B
- I
70 I
or O
the O
SH2 B
domains I
bound O
to O
the O
zeta O
chain O
or O
to O
a O
2pY B
- I
ITAM I
. O

Moreover O
, O
antibody O
binding O
to O
the O
same O
two O
determinants O
was O
also O
inhibited O
when O
ZAP B
- I
70 I
or O
the O
SH2 B
domains I
bound O
to O
the O
zeta O
chain O
or O
to O
a O
2pY B
- I
ITAM I
. O

Northern O
blot O
analysis O
confirmed O
that O
ADAMTS B
- I
1 I
was O
up O
- O
regulated O
in O
both O
metaphyseal O
( O
14 O
- O
to O
35 O
- O
fold O
) O
and O
diaphyseal O
( O
4 O
. O
2 O
- O
fold O
) O
bone O
1 O
h O
after O
PTH B
- I
( I
1 I
- I
38 I
) I
injection O
and O
returned O
to O
control O
levels O
by O
24 O
h O
. O

These O
include O
not O
only O
antioxidants O
, O
N B
- I
methyl I
- I
D I
- I
aspartate I
receptor I
antagonists O
, O
inhibitors O
of O
glutamate O
release O
, O
calcium O
channel O
blockers O
, O
polyamine O
antagonists O
, O
and O
nitric B
oxide I
synthase I
inhibitors O
, O
but O
cannabinoids O
, O
aspirin O
, O
melatonin O
, O
and O
vitamin O
B O
- O
12 O
. O

As O
to O
the O
side O
effects O
of O
SISO O
, O
cylindruria O
with O
aggravation O
of O
microscopic O
hematuria O
and O
elevations O
of O
GOT B
, O
GPT B
and O
A1 B
- I
P I
were O
observed O
each O
one O
of O
them O
, O
respectively O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

Determinants O
of O
recurrent O
ischaemia O
and O
revascularisation O
procedures O
after O
thrombolysis O
with O
recombinant O
tissue B
plasminogen I
activator I
in O
primary O
coronary O
occlusion O
. O

We O
have O
demonstrated O
that O
a O
putative O
HOX B
cofactor I
, O
PBX1A B
, O
participates O
in O
cooperative O
DNA O
binding O
with O
HOXA B
- I
1 I
and O
the O
Deformed B
group O
protein O
HOXD B
- I
4 I
. O

We O
have O
demonstrated O
that O
a O
putative O
HOX B
cofactor I
, O
PBX1A B
, O
participates O
in O
cooperative O
DNA O
binding O
with O
HOXA B
- I
1 I
and O
the O
Deformed B
group O
protein O
HOXD B
- I
4 I
. O

Heterotrimeric O
guanine B
nucleotide I
- I
binding I
proteins I
( O
G B
- I
proteins I
) O
function O
as O
signal O
transducers O
for O
a O
variety O
of O
hormone O
- O
coupled O
enzyme O
and O
ion O
transport O
systems O
in O
eukaryotic O
cells O
. O

Sequence O
analysis O
revealed O
that O
Hv B
- I
p68 I
belongs O
to O
the O
large O
family O
of O
FAD B
- I
dependent I
glucose I
methanol I
choline I
oxidoreductases I
and O
that O
it O
shares O
significant O
sequence O
identity O
( O
> O
67 O
% O
) O
with O
the O
alcohol B
oxidases I
of O
the O
methylotrophic O
yeasts O
. O

Presently O
, O
we O
made O
chain O
pair O
switch O
, O
chimeric O
, O
and O
site O
mutant B
gamma I
delta I
TCRs I
and O
transfected O
them O
into O
TCR O
- O
mutant O
Jurkat O
T O
cells O
to O
examine O
the O
effects O
of O
changing O
the O
TCR B
gamma I
junctional I
region I
sequences I
on O
reactivity O
to O
prenyl B
pyrophosphate I
Ags I
. O

Electromobility O
shift O
analysis O
using O
oligonucleotides O
encompassing O
the O
proximal O
, O
distal O
, O
and O
BED O
/ O
AP B
- I
1 I
- O
binding O
regions O
failed O
to O
demonstrate O
selective O
transactivation O
after O
CD2 B
signaling O
of O
LPMC O
. O

The O
present O
report O
shows O
that O
a O
cis O
- O
acting O
element O
between O
- O
189 O
and O
- O
175 O
bp O
, O
which O
binds O
thyroid B
transcription I
factor I
- I
1 I
( O
TTF B
- I
1 I
) O
, O
is O
involved O
in O
both O
activities O
. O

Moreover O
, O
we O
show O
that O
ectopic O
expression O
of O
the O
E2A B
protein I
E12 B
in O
this O
macrophage O
line O
results O
in O
the O
induction O
of O
many O
B O
lineage O
genes O
, O
including O
EBF B
, O
IL7Ralpha B
, O
lambda5 B
, O
and O
Rag B
- I
1 I
, O
and O
the O
ability O
to O
induce O
kappa B
light I
chain I
in O
response O
to O
mitogen O
. O

Moreover O
, O
we O
show O
that O
ectopic O
expression O
of O
the O
E2A B
protein I
E12 B
in O
this O
macrophage O
line O
results O
in O
the O
induction O
of O
many O
B O
lineage O
genes O
, O
including O
EBF B
, O
IL7Ralpha B
, O
lambda5 B
, O
and O
Rag B
- I
1 I
, O
and O
the O
ability O
to O
induce O
kappa B
light I
chain I
in O
response O
to O
mitogen O
. O

Also O
, O
anti B
- I
HIV I
gp120 I
and O
anti B
- I
CD4 I
crosslinking O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
levels O
of O
both O
PI B
3 I
- I
and I
PI I
4 I
- I
kinase I
activity O
in O
anti B
- I
CD4 I
precipitates O
. O

Also O
, O
anti B
- I
HIV I
gp120 I
and O
anti B
- I
CD4 I
crosslinking O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
levels O
of O
both O
PI B
3 I
- I
and I
PI I
4 I
- I
kinase I
activity O
in O
anti B
- I
CD4 I
precipitates O
. O

In O
contrast O
, O
dominant B
negative I
Rac I
( O
N17Rac1 B
) O
inhibited O
JNK B
activation O
by O
Galpha12 B
in O
HEK293 O
cells O
as O
well O
as O
three O
other O
cell O
lines O
. O

Expression O
of O
Msx B
- I
1 I
and O
Msx B
- I
2 I
has O
been O
studied O
during O
development O
of O
the O
osteoblast O
phenotype O
, O
but O
the O
role O
of O
Dlx B
in O
this O
context O
and O
in O
the O
regulation O
of O
bone O
- O
expressed O
genes O
is O
unknown O
. O

Expression O
of O
Msx B
- I
1 I
and O
Msx B
- I
2 I
has O
been O
studied O
during O
development O
of O
the O
osteoblast O
phenotype O
, O
but O
the O
role O
of O
Dlx B
in O
this O
context O
and O
in O
the O
regulation O
of O
bone O
- O
expressed O
genes O
is O
unknown O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

Mycobacterium O
tuberculosis O
inhibits O
IFN B
- I
gamma I
transcriptional O
responses O
without O
inhibiting O
activation O
of O
STAT1 B
. O

Paradoxically O
there O
is O
a O
decrease O
in O
the O
level O
of O
soluble B
A I
beta I
secreted O
from O
the O
cells O
. O

Using O
mammalian O
expression O
vectors O
( O
pRSV O
- O
neo O
and O
pSV2 O
- O
neo O
) O
, O
antisense O
constructs O
for O
perforin B
and O
granzyme B
B I
were O
independently O
electroporated O
into O
YT O
- O
INDY O
, O
a O
human O
non O
- O
MHC B
- O
restricted O
, O
IL B
- I
2 I
- O
independent O
, O
cytotoxic O
lymphocyte O
. O

When O
expressed O
in O
Escherichia O
coli O
, O
SH B
- I
PTP2 I
displays O
tyrosine B
- I
specific I
phosphatase I
activity O
. O

In O
the O
promoters O
of O
many O
immediate B
early I
genes I
, O
including O
c B
- I
fos I
, O
CArG O
DNA O
regulatory O
elements O
mediate O
basal O
constituitive O
expression O
and O
rapid O
and O
transient O
serum O
induction O
. O

In O
the O
promoters O
of O
many O
immediate B
early I
genes I
, O
including O
c B
- I
fos I
, O
CArG O
DNA O
regulatory O
elements O
mediate O
basal O
constituitive O
expression O
and O
rapid O
and O
transient O
serum O
induction O
. O

We O
were O
unable O
to O
construct O
chvI B
or O
chvG B
insertion I
mutants I
of O
R O
. O
meliloti O
, O
whereas O
mutants O
carrying O
insertions O
outside O
of O
these O
genes O
were O
readily O
obtained O
. O

In O
isolated O
olfactory O
cilia O
certain O
odorants O
elicit O
a O
rapid O
and O
transient O
cAMP O
response O
, O
terminated O
by O
a O
concerted O
process O
which O
requires O
the O
action O
of O
two O
protein O
kinases O
, O
protein B
kinase I
A I
( O
PKA B
) O
and O
a O
receptor B
- I
specific I
kinase I
( O
GRK3 B
) O
( O
Schleicher O
, O
S O
. O
, O
Boekhoff O
, O
I O
. O

To O
investigate O
the O
role O
of O
this O
domain O
in O
the O
incorporation O
of O
the O
SIV B
Env I
into O
virions O
, O
we O
generated O
a O
series O
of O
SIV B
Env I
mutants I
carrying O
small O
in O
- O
frame O
deletions O
within O
the O
cytoplasmic O
domain O
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

Since O
RIP140 B
generally O
down O
- O
regulates O
receptor O
activity O
in O
mammalian O
cells O
and O
specifically O
down O
- O
regulates O
coactivation O
mediated O
by O
SRC B
- I
1 I
, O
we O
propose O
a O
model O
in O
which O
RIP140 B
indirectly O
regulates O
nuclear B
receptor I
AF I
- I
2 I
activity O
by O
competition O
for O
coactivators O
such O
as O
SRC B
- I
1 I
. O

Since O
RIP140 B
generally O
down O
- O
regulates O
receptor O
activity O
in O
mammalian O
cells O
and O
specifically O
down O
- O
regulates O
coactivation O
mediated O
by O
SRC B
- I
1 I
, O
we O
propose O
a O
model O
in O
which O
RIP140 B
indirectly O
regulates O
nuclear B
receptor I
AF I
- I
2 I
activity O
by O
competition O
for O
coactivators O
such O
as O
SRC B
- I
1 I
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
histamine B
- I
2 I
receptor I
activation O
mechanisms O
may O
not O
be O
involved O
in O
postoperative O
IL B
- I
6 I
synthesis O
. O

There O
are O
two O
regulatory O
regions O
between O
the O
US3 B
and O
the O
US6 B
transcription I
units I
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src B
homology I
2 I
( O
SH2 B
) O
and O
SH3 B
domain I
- I
containing I
protein I
Grb2 B
and O
the O
p85 B
subunit O
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
associate O
constitutively O
with O
Cbl B
via O
their O
SH3 B
domains I
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

lin B
- I
49 I
and O
lin B
- I
59 I
transgenes I
are O
expressed O
widely O
throughout O
C O
. O
elegans O
animals O
. O

Interleukin B
- I
1 I
increased O
the O
noradrenaline O
release O
. O

These O
results O
point O
towards O
post O
- O
translational O
steric O
and O
/ O
or O
allosteric O
control O
of O
EKLF B
function O
that O
may O
be O
important O
not O
just O
for O
its O
DNA O
binding O
ability O
, O
but O
also O
for O
its O
potential O
to O
interact O
with O
other O
proteins O
that O
fully O
establish O
the O
correct O
stereospecific O
array O
leading O
to O
efficient O
switching O
of O
beta B
- I
globin I
transcription O
during O
development O
. O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b B
and O
b B
' I
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP B
synthase I
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b B
and O
b B
' I
proteins I
rather O
than O
two O
copies O
of O
identical O
b B
subunits I
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

To O
further O
identify O
the O
residues O
responsible O
for O
the O
activity O
, O
we O
isolated O
the O
mutant O
viruses O
that O
were O
not O
neutralized O
with O
the O
soluble O
form O
of O
MHV B
receptor I
proteins I
, O
since O
such O
mutants O
were O
expected O
to O
have O
mutations O
in O
amino O
acids O
responsible O
for O
receptor O
- O
binding O
activity O
. O

We O
provided O
evidence O
that O
CaM B
kinase I
II I
played O
a O
role O
in O
regulating O
neurite O
outgrowth O
and O
growth O
cone O
motility O
in O
these O
cells O
, O
and O
that O
the O
autophosphorylation O
is O
essential O
for O
the O
kinase O
to O
sufficiently O
exert O
its O
cellular O
function O
in O
vivo O
[ O
Y O
. O

In O
contrast O
to O
the O
reciprocal O
effects O
of O
Gab1 B
and O
Gab2 B
in O
mediating O
Elk B
- I
1 I
induction O
, O
these O
two O
molecules O
have O
a O
similar O
function O
in O
extracellular B
signal I
- I
regulated I
kinase I
activation O
induced O
by O
either O
oncogenic O
Ras B
or O
growth O
factor O
stimulation O
. O

Chromaffin O
cells O
transfected O
with O
a O
plasmid O
with O
the O
entire O
coding O
sequence O
of O
c B
- I
Rabphilin3a I
inserted O
in O
the O
antisense O
orientation O
inhibited O
secretion O
of O
co O
- O
expressed O
GH B
by O
approximately O
30 O
% O
. O

Having O
demonstrated O
proper O
localization O
of O
GFP B
- O
calmodulin B
in O
budding O
yeast O
, O
we O
examined O
the O
localization O
of O
a O
fusion O
between O
GFP B
and O
calmodulin B
( O
GFP B
- I
Camlp I
) O
in O
fission O
yeast O
, O
where O
calmodulin B
had O
not O
been O
localized O
by O
any O
method O
. O

This O
domain O
encompasses O
the O
region O
of O
ARP B
- I
1 I
/ O
COUP B
- I
TFII I
corresponding O
to O
helices O
3 O
to O
12 O
in O
the O
recently O
published O
crystal O
structure O
of O
other O
members O
of O
the O
nuclear B
receptor I
superfamily I
. O

This O
domain O
encompasses O
the O
region O
of O
ARP B
- I
1 I
/ O
COUP B
- I
TFII I
corresponding O
to O
helices O
3 O
to O
12 O
in O
the O
recently O
published O
crystal O
structure O
of O
other O
members O
of O
the O
nuclear B
receptor I
superfamily I
. O

This O
domain O
encompasses O
the O
region O
of O
ARP B
- I
1 I
/ O
COUP B
- I
TFII I
corresponding O
to O
helices O
3 O
to O
12 O
in O
the O
recently O
published O
crystal O
structure O
of O
other O
members O
of O
the O
nuclear B
receptor I
superfamily I
. O

A O
mammalian O
protein O
called O
RFX B
or O
NF B
- I
X I
binds O
to O
the O
X O
box O
( O
or O
X1 O
box O
) O
in O
the O
promoters O
of O
a O
number O
of O
major B
histocompatibility I
( I
MHC I
) I
class I
II I
genes I
. O

VBP B
and O
a1 B
/ I
EBP I
could O
mediate O
the O
high O
rates O
of O
ALV O
and O
RSV B
LTR I
- O
enhanced O
transcription O
in O
bursal O
lymphoma O
cells O
and O
many O
other O
cell O
types O
. O

The O
contribution O
of O
residues O
outside O
the O
Ras B
binding I
domain I
of O
Raf B
( O
RafRBD B
) O
to O
Ras B
- O
Raf B
interaction O
and O
Ras B
- O
dependent O
Raf B
activation O
has O
remained O
unresolved O
. O

To O
obtain O
information O
on O
the O
functional O
role O
of O
the O
Rac1 B
/ O
p38 B
/ O
MAPKAPK B
- I
2 I
pathway O
in O
RA O
signaling O
, O
the O
effects O
of O
pharmacological O
inhibition O
of O
p38 B
on O
RA O
- O
induced O
gene O
transcription O
and O
cell O
differentiation O
were O
determined O
. O

We O
report O
the O
genomic O
organization O
of O
the O
mouse O
orphan B
receptor I
related I
to I
tyrosine I
kinases I
( O
Ryk B
) O
, O
a O
structurally O
unclassified O
member O
of O
the O
growth B
factor I
receptor I
family O
. O

In O
contrast O
, O
T229E B
- I
p70s6k I
migrated O
more O
slowly O
in O
SDS O
- O
polyacrylamide O
gels O
, O
but O
demonstrated O
partial O
kinase O
activity O
( O
approximately O
20 O
% O
compared O
with O
the O
wild O
type O
) O
. O

Liver O
disease O
and O
HCV O
infection O
after O
transplantation O
of O
organs O
from O
hepatitis B
C I
antibody I
positive O
donors O
. O

The O
deduced O
amino O
- O
acid O
sequence O
of O
the O
mature O
enzyme O
showed O
very O
low O
homology O
( O
< O
20 O
. O
4 O
% O
identity O
) O
to O
those O
of O
known O
pectinolytic O
enzymes O
in O
the O
large O
pectate B
lyase I
superfamily I
( O
the O
polysaccharide B
lyase I
family I
1 I
) O
. O

This O
gene O
is O
divided O
into O
six O
exons O
spanning O
about O
3kb O
, O
and O
encodes O
a O
175 O
amino O
acid O
protein O
with O
40 O
- O
52 O
% O
identity O
with O
the O
other O
five O
mouse B
Reg I
( O
regenerating B
gene I
product I
) O
proteins O
. O

Thus O
, O
the O
pathway O
to O
Fc B
epsilonRI I
- O
mediated O
MEK B
/ O
ERK B
and O
ERK B
activation O
can O
apparently O
bypass O
Ras B
and O
Raf B
- I
1 I
. O

Competition O
and O
methylation O
interference O
assays O
showed O
that O
the O
binding O
site O
for O
the O
novel O
factor O
was O
limited O
to O
nucleotides O
in O
the O
3 O
' O
half O
of O
the O
kappa B
B I
site I
. O

These O
properties O
prompted O
us O
to O
investigate O
Ets B
- I
1 I
expression O
in O
32 O
human O
astroglial O
tumors O
of O
WHO O
grades O
I O
- O
IV O
and O
to O
correlate O
the O
data O
with O
the O
expression O
pattern O
of O
VEGF B
, O
Flt B
- I
1 I
, O
and O
KDR B
. O

These O
properties O
prompted O
us O
to O
investigate O
Ets B
- I
1 I
expression O
in O
32 O
human O
astroglial O
tumors O
of O
WHO O
grades O
I O
- O
IV O
and O
to O
correlate O
the O
data O
with O
the O
expression O
pattern O
of O
VEGF B
, O
Flt B
- I
1 I
, O
and O
KDR B
. O

E1A B
+ O
cHa B
- I
ras I
transformed O
rat O
embryo O
fibroblast O
cells O
are O
characterized O
by O
high O
and O
constitutive O
DNA O
binding O
activities O
of O
AP B
- I
1 I
dimers I
with O
significantly O
altered O
composition O
. O

Nuclear O
localization O
of O
this O
SNF2 B
- I
like I
putative O
helicase B
is O
dependent O
on O
a O
nuclear O
localization O
sequence O
located O
in O
the O
NH2 O
- O
terminal O
region O
. O

The O
feasibility O
of O
creating O
CR1 B
/ O
Ig B
chimeras O
makes O
possible O
a O
new O
strategy O
of O
targeting O
complement O
inhibition O
by O
the O
use O
of O
Ig B
fusion I
partners I
having O
particular O
antigenic O
specificities O
. O

Primer O
extension O
analysis O
and O
subcloning O
of O
the O
virJ B
- O
phoA B
fusion O
indicate O
that O
the O
acetosyringone O
- O
inducible O
promoter O
lies O
directly O
upstream O
of O
the O
virJ B
structural I
gene I
. O

Removal O
of O
ink4a B
dramatically O
reduces O
the O
lymphoid O
and O
neurological O
defects O
seen O
in O
bmi B
- I
1 I
- O
deficient O
mice O
, O
indicating O
that O
ink4a B
is O
a O
critical O
in O
vivo O
target O
for O
Bmi B
- I
1 I
. O

Removal O
of O
ink4a B
dramatically O
reduces O
the O
lymphoid O
and O
neurological O
defects O
seen O
in O
bmi B
- I
1 I
- O
deficient O
mice O
, O
indicating O
that O
ink4a B
is O
a O
critical O
in O
vivo O
target O
for O
Bmi B
- I
1 I
. O

Administration O
of O
SnCl2 O
and O
ZnSO4 O
( O
group O
V O
) O
resulted O
in O
a O
decrease O
of O
ALA B
- I
D I
activity O
and O
in O
an O
increase O
in O
CP O
- O
U O
. O

In O
this O
study O
, O
to O
elucidate O
the O
possible O
mechanism O
of O
action O
of O
EM O
, O
we O
examined O
the O
effect O
of O
the O
drug O
on O
the O
expression O
of O
neutrophil O
adhesion O
molecules O
such O
as O
L B
- I
selectin I
and O
Mac B
- I
1 I
. O

In O
this O
study O
, O
to O
elucidate O
the O
possible O
mechanism O
of O
action O
of O
EM O
, O
we O
examined O
the O
effect O
of O
the O
drug O
on O
the O
expression O
of O
neutrophil O
adhesion O
molecules O
such O
as O
L B
- I
selectin I
and O
Mac B
- I
1 I
. O

However O
, O
PC12 O
cell O
clones O
which O
expressed O
p33rsu B
- I
1 I
at O
an O
increased O
level O
in O
a O
regulatable O
fashion O
in O
response O
to O
dexamethasone O
were O
isolated O
. O

In O
this O
study O
, O
we O
verified O
that O
PI B
3 I
- I
kinase I
associates O
with O
the O
CD4 B
: O
p56lck B
complex I
as O
judged O
by O
the O
presence O
of O
PI O
3 O
- O
phosphate O
generated O
from O
anti B
- I
CD4 I
immunoprecipitates O
and O
detected O
by O
high O
- O
pressure O
liquid O
chromatographic O
analysis O
. O

Human B
plastin I
genes I
. O

C B
/ I
EBP I
delta I
( O
NFIL B
- I
6 I
beta I
) O
was O
not O
detected O
in O
complexes O
utilizing O
extracts O
from O
the O
IL B
- I
1 I
nonproducing O
T O
cell O
line O
. O

Reduced O
risk O
of O
upper O
gastrointestinal O
ulcer O
complications O
with O
celecoxib O
, O
a O
novel O
COX B
- I
2 I
inhibitor O
. O

Moreover O
, O
our O
recent O
findings O
on O
the O
Tc52 B
encoding I
gene I
underline O
the O
interest O
of O
genetic O
manipulation O
of O
T O
. O
cruzi O
, O
not O
only O
making O
it O
possible O
to O
use O
more O
closely O
an O
in O
vitro O
approach O
to O
find O
out O
how O
genes O
function O
, O
but O
also O
to O
obtain O
' O
attenuated O
' O
strains O
that O
could O
be O
used O
in O
the O
development O
of O
vaccinal O
strategies O
. O

YDL003w B
( O
also O
termed O
MCD1 B
) O
is O
a O
homologue O
of O
Schizosaccharomyces B
pombe I
rad21 I
, O
an O
essential O
gene O
implicated O
in O
DNA O
double O
- O
strand O
break O
repair O
and O
nuclear O
organization O
in O
fission O
yeast O
. O

Footprints O
on O
the O
HPV B
18 I
enhancer I
show O
five O
protected O
regions O
with O
homologies O
to O
NF1 B
, O
AP1 B
and O
EFII B
transcription I
factor I
binding I
motifs I
. O

Insulin B
binding O
to O
the O
alpha O
- O
subunit O
of O
its O
receptor O
stimulates O
the O
receptor B
tyrosine I
kinase I
to O
phosphorylate O
the O
beta O
- O
subunit O
and O
several O
endogenous O
protein O
substrates O
, O
including O
pp120 B
/ O
HA4 B
, O
a O
liver O
- O
specific O
plasma O
membrane O
glycoprotein O
of O
M O
( O
r O
) O
20 O
, O
000 O
. O

Comparison O
of O
the O
predicted O
amino O
acid O
sequence O
with O
that O
of O
the O
Drosophila B
virilis I
gene I
shows O
that O
several O
blocks O
of O
amino O
acid O
sequence O
have O
been O
very O
highly O
conserved O
. O

A O
decrease O
was O
also O
found O
of O
the O
levels O
of O
total O
cholesterol O
and O
LDL B
- I
cholesterol I
. O

Previously O
, O
we O
had O
shown O
that O
interleukin B
8 I
( O
IL B
- I
8 I
) O
is O
constitutively O
expressed O
in O
HTLV O
- O
I O
- O
infected O
cells O
and O
in O
cells O
transiently O
expressing O
Tax B
. O

Recently O
, O
we O
and O
other O
laboratories O
have O
identified O
a O
family O
of O
caveolin B
- I
related I
proteins I
; O
caveolin B
has O
been O
re O
- O
termed O
caveolin B
- I
1 I
. O

Role O
of O
zinc B
- I
finger I
proteins I
Sp1 I
and O
zif268 B
/ O
egr B
- I
1 I
in O
transcriptional O
regulation O
of O
the O
human B
synaptobrevin I
II I
gene I
. O

The O
human B
Fc I
gamma I
receptor I
gene I
Fc B
gamma I
RIIA I
is O
expressed O
in O
platelets O
, O
neutrophils O
, O
monocytes O
and O
macrophages O
. O

First O
, O
mutations O
in O
the O
IFNgamma B
- I
activated I
sequence I
( O
GAS B
) O
, O
either O
multimerized O
or O
in O
the O
context O
of O
the O
1 B
. I
7 I
- I
kb I
IRF I
- I
1 I
promoter I
, O
failed O
to O
mediate O
a O
PRL B
response O
, O
showing O
that O
the O
IRF B
- I
1 I
GAS B
is O
a O
target O
of O
PRL B
signaling O
. O

This O
selective O
squelching O
activity O
suggests O
that O
GRIM B
can O
interact O
with O
an O
essential O
component O
of O
the O
RNA B
polymerase I
II I
transcription O
machinery O
. O

A O
mutated B
ABF1 I
site I
that O
displays O
a O
very O
low O
affinity O
for O
ABF1 B
does O
not O
functionally O
replace O
the O
ILV1 B
REB1 B
site I
. O

Given O
a O
rapid O
induction O
of O
Egr B
- I
1 I
on O
stimulation O
with O
growth O
factors O
or O
injury O
, O
these O
findings O
may O
represent O
at O
least O
one O
of O
the O
molecular O
mechanisms O
underlying O
phenotypic O
modulation O
of O
smooth O
muscles O
after O
vascular O
injury O
. O

These O
findings O
suggest O
that O
IL B
- I
1 I
- O
stimulated O
, O
Rho B
- O
dependent O
cytoskeletal O
reorganization O
may O
cluster O
signaling O
molecules O
in O
specific O
architectures O
that O
are O
necessary O
for O
persistent O
cell O
activation O
in O
chronic O
inflammatory O
disease O
. O

These O
results O
demonstrate O
the O
extensive O
homology O
in O
sequence O
among O
light O
chains O
of O
IgM B
kappa I
autoantibodies I
and O
indicate O
that O
a O
particular O
V B
kappa I
germ I
line I
gene I
, O
kappa B
IIIb I
, O
is O
expressed O
as O
a O
phylogenetic O
response O
to O
certain O
self O
antigens O
or O
as O
part O
of O
a O
selection O
process O
by O
which O
these O
autoimmune O
responses O
are O
regulated O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged B
V I
kappa I
- I
C I
kappa I
gene I
. O

Among O
women O
, O
plasma B
factor I
VII I
: O
Ag O
was O
inversely O
associated O
with O
income O
. O

A O
novel O
protein B
kinase I
C I
( O
PKC B
) O
- O
interacting O
protein O
was O
identified O
by O
the O
yeast O
two O
- O
hybrid O
screening O
using O
the O
regulatory O
domain O
of O
PKC B
beta I
I I
as O
a O
bait O
. O

A O
novel O
protein B
kinase I
C I
( O
PKC B
) O
- O
interacting O
protein O
was O
identified O
by O
the O
yeast O
two O
- O
hybrid O
screening O
using O
the O
regulatory O
domain O
of O
PKC B
beta I
I I
as O
a O
bait O
. O

Inhibition O
of O
endogenous B
Cdk2 I
by O
dominant B
negative I
Cdk2 I
attenuated O
phosphorylation O
of O
Thr447 O
, O
Thr490 O
and O
Thr497 O
, O
but O
had O
no O
effect O
upon O
Ser581 O
modification O
. O

A O
rabbit O
antiserum O
raised O
against O
a O
unique O
( O
V3 O
domain O
) O
bacterially O
expressed O
PKC B
theta I
fragment I
immunoprecipitated O
specifically O
an O
82 O
- O
kDa O
protein O
from O
Jurkat O
cell O
lysates O
. O

Complementary O
DNA O
libraries O
from O
liver O
and O
ovary O
of O
an O
immature O
female O
channel O
catfish O
were O
screened O
with O
a O
homologous B
ERalpha I
cDNA I
probe O
. O

However O
, O
studies O
using O
the O
A20 B
promoter I
demonstrated O
that O
LMP1 B
transcriptionally O
activates O
the O
A20 B
gene I
through O
cis O
- O
acting O
kappa B
B I
sites I
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c B
- I
myb I
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein B
kinase I
II I
and O
mitogen B
- I
activated I
protein I
kinase I
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c B
- I
myb I
, O
respectively O
, O
are O
not O
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c B
- I
myb I
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein B
kinase I
II I
and O
mitogen B
- I
activated I
protein I
kinase I
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c B
- I
myb I
, O
respectively O
, O
are O
not O
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c B
- I
myb I
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein B
kinase I
II I
and O
mitogen B
- I
activated I
protein I
kinase I
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c B
- I
myb I
, O
respectively O
, O
are O
not O
. O

The O
activation O
of O
NF B
- I
kappaB I
- O
dependent O
reporter O
gene O
transcription O
by O
E1A B
was O
potently O
suppressed O
upon O
coexpression O
of O
the O
E1B B
19 I
- I
kDa I
protein I
( I
19K I
) I
. O

Protein B
kinase I
C I
( O
PKC B
) O
activation O
after O
treatment O
of O
human O
neuroblastoma O
SK O
- O
N O
- O
BE O
( O
2 O
) O
C O
cells O
with O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
was O
found O
to O
enhance O
transcription O
of O
the O
human O
dopamine B
beta I
- I
hydroxylase I
( O
DBH B
) O
in O
those O
cells O
. O

The O
genomic O
organization O
in O
this O
region O
is O
similar O
to O
the O
neural O
- O
restricted O
family O
members O
, O
Hel B
- I
N1 I
( O
ELAVL2 B
) O
and O
mHuD B
( O
Elavl4 B
) O
. O

Promoter O
elements O
and O
transcriptional O
control O
of O
the O
mouse B
acetylcholinesterase I
gene I
. O

Thus O
, O
BCR B
ligation O
initiates O
a O
PI B
3 I
- I
kinase I
/ O
Akt B
/ O
GSK B
- I
3 I
signaling O
pathway O
. O

This O
activity O
creates O
a O
4 O
- O
bp O
staggered O
cut O
with O
3 O
' O
OH O
overhangs O
within O
a O
specific O
sequence O
of O
the O
21S B
rRNA I
gene I
of O
omega O
- O
strains O
. O

In O
contrast O
SF B
, O
but O
not O
GM B
- I
CSF I
or O
IL B
- I
3 I
, O
induced O
tyrosine O
phosphorylation O
of O
phospholipase B
C I
- I
gamma I
( O
PLC B
- I
gamma I
) O
. O

In O
contrast O
SF B
, O
but O
not O
GM B
- I
CSF I
or O
IL B
- I
3 I
, O
induced O
tyrosine O
phosphorylation O
of O
phospholipase B
C I
- I
gamma I
( O
PLC B
- I
gamma I
) O
. O

In O
contrast O
SF B
, O
but O
not O
GM B
- I
CSF I
or O
IL B
- I
3 I
, O
induced O
tyrosine O
phosphorylation O
of O
phospholipase B
C I
- I
gamma I
( O
PLC B
- I
gamma I
) O
. O

In O
T O
cells O
these O
two O
signal O
pathways O
are O
critical O
for O
interleukin B
- I
2 I
production O
. O

Replacement O
of O
a O
valine O
( O
V68 O
) O
in O
the O
ETS B
domain O
of O
SAP1a B
by O
aspartic O
acid O
( O
as O
found O
in O
c B
- I
Ets I
- I
1 I
, O
Elk B
- I
1 I
, O
and O
Net B
) O
enhanced O
ternary O
complex O
formation O
by O
more O
than O
60 O
- O
fold O
. O

The O
NF B
- I
kappaB I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
immune O
system O
regulatory O
genes O
and O
viral B
early I
genes I
including O
the O
human B
immunodeficiency I
virus I
type I
1 I
long I
terminal I
repeat I
. O

The O
NF B
- I
kappaB I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
immune O
system O
regulatory O
genes O
and O
viral B
early I
genes I
including O
the O
human B
immunodeficiency I
virus I
type I
1 I
long I
terminal I
repeat I
. O

The O
atf1 B
+ I
gene I
of I
Schizosaccharomyces I
pombe I
encodes O
a O
bZIP B
transcription I
factor I
with O
strong O
homology O
to O
the O
mammalian B
factor I
ATF I
- I
2 I
. O

Multiple O
attempts O
aimed O
at O
disruption O
of O
the O
chromosomal B
fabG I
gene I
were O
unsuccessful O
. O

Serum B
amyloid I
A I
( O
SAA B
) O
is O
a O
plasma O
protein O
which O
has O
been O
associated O
with O
several O
diseases O
, O
including O
amyloidosis O
, O
arthritis O
, O
and O
atherosclerosis O
, O
and O
its O
abnormal O
expression O
, O
particularly O
in O
nonhepatic O
cells O
, O
is O
implicated O
in O
the O
pathogenesis O
of O
these O
diseases O
. O

The O
human B
p18 I
gene I
spans O
at O
least O
7 O
. O
5 O
kb O
and O
is O
composed O
of O
three O
exons O
, O
two O
of O
which O
encode O
the O
p18 B
protein I
. O

Therefore O
, O
it O
appears O
that O
GCN2 B
protein I
kinase I
function O
is O
stimulated O
posttranslationally O
in O
amino O
acid O
- O
starved O
cells O
. O

Genomic O
Southern O
blot O
analysis O
suggests O
that O
the O
human O
haploid O
genome O
contains O
a O
single O
Gs B
alpha I
gene I
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU B
. I
1 I
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU B
- I
SF I
) O
when O
binding O
the O
GM B
- I
CSF I
receptor I
alpha I
promoter O
PU B
. I
1 I
site O
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU B
. I
1 I
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU B
- I
SF I
) O
when O
binding O
the O
GM B
- I
CSF I
receptor I
alpha I
promoter O
PU B
. I
1 I
site O
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU B
. I
1 I
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU B
- I
SF I
) O
when O
binding O
the O
GM B
- I
CSF I
receptor I
alpha I
promoter O
PU B
. I
1 I
site O
. O

Retinoic O
acid O
, O
which O
inhibits O
the O
progression O
of O
certain O
cancers O
, O
repressed O
v B
- I
src I
- O
induced O
MMP B
- I
1 I
transcription O
. O

Retinoic O
acid O
, O
which O
inhibits O
the O
progression O
of O
certain O
cancers O
, O
repressed O
v B
- I
src I
- O
induced O
MMP B
- I
1 I
transcription O
. O

Association O
of O
Syk B
protein B
tyrosine I
kinase I
( O
PTK B
) O
with O
LMP2A B
occurs O
at O
the O
two O
tyrosines O
of O
the O
LMP2A B
immunoreceptor I
tyrosine O
- O
based O
activation O
motif O
, O
and O
it O
is O
hypothesized O
that O
Lyn B
PTK B
associates O
with O
the O
YEEA O
amino O
acid O
motif O
at O
LMP2A B
tyrosine O
112 O
( O
Y112 O
) O
. O

The O
treatment O
with O
glucocorticoids O
and O
immunosuppressants O
resulted O
in O
a O
more O
noticeable O
decrease O
in O
the O
levels O
of O
T3 O
and O
E B
- I
RCF I
. O

Four O
of O
these O
fibroblast O
clones O
were O
infected O
with O
a O
retrovirus O
containing O
the O
cDNA B
encoding I
myoD I
and O
a O
puromycin O
selection O
marker O
. O

Serum O
estriol O
levels O
during O
beta B
- I
receptor I
agonist O
infusion O
in O
the O
third O
trimester O
of O
pregnancy O
. O

Suppression O
of O
the O
cka1 B
delta I
cka2 I
- I
8 I
mutant I
phenotype O
occurs O
by O
interaction O
of O
CKB1 B
with O
the O
defective O
, O
cka2 B
- I
8 I
- O
encoded O
, O
catalytic O
subunit O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
ICSBP B
and O
PU B
. I
1 I
are O
critical O
elements O
for O
IL B
- I
18 I
gene I
expression O
. O

To O
determine O
the O
role O
of O
the O
transmembrane O
region O
of O
HN B
on O
fusion O
- O
promoting O
activity O
, O
mutant B
HN I
proteins I
were O
expressed O
and O
their O
biological O
activities O
examined O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

Likewise O
, O
the O
consensus O
signal O
believed O
to O
be O
involved O
in O
terminating O
VV B
early I
gene I
transcription O
, O
TTTTTNT O
, O
was O
evident O
at O
the O
3 O
' O
- O
boundary O
of O
both O
the O
N2 O
and O
M1 O
ORFs O
suggesting O
that O
these O
genes O
may O
be O
VV B
early I
genes I
. O

Likewise O
, O
the O
consensus O
signal O
believed O
to O
be O
involved O
in O
terminating O
VV B
early I
gene I
transcription O
, O
TTTTTNT O
, O
was O
evident O
at O
the O
3 O
' O
- O
boundary O
of O
both O
the O
N2 O
and O
M1 O
ORFs O
suggesting O
that O
these O
genes O
may O
be O
VV B
early I
genes I
. O

The O
biological O
functions O
of O
rat O
surfactant B
protein I
A I
( O
SP B
- I
A I
) O
, O
an O
oligomer O
composed O
of O
18 O
polypeptide O
subunits O
derived O
from O
a O
single O
gene O
, O
are O
dependent O
on O
intact O
disulfide O
bonds O
. O

The O
biological O
functions O
of O
rat O
surfactant B
protein I
A I
( O
SP B
- I
A I
) O
, O
an O
oligomer O
composed O
of O
18 O
polypeptide O
subunits O
derived O
from O
a O
single O
gene O
, O
are O
dependent O
on O
intact O
disulfide O
bonds O
. O

Coronary O
vasoconstriction O
caused O
by O
endothelin B
- I
1 I
is O
enhanced O
by O
ischemia O
- O
reperfusion O
and O
by O
norepinephrine O
present O
in O
concentrations O
typically O
observed O
after O
neonatal O
cardiopulmonary O
bypass O
. O

We O
conclude O
that O
transcription O
of O
both O
SCD1 B
and O
SCD2 B
genes I
is O
responsive O
to O
cellular O
sterol O
levels O
and O
to O
the O
levels O
of O
nuclear O
SREBP B
/ O
ADD1 B
and O
that O
transcriptional O
induction O
requires O
three O
spatially O
conserved O
cis O
elements O
, O
that O
bind O
SREBP B
and O
NF B
- I
Y I
. O

Three O
transcriptional O
control O
elements O
within O
300 O
base O
pairs O
of O
the O
5 O
' O
- O
flanking O
region O
of O
the O
rat B
glucagon I
gene I
interact O
with O
regulatory O
cellular O
proteins O
and O
direct O
transcription O
only O
in O
glucagon B
- O
producing O
islet O
cells O
. O

A O
role O
for O
phosphatidylinositol B
3 I
- I
kinase I
in O
the O
regulation O
of O
beta B
1 I
integrin I
activity O
by O
the O
CD2 B
antigen O
. O

Exposure O
of O
raft O
cultures O
to O
activators O
of O
protein B
kinase I
C I
, O
such O
as O
phorbol O
esters O
, O
results O
in O
the O
further O
induction O
of O
late B
gene I
expression O
as O
well O
as O
virion O
assembly O
. O

Hydroxyl O
radical O
footprinting O
of O
DNA O
complexes O
of O
the O
ets B
domain I
of O
PU B
. I
1 I
and O
its O
comparison O
to O
the O
crystal O
structure O
. O

Inhibition O
of O
Raf B
- I
1 I
signaling O
by O
a O
monoclonal O
antibody O
, O
which O
interferes O
with O
Raf B
- I
1 I
activation O
and O
with O
Mek B
substrate O
binding O
. O

Inhibition O
of O
Raf B
- I
1 I
signaling O
by O
a O
monoclonal O
antibody O
, O
which O
interferes O
with O
Raf B
- I
1 I
activation O
and O
with O
Mek B
substrate O
binding O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

The O
IFNAR B
chain I
interacts O
with O
both O
IFN B
- I
alpha I
2 I
and O
IFN B
- I
beta I
, O
as O
demonstrated O
by O
cross O
- O
linking O
. O

Dermatophagoides O
farinae O
- O
sensitized O
lymphocytes O
in O
asthmatic O
children O
as O
evaluated O
by O
interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
production O
and O
acquisition O
of O
IL B
- I
2 I
responsiveness O

Dermatophagoides O
farinae O
- O
sensitized O
lymphocytes O
in O
asthmatic O
children O
as O
evaluated O
by O
interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
production O
and O
acquisition O
of O
IL B
- I
2 I
responsiveness O

Dermatophagoides O
farinae O
- O
sensitized O
lymphocytes O
in O
asthmatic O
children O
as O
evaluated O
by O
interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
production O
and O
acquisition O
of O
IL B
- I
2 I
responsiveness O

Primers O
were O
developed O
for O
specific O
amplification O
of O
9804 B
gene I
fragments I
. O

The O
promyelocytic B
leukemia I
protein I
interacts O
with O
Sp1 B
and O
inhibits O
its O
transactivation O
of O
the O
epidermal B
growth I
factor I
receptor I
promoter O
. O

The O
Thrombolysis O
in O
Myocardial O
Infarction O
( O
TIMI O
) O
Phase O
II O
Trial O
randomized O
3 O
, O
339 O
patients O
to O
either O
an O
invasive O
( O
INV O
, O
n O
= O
1 O
, O
681 O
) O
or O
a O
conservative O
( O
CON O
, O
n O
= O
1 O
, O
658 O
) O
strategy O
after O
intravenous O
recombinant B
tissue I
- I
type I
plasminogen I
activator I
( O
rt B
- I
PA I
) O
for O
acute O
myocardial O
infarction O
. O

In O
addition O
, O
mutations O
within O
the O
Ubx B
unit I
exons I
are O
known O
and O
most O
of O
these O
behave O
as O
null O
alleles O
. O

Alterations O
in O
TCR B
- O
MHC B
contacts O
subsequent O
to O
cross O
- O
recognition O
of O
class B
I I
MHC I
and O
singly O
substituted O
peptide O
variants O
. O

Repeated O
interferon B
- I
beta I
( O
IFN B
- I
beta I
) O
silencer O
B O
motifs O
and O
a O
lysozyme B
silencer I
1 I
motif I
have O
been O
found O
in O
the O
CD95 B
gene I
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

Repeated O
interferon B
- I
beta I
( O
IFN B
- I
beta I
) O
silencer O
B O
motifs O
and O
a O
lysozyme B
silencer I
1 I
motif I
have O
been O
found O
in O
the O
CD95 B
gene I
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

In O
the O
spontaneous O
abortion O
group O
, O
the O
levels O
of O
PAPP B
- I
A I
were O
significantly O
lower O
than O
in O
normal O
pregnancy O
but O
higher O
than O
in O
non O
- O
pregnant O
controls O
. O

The O
translational O
product O
of O
UL26 B
. I
5 I
is O
infected B
- I
cell I
protein I
35c I
, I
d I
( O
ICP35c B
, I
d I
) O
( O
F O
. O

The O
translational O
product O
of O
UL26 B
. I
5 I
is O
infected B
- I
cell I
protein I
35c I
, I
d I
( O
ICP35c B
, I
d I
) O
( O
F O
. O

The O
mouse B
tapasin I
gene I
was O
mapped O
about O
70 O
kilobases O
from O
H2 B
- I
K I
at O
the O
centromeric O
end O
of O
the O
mouse B
MHC I
. O

The O
mouse B
tapasin I
gene I
was O
mapped O
about O
70 O
kilobases O
from O
H2 B
- I
K I
at O
the O
centromeric O
end O
of O
the O
mouse B
MHC I
. O

Subsequent O
analysis O
revealed O
that O
MyD88 B
possesses O
a O
unique O
modular O
structure O
, O
which O
consists O
of O
an O
N O
- O
terminal O
" O
death O
domain O
, O
" O
similar O
to O
the O
intracellular O
segments O
of O
TNF B
receptor I
1 I
and O
Fas B
, O
and O
a O
C O
- O
terminal O
region O
related O
to O
the O
cytoplasmic O
domains O
of O
the O
Drosophila B
morphogen I
Toll I
and O
vertebrate O
interleukin B
- I
1 I
receptors I
. O

Subsequent O
analysis O
revealed O
that O
MyD88 B
possesses O
a O
unique O
modular O
structure O
, O
which O
consists O
of O
an O
N O
- O
terminal O
" O
death O
domain O
, O
" O
similar O
to O
the O
intracellular O
segments O
of O
TNF B
receptor I
1 I
and O
Fas B
, O
and O
a O
C O
- O
terminal O
region O
related O
to O
the O
cytoplasmic O
domains O
of O
the O
Drosophila B
morphogen I
Toll I
and O
vertebrate O
interleukin B
- I
1 I
receptors I
. O

The O
effects O
of O
dopamine O
and O
of O
dopamine B
D2 I
receptor I
blocker O
haloperidol O
on O
the O
activity O
of O
carotid O
chemoreceptors O
were O
studied O
in O
24 O
anesthetized O
, O
paralyzed O
and O
artificially O
ventilated O
newborn O
kittens O
aged O
0 O
- O
17 O
days O
. O

The O
activity O
of O
platelet B
factor I
4 I
in O
plasma O
of O
healthy O
and O
high O
risk O
newborns O
. O

The O
p58 B
( O
PITSLRE B
beta I
1 I
) O
protein O
kinase O
( O
PK O
) O
is O
a O
member O
of O
a O
large O
supergene O
family O
related O
to O
the O
master B
mitotic I
protein I
kinase I
, O
p34cdc2 B
. O

Pax B
- I
6 I
constructs O
lacking O
the O
C O
- O
terminal O
activation O
domain O
repressed O
betaB1 B
- I
crystallin I
promoter I
activity O
as O
effectively O
as O
the O
full O
- O
length O
protein O
, O
but O
the O
PD B
alone O
or O
Pax B
- I
6 I
( I
5a I
) I
, O
a O
splice O
variant O
with O
an O
altered O
PD B
affecting O
its O
DNA O
binding O
specificity O
, O
did O
not O
. O

The O
introduction O
of O
FWD1 B
into O
cells O
significantly O
promotes O
ubiquitination O
and O
degradation O
of O
IkappaBalpha B
in O
concert O
with O
IkappaB B
kinases I
, O
resulting O
in O
nuclear O
translocation O
of O
NF B
- I
kappaB I
. O

Gene B
GPR I
51 I
was O
localized O
by O
radiation O
hybrid O
mapping O
to O
chromosome O
9 O
, O
4 O
. O
81 O
cR O
from O
the O
WI O
- O
8684 O
marker O
, O
and O
proximal O
to O
the O
hereditary B
sensory I
neuropathy I
type I
1 I
locus I
. O

The O
expression O
of O
the O
leukocyte B
EL I
- I
246 I
antigen I
was O
regulated O
in O
the O
same O
manner O
as O
L B
- I
selectin I
and O
EL B
- I
246 I
recognized O
anti B
- I
L I
- I
selectin I
mAb I
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

The O
expression O
of O
the O
leukocyte B
EL I
- I
246 I
antigen I
was O
regulated O
in O
the O
same O
manner O
as O
L B
- I
selectin I
and O
EL B
- I
246 I
recognized O
anti B
- I
L I
- I
selectin I
mAb I
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

To O
examine O
the O
functional O
relationship O
between O
distinct O
cis O
- O
active O
elements O
within O
the O
distal O
enhancer O
region O
of O
the O
rat B
PRL I
gene I
, O
we O
have O
used O
deletional O
and O
mutational O
analysis O
of O
that O
region O
in O
transient O
transfection O
studies O
in O
GH3 O
pituitary O
tumor O
cells O
. O

These O
operons O
encode O
subunits O
of O
photosystems B
I I
( O
psa B
) O
and O
II O
( O
psb B
) O
, O
the O
cytochrome B
bGf I
complex I
( O
pet B
) O
, O
the O
plastid O
NAD B
( I
P I
) I
H I
dehydrogenase I
( O
ndh B
) O
, O
and O
the O
unidentified O
open O
reading O
frame O
ycf9 B
. O

The O
phosphatidylglycerol B
/ I
phosphatidylinositol I
transfer I
protein I
( O
PG B
/ I
PI I
- I
TP I
) O
is O
a O
new O
and O
original O
phospholipid B
transfer I
protein I
( O
PLTP B
) O
isolated O
from O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

It O
is O
an O
untested O
argument O
that O
conventional O
beta B
- I
adrenoceptor I
antagonists O
possess O
unwanted O
metabolic O
effects O
that O
may O
counter O
some O
of O
their O
potential O
cardiac O
benefits O
. O

These O
studies O
reveal O
that O
CREM B
, O
a O
tissue O
- O
specific O
factor O
, O
is O
expressed O
and O
regulated O
by O
gonadotropins B
in O
the O
ovary O
, O
that O
the O
predominant O
CREM B
transcripts O
encode O
the O
repressor B
protein I
ICER I
, O
and O
that O
ICER B
is O
capable O
of O
inhibiting O
cAMP O
- O
induced O
expression O
of O
the O
inhibin B
alpha I
- I
subunit I
gene I
. O

The O
Brassica B
BTH1 I
gene I
may O
correspond O
to O
the O
Arabidopsis B
TH I
- I
1 I
gene I
. O

Acanthamoeba B
myosin I
I I
heavy I
chain I
kinase I
( O
MIHCK B
) O
phosphorylates O
the O
heavy O
chains O
of O
amoeba B
myosins I
I I
, O
increasing O
their O
actin B
- O
activated O
ATPase B
activities O
. O

The O
findings O
in O
the O
human O
multiple O
myeloma O
cell O
lines O
represent O
the O
first O
examples O
of O
B O
cells O
with O
downregulated O
PU B
. I
1 I
expression O
and O
apparently O
contradict O
observations O
in O
the O
murine O
system O
in O
which O
PU B
. I
1 I
is O
expressed O
and O
active O
in O
plasmacytoma O
cell O
lines O
. O

The O
findings O
in O
the O
human O
multiple O
myeloma O
cell O
lines O
represent O
the O
first O
examples O
of O
B O
cells O
with O
downregulated O
PU B
. I
1 I
expression O
and O
apparently O
contradict O
observations O
in O
the O
murine O
system O
in O
which O
PU B
. I
1 I
is O
expressed O
and O
active O
in O
plasmacytoma O
cell O
lines O
. O

We O
propose O
that O
unc B
- I
37 I
may O
be O
regulated O
by O
unc B
- I
4 I
. O

We O
propose O
that O
unc B
- I
37 I
may O
be O
regulated O
by O
unc B
- I
4 I
. O

High O
and O
pathological O
PAI B
- I
1 I
levels O
before O
and O
after O
the O
VO O
test O
were O
consistent O
with O
a O
defective O
fibrinolytic O
potential O
due O
to O
the O
inhibitory O
effect O
of O
PAI B
- I
1 I
on O
plasminogen B
activation O
. O

High O
and O
pathological O
PAI B
- I
1 I
levels O
before O
and O
after O
the O
VO O
test O
were O
consistent O
with O
a O
defective O
fibrinolytic O
potential O
due O
to O
the O
inhibitory O
effect O
of O
PAI B
- I
1 I
on O
plasminogen B
activation O
. O

During O
hexamethylene O
bisactamide O
( O
HMBA O
) O
- O
induced O
differentiation O
of O
murine O
erythroleukemia O
( O
MEL O
) O
cells O
erythroid O
genes O
are O
transcriptionally O
activated O
while O
c B
- I
myb I
and O
several O
other O
nuclear O
proto O
- O
oncogenes O
are O
down O
- O
regulated O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK B
gene I
fused O
to O
portions O
of O
the O
domain O
of O
alpha B
gene I
0 I
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha B
gene I
0 I
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha B
4 I
- I
and I
alpha I
27 I
- I
TK I
chimeras O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK B
gene I
fused O
to O
portions O
of O
the O
domain O
of O
alpha B
gene I
0 I
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha B
gene I
0 I
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha B
4 I
- I
and I
alpha I
27 I
- I
TK I
chimeras O
. O

In O
this O
report O
, O
we O
investigated O
whether O
the O
cleavage O
of O
the O
RRKR O
motif O
of O
MT B
- I
MMP1 I
by O
Golgi B
- I
associated I
furin I
is O
analogous O
to O
a O
similar O
enzyme O
activation O
mechanism O
observed O
with O
stromelysin B
- I
3 I
. O

In O
this O
report O
, O
we O
investigated O
whether O
the O
cleavage O
of O
the O
RRKR O
motif O
of O
MT B
- I
MMP1 I
by O
Golgi B
- I
associated I
furin I
is O
analogous O
to O
a O
similar O
enzyme O
activation O
mechanism O
observed O
with O
stromelysin B
- I
3 I
. O

Escherichia O
coli O
strains O
carrying O
recA730 B
( O
or O
other O
recA B
* I
alleles I
) O
exhibit O
dramatic O
increases O
in O
SOS O
- O
dependent O
spontaneous O
mutator O
activity O
. O

In O
marked O
contrast O
to O
the O
previously O
published O
human B
CD6 I
sequence I
, O
the O
mouse O
sequence O
predicts O
a O
long O
cytoplasmic O
tail O
that O
is O
not O
closely O
related O
to O
other O
proteins O
and O
possesses O
two O
proline O
- O
rich O
motifs O
containing O
the O
SH3 B
- I
domain I
binding I
consensus I
sequence I
, O
three O
protein B
kinase I
C I
phosphorylation I
site I
motifs I
, O
nine O
casein B
kinase I
- I
2 I
phosphorylation I
site I
motifs I
, O
and O
a O
serine O
- O
threonine O
- O
rich O
motif O
repeated O
three O
times O
. O

ET B
- I
1 I
limited O
the O
electrocardiographic O
evidence O
of O
subendocardial O
ischemia O
and O
attenuated O
contractile O
dysfunction O
compared O
with O
mechanical O
stenosis O
at O
the O
same O
coronary O
flows O
, O
even O
though O
lactate O
flux O
was O
similar O
. O

Residues O
that O
affect O
PLCbeta B
and O
adenylyl B
cyclase I
II I
activity O
are O
found O
on O
opposite O
sides O
of O
the O
central O
tunnel O
, O
suggesting O
that O
PLC B
and O
adenylyl B
cyclase I
, O
like O
the O
alpha O
subunit O
, O
make O
many O
contacts O
on O
the O
top O
surface O
. O

The O
CBS B
- I
1 I
gene I
was O
mapped O
to O
human O
chromosome O
10p12 O
between O
markers O
WI B
- I
8535 I
and O
WI B
- I
4724 I
, O
and O
is O
tightly O
linked O
to O
the O
two O
STRP O
markers O
of O
D10S1789 B
and O
D10S550 B
. O

The O
CBS B
- I
1 I
gene I
was O
mapped O
to O
human O
chromosome O
10p12 O
between O
markers O
WI B
- I
8535 I
and O
WI B
- I
4724 I
, O
and O
is O
tightly O
linked O
to O
the O
two O
STRP O
markers O
of O
D10S1789 B
and O
D10S550 B
. O

The O
ferric B
uptake I
regulation I
( O
fur B
) O
gene O
product O
participates O
in O
regulating O
expression O
of O
the O
manganese O
- O
and O
iron O
- O
containing O
superoxide B
dismutase I
genes I
of I
Escherichia I
coli I
. O

Elements O
of O
the O
hAT B
transposon I
family I
, O
such O
as O
the O
maize B
activator I
( O
Ac B
) O
, O
have O
been O
discovered O
in O
a O
large O
number O
of O
eukaryotic O
species O
. O

We O
found O
both O
the O
v B
- I
Ras I
- O
and O
PC B
- I
PLC I
- O
transformed O
cells O
to O
be O
insensitive O
to O
stimulation O
with O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
. O

We O
found O
both O
the O
v B
- I
Ras I
- O
and O
PC B
- I
PLC I
- O
transformed O
cells O
to O
be O
insensitive O
to O
stimulation O
with O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
. O

The O
tro B
operon I
is O
flanked O
by O
a O
Holliday B
structure I
DNA I
helicase I
homolog O
( O
upstream O
) O
and O
two O
ORFs O
representing O
a O
purine B
nucleoside I
phosphorylase I
homolog O
and O
tpp15 B
, O
a O
previously O
characterized O
gene O
encoding O
a O
membrane O
lipoprotein O
( O
downstream O
) O
. O

In O
order O
to O
search O
for O
mutations O
in O
the O
multicopy B
RBM I
genes I
that O
might O
be O
associated O
with O
male O
infertility O
, O
we O
have O
used O
sequence O
data O
from O
the O
reported O
cDNA O
clone O
to O
determine O
the O
intron O
exon O
boundaries O
of O
the O
YRRM B
1 I
gene I
. O

In O
order O
to O
search O
for O
mutations O
in O
the O
multicopy B
RBM I
genes I
that O
might O
be O
associated O
with O
male O
infertility O
, O
we O
have O
used O
sequence O
data O
from O
the O
reported O
cDNA O
clone O
to O
determine O
the O
intron O
exon O
boundaries O
of O
the O
YRRM B
1 I
gene I
. O

No O
cleavage O
of O
gp B
130 I
was O
observed O
in O
analogous O
pulse O
- O
chase O
radiolabelling O
of O
Ad O
- O
gB B
- O
infected O
human O
fibroblasts O
, O
even O
though O
these O
cells O
are O
permissive O
for O
HCMV O
replication O
and O
can O
process O
the O
native B
gB I
molecule I
. O

A O
phylogenetic O
comparison O
of O
32 O
species O
showed O
minor O
differences O
in O
the O
apoB B
mRNA I
sequence I
, O
and O
the O
apoB B
mRNA I
from O
31 O
species O
was O
robustly O
edited O
in O
vitro O
. O

Sugar O
analysis O
was O
performed O
on O
alpha B
- I
TM I
to O
investigate O
a O
possible O
biosynthetic O
mechanism O
for O
part O
- O
time O
PGs O
. O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

TRAF2 B
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear B
factor I
kappaB I
( O
NFkappaB B
) O
and O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription B
factor I
activating I
protein I
1 I
( O
AP1 B
) O
mainly O
via O
phosphorylation O
of O
the O
c B
- I
Jun I
component O
. O

TRAF2 B
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear B
factor I
kappaB I
( O
NFkappaB B
) O
and O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription B
factor I
activating I
protein I
1 I
( O
AP1 B
) O
mainly O
via O
phosphorylation O
of O
the O
c B
- I
Jun I
component O
. O

The O
host O
range O
( O
HR O
) O
of O
poliovirus O
is O
thought O
to O
be O
primarily O
determined O
by O
a O
cell O
surface O
molecule O
that O
functions O
as O
poliovirus B
receptor I
( O
PVR B
) O
, O
since O
it O
has O
been O
shown O
that O
transgenic O
mice O
are O
made O
poliovirus O
sensitive O
by O
introducing O
the O
human B
PVR I
gene I
into O
the O
genome O
. O

Human B
alcohol I
dehydrogenase I
( O
ADH B
) O
exists O
as O
a O
heterogeneous O
group O
of O
isozymes O
capable O
of O
oxidizing O
a O
wide O
variety O
of O
aliphatic O
and O
aromatic O
alcohols O
. O

The O
effect O
of O
the O
negative O
regulatory O
element O
is O
negated O
by O
the O
viral B
IE2 I
protein I
( O
L O
. O

Characterization O
of O
a O
unique O
protein O
component O
of O
yeast B
RNase I
MRP I
: O
an O
RNA O
- O
binding O
protein O
with O
a O
zinc O
- O
cluster O
domain O
. O

We O
concluded O
that O
RXR B
- I
gamma I
induced O
terminal O
differentiation O
in O
SCC O
lines O
, O
suggesting O
a O
potential O
tumor O
suppressor O
function O
for O
this O
transcription O
factor O
. O

Similarly O
, O
interfering O
with O
MEKK B
, O
which O
lies O
upstream O
of O
JNK1 B
, O
using O
a O
dominant O
negative O
expression O
vector O
reduced O
MMP B
- I
9 I
promoter I
activity O
over O
the O
same O
concentration O
range O
which O
repressed O
the O
AP B
- I
1 I
- O
thymidine B
kinase I
CAT B
reporter O
construct O
. O

This O
constant O
expression O
profile O
, O
coupled O
with O
the O
observation O
that O
over O
- O
expression O
of O
mSin3A B
does O
not O
augment O
the O
anti B
- I
Myc I
activity O
of O
Mxi1 B
- O
SR O
in O
the O
rat O
embryo O
fibroblast O
( O
REF O
) O
transformation O
assay O
, O
suggests O
that O
mSin3A B
is O
not O
a O
limiting O
factor O
in O
the O
regulation O
of O
Myc B
superfamily I
function O
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant B
SH2 I
domains I
from O
v B
- I
src I
and O
v B
- I
fps I
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic B
PTK I
family I
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant B
SH2 I
domains I
from O
v B
- I
src I
and O
v B
- I
fps I
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic B
PTK I
family I
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant B
SH2 I
domains I
from O
v B
- I
src I
and O
v B
- I
fps I
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic B
PTK I
family I
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant B
SH2 I
domains I
from O
v B
- I
src I
and O
v B
- I
fps I
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic B
PTK I
family I
. O

The O
broad O
range O
protein B
tyrosine I
kinase I
inhibitor O
genistein O
and O
the O
phosphatidylinositol B
3 I
- I
kinase I
inhibitors O
wortmannin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholinyl O
) O
- O
8 O
- O
phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
also O
blocked O
adenosine B
A3 I
receptor I
stimulation O
of O
p42 B
/ O
p44 B
MAPK O
. O

The O
broad O
range O
protein B
tyrosine I
kinase I
inhibitor O
genistein O
and O
the O
phosphatidylinositol B
3 I
- I
kinase I
inhibitors O
wortmannin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholinyl O
) O
- O
8 O
- O
phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
also O
blocked O
adenosine B
A3 I
receptor I
stimulation O
of O
p42 B
/ O
p44 B
MAPK O
. O

The O
metalloproteinase B
mediating O
Met B
cleavage O
was O
specifically O
inhibited O
by O
the O
tissue B
inhibitor I
of I
metalloproteinases I
( I
TIMP I
) I
- I
3 I
, O
but O
not O
by O
TIMP B
- I
1 I
or O
TIMP B
- I
2 I
. O

The O
metalloproteinase B
mediating O
Met B
cleavage O
was O
specifically O
inhibited O
by O
the O
tissue B
inhibitor I
of I
metalloproteinases I
( I
TIMP I
) I
- I
3 I
, O
but O
not O
by O
TIMP B
- I
1 I
or O
TIMP B
- I
2 I
. O

Instead O
, O
HBx B
is O
shown O
to O
activate O
the O
cyclin B
A I
promoter I
, O
induce O
cyclin B
A I
- O
cyclin B
- I
dependent I
kinase I
2 I
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src B
tyrosine I
kinases I
. O

Instead O
, O
HBx B
is O
shown O
to O
activate O
the O
cyclin B
A I
promoter I
, O
induce O
cyclin B
A I
- O
cyclin B
- I
dependent I
kinase I
2 I
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src B
tyrosine I
kinases I
. O

Growth B
hormone I
exerts O
its O
effects O
on O
the O
ovarian O
follicular O
cycle O
directly O
or O
by O
local O
production O
of O
insulin B
- I
like I
growth I
factor I
1 I
( O
IGF B
- I
1 I
) O
. O

Fluorescence O
in O
situ O
hybridization O
was O
used O
to O
investigate O
the O
physical O
distribution O
and O
revealed O
that O
both O
retrotransposon O
families O
are O
present O
on O
all O
sugar O
beet O
chromosomes O
and O
largely O
excluded O
from O
chromosomal O
regions O
harbouring O
the O
18S B
- O
5 B
. I
8S I
- O
25S B
rRNA O
genes O
. O

A O
genomic O
clone O
of O
the O
chicken B
osteopontin I
- I
encoding I
gene I
( O
opn B
) O
was O
isolated O
and O
found O
to O
be O
organized O
as O
follows O
: O
an O
untranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
recognition O
sequence O
for O
phosphorylation O
by O
casein B
kinase I
II I
; O
a O
domain O
containing O
a O
possible O
O O
- O
linkage O
site O
for O
glycosylation O
; O
a O
second O
casein B
kinase I
II I
phosphorylation I
site I
; O
an O
exon O
containing O
three O
functional O
regions O
, O
the O
poly O
- O
Asp O
sequence O
of O
seven O
consecutive O
Asp O
residues O
, O
the O
RGD B
integrin I
recognition I
site I
and O
a O
potential O
N O

However O
, O
neither O
SF B
- I
1 I
nor O
NGF B
- I
IB I
alone O
, O
binding O
as O
monomers O
, O
increases O
transcription O
. O

However O
, O
neither O
SF B
- I
1 I
nor O
NGF B
- I
IB I
alone O
, O
binding O
as O
monomers O
, O
increases O
transcription O
. O

Structural O
organization O
of O
the O
human B
Elk1 I
gene I
and O
its O
processed O
pseudogene B
Elk2 I
. O

SCOF B
- I
1 I
localized O
to O
the O
nucleus O
but O
did O
not O
bind O
directly O
to O
either O
C O
- O
repeat O
/ O
dehydration O
( O
CRT O
/ O
DRE O
) O
or O
ABA O
responsive O
element O
( O
ABRE O
) O
, O
cis O
- O
acting O
DNA O
regulatory O
elements O
present O
in O
COR B
gene I
promoters I
. O

SCOF B
- I
1 I
localized O
to O
the O
nucleus O
but O
did O
not O
bind O
directly O
to O
either O
C O
- O
repeat O
/ O
dehydration O
( O
CRT O
/ O
DRE O
) O
or O
ABA O
responsive O
element O
( O
ABRE O
) O
, O
cis O
- O
acting O
DNA O
regulatory O
elements O
present O
in O
COR B
gene I
promoters I
. O

Furthermore O
, O
we O
detect O
hCoch B
- I
5B2 I
on O
three O
overlapping O
YACs O
, O
two O
of O
which O
also O
contain O
one O
of O
the O
markers O
linked O
to O
DFNA9 B
. O

mCoch B
- I
5B2 I
was O
genetically O
mapped O
in O
the O
mouse O
to O
chromosome O
12 O
, O
in O
a O
region O
of O
homologous O
synteny O
with O
human O
14q11 O
. O
2 O
- O
q13 O
, O
which O
contains O
the O
asp1 B
( O
audiogenic B
seizure I
prone I
) O
locus O
in O
the O
mouse O
. O

mCoch B
- I
5B2 I
was O
genetically O
mapped O
in O
the O
mouse O
to O
chromosome O
12 O
, O
in O
a O
region O
of O
homologous O
synteny O
with O
human O
14q11 O
. O
2 O
- O
q13 O
, O
which O
contains O
the O
asp1 B
( O
audiogenic B
seizure I
prone I
) O
locus O
in O
the O
mouse O
. O

Cross O
- O
talk O
between O
transcription O
factors O
NF B
- I
kappa I
B I
and O
C B
/ I
EBP I
in O
the O
transcriptional O
regulation O
of O
genes O
. O

The O
data O
also O
suggest O
that O
gamma B
CACCC I
box I
binding I
factors I
mediate O
LCR B
- I
gamma I
interactions O
which O
normally O
enhance O
gamma B
- I
globin I
and O
suppress O
beta B
- I
globin I
gene I
expression O
in O
fetal O
erythroid O
cells O
. O

The O
data O
also O
suggest O
that O
gamma B
CACCC I
box I
binding I
factors I
mediate O
LCR B
- I
gamma I
interactions O
which O
normally O
enhance O
gamma B
- I
globin I
and O
suppress O
beta B
- I
globin I
gene I
expression O
in O
fetal O
erythroid O
cells O
. O

ES O
cells O
in O
which O
the O
gene O
for O
the O
erythroid O
transcription O
factor O
GATA B
- I
1 I
has O
been O
disrupted O
fail O
to O
produce O
mature O
erythroid O
cells O
either O
in O
vivo O
or O
in O
vitro O
. O

The O
5 O
' O
ends O
of O
the O
P B
and O
O B
gene I
mRNAs I
are O
separated O
by O
109 O
nucleotide O
pairs O
in O
the O
DNA O
template O
. O

TGF B
- I
beta1 I
induced O
phosphorylation O
of O
Smad2 B
and O
Smad3 B
in O
Mv1Lu O
mink O
lung O
epithelial O
cells O
. O

Although O
the O
cDNAs O
of O
HMG B
- I
14 I
and O
HMG B
- I
17 I
do O
not O
cross O
- O
hybridize O
, O
they O
have O
several O
similar O
structural O
features O
: O
the O
open O
reading O
frame O
comprises O
only O
23 O
% O
of O
the O
transcripts O
, O
the O
5 O
' O
- O
untranslated O
region O
is O
extremely O
GC O
rich O
whereas O
the O
3 O
' O
- O
untranslated O
region O
is O
unusually O
long O
and O
AT O
rich O
. O

Although O
the O
cDNAs O
of O
HMG B
- I
14 I
and O
HMG B
- I
17 I
do O
not O
cross O
- O
hybridize O
, O
they O
have O
several O
similar O
structural O
features O
: O
the O
open O
reading O
frame O
comprises O
only O
23 O
% O
of O
the O
transcripts O
, O
the O
5 O
' O
- O
untranslated O
region O
is O
extremely O
GC O
rich O
whereas O
the O
3 O
' O
- O
untranslated O
region O
is O
unusually O
long O
and O
AT O
rich O
. O

In O
gel O
mobility O
shift O
assays O
, O
high O
binding O
activities O
of O
ATPC B
- I
2 I
and O
low O
binding O
activities O
of O
CBF B
were O
observed O
with O
nuclear O
extracts O
from O
tissue O
with O
low O
AtpC B
expression O
levels O
, O
and O
the O
opposite O
was O
observed O
with O
extracts O
from O
tissues O
with O
high O
AtpC B
expression O
levels O
. O

Activation O
of O
tyrosine B
kinase I
- I
containing I
receptors I
, O
heterotrimeric B
G I
proteins I
, O
and O
protein B
kinase I
C I
enhanced O
the O
activities O
of O
both O
MEK B
isoforms I
in O
293 O
and O
PC12 O
cells O
. O

Activation O
of O
tyrosine B
kinase I
- I
containing I
receptors I
, O
heterotrimeric B
G I
proteins I
, O
and O
protein B
kinase I
C I
enhanced O
the O
activities O
of O
both O
MEK B
isoforms I
in O
293 O
and O
PC12 O
cells O
. O

There O
was O
a O
57 O
% O
reduction O
in O
IGF B
IR I
mRNA I
levels O
in O
clone O
CA9 O
after O
confluence O
compared O
with O
clone O
ME10 O
. O

Oligomers O
corresponding O
to O
the O
region O
of O
the O
mlc B
- I
1 I
/ I
3 I
enhancer I
, O
which O
encompasses O
this O
conserved O
sequence O
, O
bound O
MEF B
- I
2 I
and O
competed O
for O
its O
binding O
to O
the O
mck B
enhancer O
. O

This O
difference O
between O
SP B
- I
1 I
and O
SP B
- I
2 I
peptides I
was O
not O
due O
to O
their O
differential O
uptake O
by O
cell O
, O
since O
approximately O
100 O
times O
more O
SP B
- I
2 I
peptide I
could O
be O
found O
in O
cytoplasmic O
extracts O
than O
SP B
- I
1 I
peptide I
in O
experiments O
using O
radiolabeled O
peptides O
. O

Apoptosis O
triggered O
through O
Fas B
and O
F B
/ I
F I
was O
inhibited O
by O
coexpression O
of O
CrmA B
and O
p35 B
, O
but O
not O
Bcl B
- I
xL I
. O

Apoptosis O
triggered O
through O
Fas B
and O
F B
/ I
F I
was O
inhibited O
by O
coexpression O
of O
CrmA B
and O
p35 B
, O
but O
not O
Bcl B
- I
xL I
. O

We O
identified O
two O
potential O
phosphorylation O
sites O
at O
serine49 O
and O
serine133 O
, O
both O
of O
which O
seem O
to O
be O
necessary O
for O
Myf B
- I
5 I
activity O
. O

We O
constructed O
a O
series O
of O
chimeric O
genes O
containing O
part O
of O
the O
first O
exon O
and O
increasingly O
longer O
5 O
' O
flanking O
sequences O
of O
the O
ODC B
gene I
fused O
to O
either O
bacterial B
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
or O
luciferase B
reporter I
genes I
. O

We O
constructed O
a O
series O
of O
chimeric O
genes O
containing O
part O
of O
the O
first O
exon O
and O
increasingly O
longer O
5 O
' O
flanking O
sequences O
of O
the O
ODC B
gene I
fused O
to O
either O
bacterial B
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
or O
luciferase B
reporter I
genes I
. O

The O
gene O
encoding O
the O
Neisseria B
lactamica I
III I
DNA I
methyltransferase I
( O
M B
. I
NlaIII I
) O
which O
recognizes O
the O
sequence O
CATG O
has O
been O
cloned O
and O
expressed O
in O
Escherichia O
coli O
. O

This O
latter O
complex O
reacts O
with O
an O
antibody O
to O
serum B
response I
factor I
( O
SRF B
) O
and O
exhibits O
the O
same O
binding O
characteristics O
as O
purified O
SRF B
. O

In O
several O
steps O
we O
converted O
the O
retinoid O
specific O
response O
element O
of O
the O
human B
retinoic I
acid I
receptor I
beta I
promoter I
into O
the O
vitamin O
D O
/ O
retinoic O
acid O
response O
element O
of O
the O
human B
osteocalcin I
promoter I
. O

Two O
of O
the O
proteins O
UPRF B
- I
1 I
and O
UPRF B
- I
2 I
( O
which O
is O
apparently O
a O
proteolytic O
degradation O
product O
of O
UPRF B
- I
1 I
) O
bind O
inefficiently O
to O
mutant O
versions O
of O
the O
UPR O
that O
are O
unable O
to O
confer O
responsiveness O
to O
unfolded O
proteins O
to O
the O
( O
CYC1 B
) O
promoter O
. O

Two O
of O
the O
proteins O
UPRF B
- I
1 I
and O
UPRF B
- I
2 I
( O
which O
is O
apparently O
a O
proteolytic O
degradation O
product O
of O
UPRF B
- I
1 I
) O
bind O
inefficiently O
to O
mutant O
versions O
of O
the O
UPR O
that O
are O
unable O
to O
confer O
responsiveness O
to O
unfolded O
proteins O
to O
the O
( O
CYC1 B
) O
promoter O
. O

Two O
of O
the O
proteins O
UPRF B
- I
1 I
and O
UPRF B
- I
2 I
( O
which O
is O
apparently O
a O
proteolytic O
degradation O
product O
of O
UPRF B
- I
1 I
) O
bind O
inefficiently O
to O
mutant O
versions O
of O
the O
UPR O
that O
are O
unable O
to O
confer O
responsiveness O
to O
unfolded O
proteins O
to O
the O
( O
CYC1 B
) O
promoter O
. O

Upstream B
stimulatory I
factor I
USF B
is O
a O
human O
transcriptional O
activation O
factor O
, O
which O
uses O
a O
basic O
/ O
helix O
- O
loop O
- O
helix O
/ O
leucin O
zipper O
( O
b O
/ O
HLH O
/ O
Z O
) O
motif O
to O
homodimerize O
and O
recognize O
specific O
sequences O
in O
the O
promoter O
region O
of O
both O
nuclear O
and O
viral O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

Upstream B
stimulatory I
factor I
USF B
is O
a O
human O
transcriptional O
activation O
factor O
, O
which O
uses O
a O
basic O
/ O
helix O
- O
loop O
- O
helix O
/ O
leucin O
zipper O
( O
b O
/ O
HLH O
/ O
Z O
) O
motif O
to O
homodimerize O
and O
recognize O
specific O
sequences O
in O
the O
promoter O
region O
of O
both O
nuclear O
and O
viral O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

DNA O
sequence O
of O
the O
UL6 B
to O
UL20 B
genes I
of O
infectious O
laryngotracheitis O
virus O
and O
characterization O
of O
the O
UL10 B
gene I
product I
as O
a O
nonglycosylated O
and O
nonessential O
virion O
protein O
. O

Only O
the O
27 O
- O
kDa O
protein O
was O
detected O
after O
N B
- I
glycosidase I
treatment O
, O
indicating O
that O
PLP B
- I
H I
is O
a O
glycoprotein O
. O

Only O
the O
27 O
- O
kDa O
protein O
was O
detected O
after O
N B
- I
glycosidase I
treatment O
, O
indicating O
that O
PLP B
- I
H I
is O
a O
glycoprotein O
. O

These O
results O
demonstrate O
that O
GGTase B
- I
I I
inhibitors O
arrest O
cells O
in O
G0 O
/ O
G1 O
and O
induce O
accumulation O
of O
p21WAF B
in O
a O
p53 B
- O
independent O
manner O
and O
that O
FTase B
inhibitors O
can O
interfere O
with O
cell O
cycle O
events O
by O
a O
mechanism O
that O
involves O
neither O
p21WAF B
nor O
p27KIP B
. O

In O
those O
patients O
who O
before O
transplantation O
were O
serological O
negative O
for O
CMV O
but O
had O
received O
organs O
from O
CMV B
- I
IgG I
positive O
donors O
, O
the O
incidence O
of O
the O
disease O
was O
highest O
. O

We O
compared O
retrospectively O
the O
efficacy O
of O
granulocyte B
colony I
stimulating I
factor I
( O
G B
- I
CSF I
) O
alone O
with O
chemotherapy O
plus O
G B
- I
CSF I
in O
mobilizing O
CD34 B
- O
positive O
cells O
in O
patients O
with O
malignant O
lymphoma O
. O

We O
compared O
retrospectively O
the O
efficacy O
of O
granulocyte B
colony I
stimulating I
factor I
( O
G B
- I
CSF I
) O
alone O
with O
chemotherapy O
plus O
G B
- I
CSF I
in O
mobilizing O
CD34 B
- O
positive O
cells O
in O
patients O
with O
malignant O
lymphoma O
. O

We O
now O
show O
that O
purified O
recombinant O
c B
- I
sis I
/ O
PDGF B
can O
induce O
this O
binding O
activity O
which O
we O
have O
termed O
SIF B
, O
for O
sis B
- I
inducible I
factor I
. O

Binding O
of O
ZAP B
- I
70 I
to O
phospho O
- O
TAMs O
is O
notable O
for O
the O
high O
level O
of O
cooperativity O
between O
the O
two O
SH2 B
domains I
, O
which O
individually O
demonstrate O
low O
affinity O
interaction O
with O
the O
ligand O
. O

The O
leader O
peptide O
was O
hypothesized O
to O
inhibit O
ribosome O
release O
at O
the O
tnaC B
stop I
codon I
, O
thereby O
blocking O
Rho B
' O
s O
access O
to O
the O
transcript O
. O

The O
PEP4 B
gene I
was O
isolated O
from O
a O
genomic O
DNA O
library O
by O
complementation O
of O
the O
pep4 B
- I
3 I
mutation O
. O

Mapping O
of O
the O
region O
in O
KAP B
- I
1 I
required O
for O
HP1 B
interaction O
showed O
that O
amino O
acid O
substitutions O
which O
abolish O
HP1 B
binding O
in O
vitro O
reduce O
KAP B
- I
1 I
mediated O
repression O
in O
vivo O
. O

Mapping O
of O
the O
region O
in O
KAP B
- I
1 I
required O
for O
HP1 B
interaction O
showed O
that O
amino O
acid O
substitutions O
which O
abolish O
HP1 B
binding O
in O
vitro O
reduce O
KAP B
- I
1 I
mediated O
repression O
in O
vivo O
. O

METHODS O
: O
Levels O
of O
sIL B
- I
2R I
were O
measured O
simultaneously O
in O
plasma O
and O
pleural O
fluid O
in O
111 O
patients O
with O
pleural O
effusions O
of O
unknown O
causes O
. O

The O
receptor O
for O
CSF B
- I
1 I
, O
c B
- I
Fms I
, O
is O
expressed O
in O
osteoclasts O
, O
possesses O
intrinsic O
tyrosine B
- I
kinase I
activity O
, O
and O
signals O
via O
rapid O
phosphorylation O
of O
selected O
proteins O
. O

The O
receptor O
for O
CSF B
- I
1 I
, O
c B
- I
Fms I
, O
is O
expressed O
in O
osteoclasts O
, O
possesses O
intrinsic O
tyrosine B
- I
kinase I
activity O
, O
and O
signals O
via O
rapid O
phosphorylation O
of O
selected O
proteins O
. O

The O
receptor O
for O
CSF B
- I
1 I
, O
c B
- I
Fms I
, O
is O
expressed O
in O
osteoclasts O
, O
possesses O
intrinsic O
tyrosine B
- I
kinase I
activity O
, O
and O
signals O
via O
rapid O
phosphorylation O
of O
selected O
proteins O
. O

The O
existence O
of O
a O
TFIIIB B
assembly O
pathway O
leading O
to O
the O
faithful O
transcription O
of O
natural O
eukaryotic O
tRNA O
genes O
in O
the O
absence O
of O
TFIIIC B
provides O
novel O
insights O
into O
the O
functional O
flexibility O
of O
the O
eukaryotic O
tRNA O
gene O
transcription O
machinery O
and O
on O
its O
evolution O
from O
an O
ancestral O
RNA B
polymerase I
III I
system O
relying O
on O
upstream O
, O
TATA O
- O
centered O
control O
elements O
. O

Ectopic O
Xbra B
can O
induce O
Xegr B
- I
1 I
transcription O
by O
an O
indirect O
mechanism O
that O
appears O
to O
operate O
via O
primary O
activation O
of O
fibroblast B
growth I
factor I
secretion O
. O

Ectopic O
Xbra B
can O
induce O
Xegr B
- I
1 I
transcription O
by O
an O
indirect O
mechanism O
that O
appears O
to O
operate O
via O
primary O
activation O
of O
fibroblast B
growth I
factor I
secretion O
. O

Here O
we O
investigate O
the O
mechanism O
of O
TPA O
induction O
of O
FGF B
- I
BP I
gene O
expression O
in O
the O
human O
ME O
- O
180 O
SCC O
cell O
line O
. O

The O
MIC90 O
of O
ABK O
against O
coagulase B
type I
IV I
strains O
was O
rather O
high O
, O
12 O
. O
5 O
micrograms O
/ O
ml O
. O

These O
results O
demonstrate O
that O
m2 B
receptors I
couple O
to O
both O
G B
alpha I
i2 I
and O
G B
alpha I
i3 I
in O
vivo O
and O
that O
this O
interaction O
is O
integral O
to O
both O
positive O
and O
negative O
regulatory O
pathways O
leading O
to O
activation O
of O
PLC B
and O
desensitization O
of O
receptor O
signaling O
. O

These O
results O
demonstrate O
that O
m2 B
receptors I
couple O
to O
both O
G B
alpha I
i2 I
and O
G B
alpha I
i3 I
in O
vivo O
and O
that O
this O
interaction O
is O
integral O
to O
both O
positive O
and O
negative O
regulatory O
pathways O
leading O
to O
activation O
of O
PLC B
and O
desensitization O
of O
receptor O
signaling O
. O

HC B
- I
toxin I
exerts O
a O
potent O
cytostatic O
effect O
on O
plant O
and O
animal O
cells O
by O
inhibiting O
histone B
deacetylase I
. O

